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ABSTRACT
This thesis describes the identification and characterisation of genes important in 
development of the pharyngeal apparatus and heart, the major structures affected in 
DiGeorge syndrome (DOS). DOS is characterised by craniofacial, cardiovascular, 
thymus and parathyroid defects. It is most commonly caused by heterozygous deletion 
of a 3Mb region of chromosome 22ql 1 encompassing at least 30 genes. 
Haploinsufficiency of the TBXl transcription factor is considered to be the major 
underlying cause of this syndrome. Animal models of DiGeorge syndrome have 
demonstrated the importance of Tbxl in pharyngeal and heart development and 
therefore, identifying the downstream targets of Tbxl is of vital importance in 
understanding the development of these systems.
This project was aimed at identifying cell autonomous effects of Tbxl by isolating 
Tbxl-lacZ expressing cells and comparing the gene expression profiles of Tbxl null and 
heterozygous cells by microarray analysis. Validation of the downregulated gene, Hesl 
has been further investigated by the characterisation of pharyngeal and heart defects in 
mice carrying null alleles of this potential Tbxl target. In addition, BAG 
recombineering was also conducted to generate a transgenic mouse carrying a GFP- 
labelled, reversible, mutant Tbxl allele. This modified Tbxl allele should provide the 
basis for further enrichment of Tbxl targets by allowing isolation of 716x7-expressing 
cells from transgenic mice and subsequent restoration of Tbxl function by cre-mediated 
recombination. Furthermore, in order to identify other pathways important in heart 
development, DGS patients with atypical chromosome rearrangements were analysed. 
This approach led to the identification of a potentially disrupted gene, H1C2, whose 
function was analysed using gene trap mouse models and which was shown to play a 
role in heart development.
Overall these experiments have led to the elucidation of novel genes and genetic 
pathways affected in DGS and have contributed to a better understanding of the 
mechanisms controlling morphogenesis of the pharyngeal apparatus and heart.
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CHAPTER 1. INTRODUCTION
1.1 DIGEORGE SYNDROME
DiGeorge syndrome (DGS) is most frequently caused by a 3Mb heterozygous deletion 
of chromosome 22ql 1, and represents the most common microdeletion in humans, 
occurring at a frequency of approximately 1 in 4000 births (Scambler, 2000). DGS, 
Velocardiofacial syndrome (VCFS) and Conotruncal Anomaly Face Syndrome 
(CTAFS) represent different clinical manifestations of the same genetic deletion and 
together are referred to as the 22ql 1 Deletion syndromes (22ql IDS) (Scambler, 2000). 
DGS is one of the most clinically variable syndromes and over 180 symptoms have 
been associated with the deletion (Robin and Shprintzen, 2005). However, the major 
features of DGS can be attributed to aberrant development of the pharyngeal apparatus 
which results in craniofacial anomalies, thymus and parathyroid gland hypo/aplasia and 
cardiovascular defects which mainly affect the outflow tract (OFT) and derivatives of 
the pharyngeal arch arteries (PAA). Patients also exhibit other physical malformations 
including renal and skeletal defects and often display behavioural problems ranging 
from cognitive deficits and learning difficulties to pyschiatric disorders such as 
schizophrenia (Scambler, 2000). Most patients with DGS (~ 90%) have the common 
3Mb, 22ql 1 deletion encompassing approximately 30 genes. Another 8% have a 
smaller, 1.5Mb nested deletion and some DGS patients have rare, atypical deletions of 
chromosome 22ql 1 (Carlson et al., 1997; Morrow et al., 1995). However, the size of 
the deletion does not correlate with the penetrance or severity of the disease. DGS may 
be a contiguous gene syndrome in which more than one gene contributes to the 
phenotype.
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1.2 THE PHARYNGEAL APPARATUS
Many of the structures affected in DGS derive from the pharyngeal apparatus, an 
important, transient structure in vertebrates functioning in feeding and respiration and 
also in the formation of the heart, thyroid, parathyroid and thymus (Graham, 2003).
The pharyngeal apparatus is apparent as a series of paired bulges in vertebrate embryos. 
These bulges form on the lateral surface of the head in a cranial to caudal manner and 
are separated externally by ectodermal clefts and internally by endodermal pouches 
(Figure 1.1). In amniotes, 5 pharyngeal arches form, numbered 1, 2, 3, 4 and 6, 
separated by 4 pouches. Each pharygeal arch is composed of a number of embryonic 
cell types; the outer ectoderm, inner endoderm and, within each arch, a group of neural 
crest (NC) cells that surround the mesoderm. In addition, each pharyngeal arch 
surrounds an aortic arch artery (Figure 1.1). The complex interactions between these 
different cell types are carefully co-ordinated for development to occur normally and 
each cell type contributes to a different tissue of the pharynx. The ectoderm forms the 
epidermis and sensory neurons of the pharynx, the endoderm forms the internal 
epithelial lining and endocrine glands (parathyroid, thyroid and thymus) while the 
mesoderm gives rise to the endothelial cells and musculature of the arch arteries. The 
NC forms the connective and skeletal tissues of the arches (Graham, 2003).
While the pharyngeal arches may appear to be organised in the same manner, each arch 
forms distinct derivatives. The most anterior arch, pharyngeal arch one develops into 
the jaw. Pharyngeal arch two develops into the hyoid apparatus. The more posterior 
arches form the pharynx in birds and mammals (Graham, 2003). The distinct identity of 
each arch is evident molecularly by the spatially restricted expression of genes within 
the arches (Muller et al., 1996; Wall and Hogan, 1995). For example, Hoxa2 is only 
expressed in the pharyngeal arches up to arch 2 whereas HoxaS has a rostral boundary 
at the level of pharyngeal arch three. In addition, each pharyngeal arch is polarised; 
Bmp7 is normally expressed only in the rostral half of each pouch whereas Fgf8 is 
expressed in the caudal region (Wall and Hogan, 1995).
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Figure 1.1 . The phary ngeal apparatus
(A) Lateral view of a mouse embryo. (B) Frontal view of the pharyngeal apparatus. The 
pharyngeal apparatus is a transient structure in vertebrates which arises as a series of 
paired bulges on the lateral surface of the head (A) separated by pharyngeal pouches 
internally (arrows) and pharyngeal arches externally. The outer ectoderm (green) gives 
rise to the epidermis and sensory neurons of the pharynx and the endoderm (blue) forms 
the epithelial lining of the pharynx and endocrine glands. The neural crest (red) forms 
skeletal and connective tissue and the mesoderm (yellow) gives rise to the endothelial 
cells and musculature of the arch arteries. In addition each arch has a unique identity 
and forms distinct head structures. Abbreviations: A, anterior, P, posterior (Lindsay, 
2001).
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1.2.1 The role of the neural crest
Until recently the NC cell population was considered to play the most important role in 
patterning the pharyngeal arches. The NC is a multipotential cell population which 
forms at the border between the neural plate and surface ectoderm (Basch and Bronner- 
Fraser, 2006). It delaminates from the dorsal neural tube, migrates throughout the body 
and differentiates into multiple cells types (Graham, 2003). NC can be divided into 2 
subpopulations; the cranial neural crest and the trunk neural crest. The cranial NC 
originate from the mid-diencephalon to somite 5, segregating into three distinct streams. 
These are the trigeminal, hyoid and post-otic streams each of which gives rise to 
discrete structures (Graham et al., 2004). The trigeminal neural crest arises from the 
midbrain and rhombomeres one and two and forms part of the trigeminal ganglion and 
skeletal elements of the lower and upper jaw (Lumsden et al., 1991; Schilling and 
Kimmel, 1994). The hyoid stream arises from rhombomere four and gives rise to the 
hyoid skeleton, part of the second pharyngeal arch and the proximal facial ganglion 
neurons (Lumsden et al., 1991; Schilling and Kimmel, 1994). Finally, the post-otic 
stream or cardiac neural crest (CNC) arises from rhombomeres six, seven and eight in 
the hindbrain (to the level of somite three) and migrates through pharyngeal arches 
three, four and six to form proximal and jugular ganglia neurons and skeletal elements 
of the caudal arches. These cell also contribute to the aorticopulmonary septum, the 
pharyngeal-derived endocrine glands and the tunica media of the persisting arch arteries 
(Bockman and Kirby, 1984; Kirby et al., 1983; Le Lievre and Le Douarin, 1975; 
Lumsden et al., 1991; Schilling and Kimmel, 1994).
Due to their segregation and contribution to the structure of the pharyngeal arches, NC 
cells were thought to play a major role in pharyngeal morphogenesis. This theory was 
originally supported by experiments in which neural crest from the first arch was 
grafted in place of second arch neural crest and resulted in derivatives of a distinctly 
pharyngeal arch one phenotype ie. skeletal elements of the jaw (Noden, 1983).
However, subsequent studies showed that when the neural tube was ablated before 
neural crest could form, the pharyngeal arches still developed normally and had identity 
as evidenced by the expression of regionally-restricted pharyngeal arch markers Bmp7, 
FgfS, Paxl and Shh (Gavalas et al., 2001; Veitch et al., 1999). Thus it became apparent 
that the neural crest was not the sole source of patterning signals and other pharyngeal 
arch tissues may play a more important role in patterning and segmentation.
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The neural crest may not be as important for patterning the pharyngeal apparatus as 
once thought. However, it does not act entirely passively in this process. Through the 
restricted expression of transcription factors, regionalised neural crest is able to 
modulate its response to the endoderm. For example, Hox genes, as well as being 
regionally restricted in the pharyngeal endoderm, are also regionally restricted within 
the pharyngeal neural crest streams. The first arch does not express any Hox genes, 
Hoxa2 is normally restricted to the neural crest within pharyngeal arch two and HoxaS, 
HoxbS and HoxdS are expressed only within arch three (Hunt et al., 1991). However, 
when Hoxa2 is ectopically expressed within arch one, normal jaw development is 
repressed and pharyngeal arch two skeletal elements form instead (Grammatopoulos et 
al., 2000; Pasqualetti et al., 2000). In addition, the ability of neural crest to form 
distinct skeletal structures in response to pharyngeal endoderm cues is species-specific. 
Grafting experiments between duck and quail demonstrate that when neural crest from 
pharyngeal arch one is transferred to another species, the resulting neural crest 
derivatives are always donor-specific in shape (Tucker and Lumsden, 2004).
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1.2.2 The role of the endoderm in patterning the pharyngeal apparatus
The endoderm displays regionalised Hox gene expression and is required for formation 
of epibranchial placodes within the adjacent head mesenchyme (Begbie et ah, 1999; 
Manley and Capecchi, 1995). In fact, a segmented pharyngeal endoderm appears to 
have evolved prior to neural crest since it is present in all chordates (Mahadevan et al., 
2004). In amphioxus, an organism which represents the last common invertebrate 
ancestor of the vertebrates, pharyngeal pouches display regionalised gene expression 
(Holland and Holland 1996). Subsequent reports have now shown that neural crest 
depends on signals from the endoderm for identity, survival and differentiation which is 
carried out in part by Fg/*signalling (Couly et al., 2002; Crump et al., 2004; David et al., 
2002; Nissen et al., 2003; Ruhin et al., 2003; Trumpp et al., 1999; Walshe and Mason, 
2003). Transplantation experiments in chick and zebrafish show that pharyngeal 
endoderm is sufficient and necessary for correct formation and orientation of neural 
crest derived skeletal elements (Couly et al., 2002; David et al., 2002; Ruhin et al., 
2003). In the zebrafish mutant, vgo, the pharyngeal arches are not segmented properly. 
The endodermal pouches fail to form, while neural crest migration is initially normal. 
This defect is rescued by implantation of wild type pharyngeal endoderm, implying that 
the endoderm may function in patterning the arches (Piotrowski and Nusslein-Volhard, 
2000). This finding was not surprising considering that previous experiments had 
indicated the potential importance of the endoderm in patterning.
Anterior-posterior patterning of the pharyngeal endoderm requires pathways involving 
retinoic acid (RA), particularly for formation of the caudal arches and pouches. RA 
levels are controlled by RA-synthesizing enzymes which include retinaldeyhyde 
dehydrogenases (Raldhl-4) and RA-metabolising enzymes (Cytochrome P450 
enzymes, Cyp26al, bl and cl). The effects of RA are mediated through RA receptors 
(RARa, p and y) and retinoid X receptors (RXRa, p and y) which bind as heterodimers 
to RA-response elements in target genes (Mark et al., 2004). Alterations in RA 
homeostasis by disrupting RA-synthesizing enzymes such as Raldh2 in the pharyngeal 
mesoderm (Kopinke et al., 2006; Niederreither et al., 2003; Vermot et al., 2003) or the 
vitamin A forming enzyme, bcox in zebrafish (Lampert et al., 2003) lead to aplasia of 
the arches caudal to pharyngeal arch 2 and the same defects are seen when RA-receptor 
function is disrupted (Dupe et al., 1999; Wendling et al., 2000). The endoderm is 
primarily affected, exhibiting downregulation of specific markers such as Hoxal,
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Hoxbl, and Pax9 which are required for endodermal patterning (Wendling et al., 2000). 
A similar phenotype occurs in the presence of excess RA when the Cyp26 RA- 
metabolising enzymes are disrupted (Roberts et al., 2006).
In conclusion, the patterning of the pharyngeal apparatus is now considered to be due to 
a consensual process that involves interactions between all cell types of the pharyngeal 
apparatus and the genes involved in the aetiology of DGS are likely to play a part in this 
process.
1.3 HEART DEVELOPMENT
Congenital heart defects presented by DGS patients often involve abnormalities of the 
OFT or great vessels of the heart. Defects in OFT septation and alignment result in 
heart malformations including common arterial trunk and tetralogy of Fallot, a complex 
heart defect consisting of an overriding aorta, pulmonary stenosis, ventricular septal 
defect and right ventricular hypertrophy. Great vessel defects in DGS patients mainly 
involve derivatives of the fourth PAA and thus, the most common anomalies are 
aberrant origin of the right subclavian artery and interrupted aortic arch type B (Figure 
1.3) (Robin and Shprintzen, 2005; Sullivan, 2004).
1.3.1 An overview of heart development
The heart forms from a set of mesodermal cells which emerge from the primitive streak 
during gastrulation (Garcia-Martinez and Schoenwolf, 1993; Tam et al., 1997). These 
cells migrate in an anterior-lateral direction to a position under the head folds where 
they form a crescent shape in which the apex lies toward the anterior end and the lateral 
arms extend caudally which in mice occurs at ~ E7.75 (Figure 1.2A). At approximately 
E8.0, cells within the cardiac crescent move ventrally and fuse to form a primitive heart 
tube composed of endothelial cells surrounded by a layer of myocardial cells (Figure 
1.23). The heart first begins to beat at this timepoint and blood flows from the caudal, 
inflow regions in an anterior direction and out through the arterial OFT (Buckingham et 
al., 2005). The heart grows through myocardial proliferation and the addition of cells to 
the arterial and venous poles. It undergoes looping in which the heart tube swings to the 
right and the inflow regions move dorsally and anteriorly, to a position adjacent to the 
OFT (Buckingham et al., 2005) (Figure 1.2C). During looping, the chambers of the
24
heart form by ballooning out from the heart tube at discrete positions. From the end of 
looping, the heart undergoes extensive remodelling in which myocardial trabeculae 
develop within the lumen of the ventricles and the outer layer of the ventricles thickens 
to form the compact layer (Figure 1.2D) (Christoffels et al., 2000). Myocardial cells 
within the left and right ventricles contribute to formation of an interventricular septum 
(Franco et al., 2006). Endocardial cushions develop within the atrioventricular canal 
(AVC), forming precursors of the mitral and tricuspid valves. Endocardial cushions 
also form within the OFT as precursors of the aortic and pulmonary valves and 
aorticopulmonary (AP) septum which separates the aorta from the pulmonary artery 
(Markwald et al., 1977; Markwald et al., 1975; Nakajima et al., 2000). Further 
remodelling of the heart results in the correct alignment of the septa, and valves to form 
the mammalian four chambered heart (Dunwoodie, 2007).
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Figure 1.2 An overview of heart development
The top picture is a ventral view of the heart and the bottom picture represents 
transverse (A, B) and frontal (C, D) sections of the heart. (A) Mesodermal precursors of 
the heart emerge from the primitive streak and form in a crescent shape at a position just 
under the head folds. (B). These precursor cells move ventrally and fuse to form a 
primitve heart tube. (C) Between E8.5 and E l0.5, the heart tube elongates and 
undergoes rightward looping. The chambers of the heart begin to balloon out from the 
heart tube. (D) During heart remodelling, myocardial trabeculae form within the 
ventricles, endocardial cushions from within the OFT and AVC as precursors to cardiac 
valves and septa and an interatrial and interventricular septum develops. Abbreviations: 
avc, atrioventricular canal; avs, atrioventricular septum; ca common atrium; cc, cardiac 
crescent; co, coelum; dm, dorsal mesocardium; dp, dorsal pericardium; e, endocardium; 
ec, endocardial cushion; fe, foregut endoderm; fg, foregut; hm, head mesoderm; ias, 
interatrial septum; ivs, interventricular septum; la, left atrium; Iv, left ventricle; m, 
myocardium; ne, neural epithelium; oft, outflow tract; ra, right atrium; rv, right 
ventricle; som, somatic mesoderm; spm, splanchnic mesoderm; tr, trabeculae. (Stennard 
and Harvey, 2005)
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During the looping and remodelling of the heart, the pharyngeal arch arteries play a role 
in formation of the great vessels. The arch arteries form sequentially and are initially a 
series of bilateral vessels which pass through each pharyngeal arch and connect the 
heart tube to the dorsal aortae via the aortic sac (Figure 1.3 A). Throughout 
development, the arteries of pharyngeal arches one and two regress to form capillary 
beds. The more caudal arch arteries, three, four and six remodel to form part of the 
common carotid arteries, aortic arch, right subclavian artery and ductus arteriosus 
(Kirby and Waldo, 1995) (Figure 1.3B).
Figure 1.3 Formation of the great vessels of the heart
(A) At E l0.5, PAAs 3 (green), 4 (red and purple) and 6 (blue) form as three pairs of 
symmetrical vessels connecting the heart to the dorsal aorta. NC cells which delaminate 
from the neural tube also contribute to the formation of the arch arteries. (B) The origins 
of great vessels of the mature heart which arise from the aortic arch arteries. Orange 
vessels represent the seventh intersegmental arteries and their derivatives.
Abbreviations: AoA, aortic arch; DA, ductus arteriosus; L, left; LCC, left common 
carotid; LSCA, left subclavian artery; NC, neural crest; NT, neural tube; PA, pulmonary 
artery; PAA, pharyngeal arch artery; R, right; RCC, right common carotid; RSCA, right 
subclavian artery. (Modified from (Yamagishi and Srivastava, 2003)).
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1.3.2 The heart fields
It has recently become apparent that the heart forms from two sources of myocardial 
cells. Early studies in chick and mouse show that cells are progressively added to the 
arterial and venous poles of the heart during development (de la Cruz et al., 1977; 
Stalsberg and DeHaan, 1969; Viragh and Challice, 1973). However, the origin of these 
cells has only recently been discovered. The cardiac crescent which was originally 
thought to give rise to the entire heart, is now considered to mainly represent cells of the 
first heart field (FHF) which forms the primitive heart tube and mainly gives rise to the 
left ventricle, parts of the atria and some of the right ventricle (Meilhac et al., 2004; 
Zaffran et al., 2004). The second heart field (SHF) consists of mesodermal cells which 
initially lie dorsal and medial to the cardiac crescent and then later dorsal to the heart 
tube, and contributes the majority of cells to the OFT, right ventricle (RV) and also to 
parts of the atria (Figure 1.4) (Cai et al., 2003a; Kelly et al., 2001; Meilhac et al., 2004; 
Mjaatvedt et al., 2001; Verzi et al., 2005; Waldo et al., 2001; Zaffran et al., 2004).
Figure 1.4 Heart fields in the mouse embryo
At E7.5, the first heart field (FHF) (red) is positioned just under the head folds within 
the cardiac crescent. The second heart field (SHF) (green) is positioned more dorsal and 
medial to the cardiac crescent. At E8.0, the FHF contributes cells to the primitive heart 
tube and the SHF is contained within pharyngeal and splanchnic mesoderm. SHF 
precursors contribute cells to the arterial and venous poles of the elongating heart tube 
from E8.5 to E l0.5. Myocardial cells derived from the FHF give rise to the left 
ventricle, the atria and part of the right ventricle. The SHF mainly gives rise to the 
outflow tract, right ventricle and parts of the atria. Abbreviations: PA, primitive atria; 
PhA, pharyngeal arches; LA, left atrium; LV, left ventricle; OFT, outflow tract; RA, 
right atrium; RV, right ventricle. (Buckingham et al., 2005)
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The identification of the two heart fields was established initially through tissue ablation 
and cell lineage analysis in chick which revealed that the pharyngeal mesoderm forms a 
second source of myocardial cells which contribute to the OFT (Mjaatvedt et al., 2001; 
Waldo et al., 2001). Recent studies have also indicated that these cells contribute to 
smooth muscle at the arterial pole of the heart and to the right ventricle (Rana et al., 
2007; Waldo et al., 2005b). In the mouse, the random integration of a lacZ reporter 
transgene upstream of the FgflO locus showed that cells initially medial to the cardiac 
crescent and later contained within the pharyngeal mesoderm and splanchnic mesoderm 
contribute to the OFT and RV of the heart (Kelly et al., 2001 ; Kitamoto et al., 2005).
Dil labelling studies confirmed these results and also showed that the primitive heart 
tube mainly exhibits left ventricular identity (Zaffran et al., 2004). In addition, Cai et al 
(2003) showed that Isll marks a more extensive SHF domain which also contributes 
cells to the venous pole of the heart (Cai et al., 2003a).
The existence of two heart fields was further supported by retrospective clonal analysis 
which was used to investigate the contribution of precursor cells to different regions of 
the heart through analysis of clonal descendents from single cells (Meilhac et al., 2004). 
This study revealed that two lineages contribute to the heart, probably arising from a 
common progenitor pool of approximately 140 myocardial founder cells which 
segregates just prior to formation of the cardiac crescent. The first lineage contributes 
cells to both ventricles, atria and the AVC, whereas the second lineage contributes cells 
to the OFT, RV, both atria and the AVC (Meilhac et al., 2004) corresponding to Isll- 
expressing SHF precursors (Cai et al., 2003a). Thus, the first and second lineages can 
be distinguished by their contribution to the left ventricle and OFT, respectively 
(Meilhac et al., 2004).
These studies demonstrated that the two heart fields make distinct regionalised 
contributions to the heart. While there is some controversy over how extensively the 
SHF contributes to the heart, it is clear that the SHF is molecularly distinct and recent 
studies have begun to elucidate the transcriptional pathways underlying SHF 
development.
Isll has been proposed to be central to regulation of SHF development. IsU'^' mutants 
exhibit severe heart defects in which the heart tube fails to undergo looping and consists 
only of a primitive left ventricle and atrium, consistent with its important role in
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proliferation and survival of SHF precursors (Cai et al., 2003a). Gene knockouts, cell 
lineage tracing, expression analyses and in vitro promoter analyses have identified 
transcription factors {Mef2c, Nkx2.5, Foxhl, Foxcl, Foxc2, Gata4, Smydl, Hand2,
Tbxl, Pitx2c) and signalling molecules {Shh, Fgf8, FgflO, Bmp4, BmpT) which function 
in SHF development (Abu-Issa et al., 2002; Ai et al., 2006; Cai et al., 2003a; Dodou et 
al., 2004; Frank et al., 2002; Gottlieb et al., 2002; Ilagan et al., 2006; Jerome and 
Papaioannou, 2001; Kelly et al., 2001; Kume et al., 2001; Lin et al., 2006; Lin et al., 
1997; Lindsay et al., 2001; Merscher et al., 2001; Park et al., 2006; Seo and Kume,
2006; Srivastava et al., 1997; Verzi et al., 2005; von Both et al., 2004; Washington 
Smoak et al., 2005). These studies have also led to a putative transcriptional network 
governing SHF development in which combinatorial signalling and reinforcing 
regulatory feedback loops may play an important role (Figure 1.5) (Black, 2007; Xu and 
Baldini, 2007).
Figure 1.5 A putative transcriptional network governing SHF development
Isll plays a key role in SHF development and functions together with other transcription 
factors to regulate development of SHF derivatives, in particular the outflow tract and 
right ventricle of the heart. (Modified from (Xu and Baldini, 2007))
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1.3.3 The cardiac neural crest
In addition to the heart fields, the cardiac neural crest (CNC) also contributes 
substantially to development of the heart, specifically in OFT and pharyngeal arch 
artery development. The CNC refers to the neural crest which originates from the level 
of the otic placode to somite three (Figure 1.6) (Kirby and Waldo, 1995). CNC cells 
from this region migrate through pharyngeal arches three, four and six and contribute to 
the smooth muscle of the arch arteries and the connective tissue of the thymus, 
parathyroid and thyroid glands (Figure 1.6) (Bockman and Kirby, 1984; Le Lievre and 
Le Douarin, 1975). CNC is also important in aorticopulmonary septation (Kirby et al., 
1983). Quail-chick chimera experiments and cell lineage analyses in mice have 
demonstrated that CNC cells migrate into the endocardial cushions of the OFT and 
together with the aortic sac form the aorticopulmonary septation complex (Epstein et 
al., 2000; Gitler et al., 2003; Jiang et al., 2000; Li et al., 2000; Phillips et al., 1987). This 
complex participates in septation of the aorta and pulmonary artery through remodelling 
of the aortic sac and OFT and fusion of the endocardial cushions (Hutson and Kirby, 
2007; Waldo et al., 1998).
Figure 1.6 Cardiac neural crest
Cardiac neural crest (CNC) migrates from the neural tube at the level of the otic vesicle 
to somite 3, through pharyngeal arch arteries 3, 4 and 6 to the aorticopulmonary septum. 
The CNC contributes to the smooth muscle of the arch arteries and participates in 
septation of the aorta and pulmonary trunk. Abbreviations: Ao, aorta, P, pulmonary 
trunk; oto, otocyst; S, somite. (Hutson and Kirby, 2007).
31
Ablation of the neural crest leads to a phenocopy of DGS with pharyngeal arch artery 
defects (Bockman et ah, 1989; Bockman et al., 1987; Waldo et al., 1996), hypoplastic or 
aplastic thymus and parathyroid glands (Bockman and Kirby, 1984) and failure of the 
OFT to undergo septation resulting in persistent truncus arteriosus (PTA) (Nishibatake 
et al., 1987). Furthermore, NC ablation also affects addition of SHF-derived 
myocardium to the OFT causing abnormal cardiac looping and OFT alignment defects 
(Waldo et al., 2005a; Waldo et al., 2005b; Yelbuz et al., 2002). In these embryos, SHF 
cells over-proliferate and fail to migrate and differentiate into OFT myocardium. This 
defect was shown to be due to increased levels of Fgf8 within the pharynx and could be 
rescued by treating embryos with an FgfS antibody (Hutson et al., 2006). However, 
downregulating FgfS expression in sham-operated embryos also causes SHF defects 
indicating that precise levels of FgfS are required for normal OFT development (Hutson 
et al., 2006).
Genes which play important roles in CNC function have generally been identified 
through analysis of mouse models. Some of the genes which have been implicated in 
CNC migration, proliferation, survival and patterning include members of the TgfB 
superfamily {Bmprla, Alk2, Bmpr2, Msx2) (Delot et al., 2003; Kaartinen et al., 2004; 
Kwang et al., 2002; Stottmann et al., 2004), genes involved in Wnt signalling (Dvl2, 
WntJ, Wnt3a, Wnt5a, AFC) (Hamblet et al., 2002; Hasegawa et al., 2002; Ikeya et al., 
1997; Saint-Jeannet et al., 1997; Schleiffarth et al., 2007), Semaphorin signalling 
{SemaSc, PlexinA2, Npnl, PlexinDl) (Feiner et al., 2001; Gitler et al., 2004; Gu et al., 
2003; Kawasaki et al., 1999) Vegf signalling (VEGF165, Hifl-alpha) (Compemolle et 
al., 2003; Stalmans et al., 2003) and Fgf signalling (FgfS) (Abu-Issa et al., 2002; Frank 
et al., 2002; Macatee et al., 2003). These studies have demonstrated that CNC 
interactions with adjacent tissues such as the ectoderm, endoderm, SHF and 
myocardium play an important role in normal CNC development.
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1.4 MECHANISM OF DELETION
Chromosome 22ql 1 is highly susceptible to rearrangements and is associated with 
several disorders including DGS, cat eye syndrome (CES) and der(22) syndrome 
(Shaikh et al., 2001). CES patients have a supernumary, bisatellited chromosome 
22pter-ql 1 resulting from an inverted duplication of chromosome 22 (Mears et al.,
1994; Mears et al., 1995; Schinzel et al., 1981). Der(22) syndrome is associated with 
partial trisomy of chromosome 11 and 22 which can occur in offspring from carriers of 
the non-robertsonian, constitutional translocation t(l l;22)(q23;ql 1) (Fraccaro et al., 
1980; Zackai and Emanuel, 1980). However, the most common chromosome 22 
disorder is DGS in which the majority of patients (approx 90%) share a common 3 Mb 
deletion of chromosome 22ql 1, termed the typically deleted region (TDR) (Figure 1.7). 
A smaller proportion of DGS patients (approx 8%) have a nested 1.5Mb deletion within 
the TDR (Carlson et al., 1997; Morrow et al., 1995). Some patients with DGS have 
other rare, variant deletions of chromosome 22ql 1 (Amati et al., 1999; Carlson et al., 
1997; Levy et al., 1995; McQuade et al., 1999; Rauch et al., 1999; Saitta et al., 1999; 
Weksberg et al., 2006). The instability of chromosome 22 has been attributed to the 
presence of multiple, highly homologous low copy repeat (LCR) sequences which span 
the chromosome and act as substrates for aberrant recombination events (Edelmann et 
al., 1999a; Edelmann et al., 1999b; Saitta et al., 2004; Shaikh et al., 2000) (Figure 1.7, 
1.8 ).
Figure 1.7 Chromosome 22qll LCRs and deletions associated with DGS
Eight LCRs, LCR-A to H are contained within 22ql 1, which mediate aberrant 
recombination events resulting in deletions, duplications and translocations. Most 
patients with DGS have a 3 Mb deletion which occurs between LCR-A and D. Some 
patients have a smaller, 1.5Mb deletion which occurs between LCR-A and B. Unique 
markers and genes located within chromosome 22ql 1 are indicated in black. 
Abbreviations: Cen, centromere; Tel, telomere (Modified from (Shaikh et al., 2007)).
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LCRs consist of repeated modules which share high levels of sequence identity (97- 
98%) (Figure 1.8) (Edelmann et al., 1999a; Shaikh et al., 2000). There are at least eight 
LCRs located on chromosome 22ql 1, (LCR-A to LCR-H) with LCR-A being most 
centromeric (Edelmann et al., 1999a; Shaikh et al., 2000) (Figure 1.7). LCR-A and 
LCR-D, the largest and most complex of the LCRs, mediate the common 3Mb deletion 
and are also the sites of CES breakpoints (Edelmann et al., 1999b; McTaggart et al., 
1998; Shaikh et al., 2000). The distal breakpoint of the 1.5Mb DGS deletion and the 
t(l 1;22) translocation occurs within LCR-B (Figure 1.7) (Funke et al., 1999). In 
addition, the more distal LCRs, E to H, have been associated with DGS patients 
containing atypical chromosome 22 deletions (Rauch et al., 1999; Saitta et al., 1999; 
Shaikh et al., 2007). Rearrangements between LCRs on chromosome 22 have been 
proposed to occur due to aberrant inter and intrachromosomal homologous 
recombination events (Saitta et al., 2004; Shaikh et al., 2001). In comparison, the 
t(l 1 ;22) translocation is mediated by non-homologous recombination between A/T rich 
palindromes on chromosome 22ql 1 and 1 lq23 (Edelmann et al., 2001a; Kurahashi and 
Emanuel, 2001; Kurahashi et al., 2000). Other de novo translocations involving 
chromosome 22 also often occur within the 22ql 1 LCRs (Spiteri et al., 2003) 
demonstrating that LCRs are responsible for mediating many aberrant recombination 
events involving chromosome 22.
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Figure 1.8 LCR organisation
The arrangement of repeated modules within LCR-A to D. Each repeated module is 
represented by a different colour and the arrows represent the orientation of the module 
with respect to other copies within the same LCR or on a different LCR. Unique 
markers are represented in black at the ends of each LCR. (Modified from (Shaikh et 
al., 2000)).
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1.5 ANIMAL MODELS
The 3Mb heterozygous deletion of chromosome 22ql 1 encompasses at least 30 genes of 
which one or more are thought to underlie the main defects of the disorder (Lindsay, 
2001; Shaikh et al., 2000). However, determining the causative gene has proved to be 
difficult since the phenotype does not correlate with the size of the deletion and a 
number of DGS patients have non-overlapping deletions (Amati et al., 1999; McQuade 
et al., 1999; O'Donnell et al., 1997). Subsequently, studies have focused on animal 
models of the disease to try to determine which gene(s) is responsible.
1.5.1 D fl mouse
Most of the genes contained within the hemizygously deleted region on human 
chromosome 22ql 1 are conserved within a homologous, syntenic region of mouse 
chromosome 16B1, albeit in a slightly different order due to inversions (Figure 1.9,
Hira to ZdhhcS, purple genes) and other rearrangements during evolution (Botta et al., 
1997; Puech et al., 1997; Sutherland et al., 1998) (Figure 1.9). Researchers have taken 
advantage of this conservation by examining the phenotypic consequences of 
engineered deletions of chromosome 16.
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Figure 1.9 Human chromosome 22qll and the syntenic region of mouse 
chromosome 16
The 3Mb typical deletion (large grey box) on human chromosome 22ql 1 contains 
approximately 30 genes of which most are conserved in a syntenic region of mouse 
chromosome 16 although in a different order (as shown by the different coloured genes 
where each colour represent a block of contiguous genes). The smaller, 1.5Mb 22ql 1 
deletion (small grey box) is also shown as well as the Dfl deletion which models DGS 
in mice. Other engineered deletions of mouse chromosome 16 are shown in purple and 
green. The orange boxes represent LCRs on 22ql 1. (Modified from (Paylor and 
Lindsay, 2006)).
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Zy7/+ mice represent the first mouse model of DGS and were generated through Cre- 
loxP-mediated deletion of at least 22 genes (including Tbxl) within chromosome 16 
(Lindsay et al., 1999) (Figure 1.9). All Dfl/+  heterozygotes exhibit fourth pharyngeal 
arch artery hypo/aplasia at E l0.5 (Figure 1.1 CD) (Lindsay and Baldini, 2001; Lindsay et 
al., 1999; Taddei et al., 2001). Depending on the genetic background, a proportion of 
mutants recover from this defect during development (Lindsay and Baldini, 2001;
Taddei et al., 2001). At E l8.5, Dfl/+  heterozygotes exhibit great vessel defects such as 
interrupted aortic arch type B (lAA-B) and aberrant right subclavian artery, consistent 
with the earlier pharyngeal arch artery abnormalities (Figure 1.1 OD). Some D/1/+ 
mutants also exhibit tetralogy of Fallot-like defects including overriding aorta, 
pulmonary stenosis and VSD (Lindsay et al., 1999). In addition, Dfl/+  mice exhibit a 
neurobehavioural phenotype similar to DGS patients (Paylor et al., 2001). On certain 
backgrounds, D/1/+ mice have thymic and parathyroid hypoplasia (Taddei et al., 2001). 
Thus, these mutants represent a good model for DGS.
The Dfl/+  phenotype was rescued with the corresponding duplication. D pi indicating 
that the defects were due to haploinsufficiency of one or more of the genes within the 
deletion and not due to long-range effects on other genes (Lindsay et al., 1999). 
Additional, overlapping deletions of this syntenic region also helped to narrow down the 
causative region of cardiovascular defects (Figure 1.9) (Kimber et al., 1999; Lindsay et 
al., 2001; Puech et al., 2000). Four candidate genes, Gnbll, Tbxl, Gplbfi and Cdcrell 
were contained within the critical region. Genetic complementation studies using a 
140Kb PI-derived artificial chromosome (PAC) containing these four genes rescued the 
Zy7/+ cardiovascular defects confirming that one of these genes was responsible for the 
phenotype (Lindsay et al., 2001). Gplbfi and Cdcrell were not implicated in DGS 
because Gplbfi mutations have been associated with Bernard Soulier syndrome, a 
recessive bleeding disorder with no other cardiovascular defects (Ludlow et al., 1996; 
Moran et al., 2000) and Cdcrell'^' mice exhibit no phenotype (Lindsay et al., 2001). Of 
the two genes that were left, only Tbxl was strongly expressed within developmental 
structures affected in DGS, namely the pharyngeal arches, head mesenchyme and otic 
vesicle (Chapman et al., 1996).
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1.5.2 Tbxl mouse
Three groups concurrently identified Tbxl as a critical, haploinsufficient gene in DGS, 
generating knockout mouse mutants which displayed many defects reminiscent of the 
disease in humans (Jerome and Papaioannou, 2001; Lindsay et al., 2001; Merscher et 
al., 2001). Heterozygous Tbxl mutants were found to be phenotypically identical to 
D/7/+ mice, displaying the same cardiovascular defects (Figure 1.1 OD). Similarly, 
Dfl/+;Tbxl^^' compound heterozygotes were identical to TbxT^' homozygotes which 
exhibit more severe abnormalities in pharyngeal development (Figure 1. lOD). At 
E l0.5, TbxT^' embryos have a hypoplastic second pharyngeal arch and the caudal arches 
fail to segment resulting in absent third, fourth and sixth pharyngeal arches and arch 
arteries (Figure 1 .IOC). TbxT^' mutants also have a hypoplastic outflow tract and small 
otic vesicle at this stage (Jerome and Papaioannou, 2001; Lindsay et al., 2001; Vitelli et 
al., 2002a). These defects reflect areas of Tbxl expression during pharyngeal 
development (Figure 1.1 OA, A’, B).
Tbxl is first expressed at E7.5 within SHF mesoderm dorsal to the cardiac crescent and 
head mesenchyme (Chapman et al., 1996; Huynh et al., 2007). From E8.0, Tbxl is 
detected within the pharyngeal endoderm, mesoderm, ectoderm and head mesenchyme 
(Zhang et al., 2005) (Figure 1.1 OA, A’) and is expressed in the otic placode from E8.5 
(Raft et al., 2004). Pharyngeal mesoderm, endoderm, head mesenchyme and otic 
vesicle expression are strong at E9.5 (Figure l.lOB) and persist until E12.5 (Chapman 
et al., 1996; Lindsay et al., 2001; Raft et al., 2004).
Later in development, TbxT^' mice mainly exhibit defects in structures which derive 
from the pharyngeal region. At E l8.5, mutants present with craniofacial abnormalities 
including bone and muscle malformations and cleft palate which occur due to aberrant 
development of the first and second pharyngeal arches (Jerome and Papaioannou, 2001; 
Kelly et al., 2004). In addition, TbxT^' mutants exhibit great vessel anomalies and 
failure of OFT septation and alignment resulting in persistent truncus arteriosus with an 
accompanying VSD (Figure 1.1 OD). Thymic, parathyroid and thyroid hypo/aplasia are 
also apparent in TbxT^' mice as well as outer, middle and inner ear defects (Jerome and 
Papaioannou, 2001; Liao et al., 2004; Lindsay et al., 2001; Vitelli et al., 2002a; Vitelli 
et al., 2003).
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Figure 1.10 Tbxl expression and mouse mutant phenoty
Tbxl-lacZ knockin 
embryos. Expression of Tbxl at E8.5 in a whole embryo (A) and a transverse section 
(A’) within the pharyngeal endoderm, mesoderm and ectoderm. (B) Expression of Tbxl 
at E9.5 within the head mesenchyme, otic vesicle, pharyngeal and splanchnic mesoderm 
and pharyngeal endoderm, (C) TbxT^' embryos at E9.5 have a hypoplastic second 
pharyngeal arch and the caudal arches do not form. (D) Heart defects in Tbxl mutant
mice. a. At E l0.5, in T b x t'' and DfH+ embryos, the 4'" PAA is hypoplastic or fails to 
form. In Tbxl''' embryos, the caudal pharyngeal arches, pouches and arch arteries fail 
to develop and the heart connects directly to the dorsal aorta via the aortic sac. b. In 
El 8.5 DfH+ and T b x f '  embryos, defects in 4“^ PAA development lead to aberrant right 
subclavian artery and interrupted aortic arch (asterisk). In TbxV'' embryos, failure of 
development of the pharyngeal apparatus leads to great vessel anomalies and defects in 
OFT alignment and septation resulting in persistent truncus arteriosus, in which there is 
only one outflow vessel from the heart. AO, aorta; AS, aortic sac; DA, dorsal aorta; hm, 
head mesenchyme; LCC, left common carotid; LPA, left pulmonary artery; ESA, left 
subclavian artery; ov, otic vesicle; p, pharynx; pe; pharyngeal endoderm; pm, 
pharyngeal mesoderm; PT, pulmonary trunk; RCC, right common carotid; RSA, right 
subclavian artery; se, surface ectoderm; TA, truncus arteriosus. (Jerome and 
Papaioannou, 2001; Lindsay, 2001; Zhang et al., 2005)
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The phenotype of Tbxl''' mice closely resembles defects which occur due to NC 
ablation (Bockman et al., 1989; Bockman et al., 1987; Waldo et al., 1996). NC 
migration through the pharyngeal arches is defective in TbxT^' mutants. However, Tbxl 
is not expressed in NC cells or their derivatives. Thus, NC abnormalities are considered 
to occur secondary to loss of patterning or directional cues from other pharyngeal 
tissues (Chapman et al., 1996; Vitelli et al., 2002a).
The critical role of TBXl in the aetiology of DGS is supported by the identification of 
frameshift and missense mutations within TBXl in DGS patients who do not have the 
22ql 1 deletion (Paylor et al., 2006; Stoller and Epstein, 2005; Yagi et al., 2003; Zweier 
et al., 2007). Frameshift mutations disrupt a TBXl nuclear localisation signal and a C- 
terminal transactivation domain (Paylor et al., 2006; Stoller and Epstein, 2005). There 
is conflicting data associated with missense mutations occurring in the T-box domain or 
just downstream. These mutations have been reported as gain of function (GOT) 
mutations according to some reporter assays (Zweier et al., 2007) and loss of function 
mutations according to other reporter assays (P. Ataliotis, pers. comm.). Considering 
that overexpression of Tbxl in the mouse causes DGS-like defects similar to loss of 
function mutants, it is possible that GOF mutations in human TBXl also result in a 
DGS-like phenotype (Liao et al., 2004; Merscher et al., 2001).
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1.6 T-BOX GENES AND DEVELOPMENT
Thxl is a member of the evolutionarily conserved T-box family of transcription factors, 
whose members are defined by a common T-box DNA binding domain (Naiche et ah, 
2005). The first T-box gene identified, T or Brachyury was named after its short tail 
mouse mutant phenotype (Herrmann et al., 1990). Since then, at least 18 T-box genes 
have been found in vertebrates and these have been divided into 5 subfamilies based on 
phylogenetic analyses (Figure 1.11 A) (Papaioannou, 2001). T-box genes are involved 
in multiple developmental processes including gastrulation, craniofacial, heart and limb 
morphogenesis. Mutations in several T-box genes have been linked to human disorders 
(Naiche et al., 2005). Most of the disorders associated with T-box genes occur in the 
heterozygous state such as Ulnar-Mammary syndrome {TBX3\ Small Patella syndrome 
{TBX4), Holt Oram syndrome {TBX5) and congenital heart defects caused by TBX20 
mutations (Bamshad et al., 1999; Bamshad et al., 1997; Basson et al., 1997; Bongers et 
al., 2004; Kirk et al., 2007; Li et al., 1997). Similarly, mouse studies have shown that 
several T-box genes such as Tbx3, Tbx5 and Tbx20 are haploinsufficient demonstrating 
that development of many organs are sensitive to altered T-box gene dosage (Bruneau et 
al., 2001; Davenport et al., 2003; Jerome-Majewska et al., 2005; Stennard et al., 2005).
Ail T-box proteins share a conserved, 180 amino acid, sequence-specific T-box DNA 
binding domain. However, all other domains are highly divergent reflecting their 
different functional roles in development (Figure 1.1 IB) (Naiche et al., 2005). Studies 
on the original T-box gene, Brachyury identified a palindromic T-box DNA binding 
element (TBE) consisting of two 5’-AGGTGTGAAA-3’ T-half sites which Brachyury 
binds as a homodimer (Kispert and Herrmann, 1993). Subsequent studies have shown 
that many T-box factors can bind to the T-half site (Bruneau et al., 2001 ; Lamolet et al., 
2001; Papapetrou et al., 1997; Paxton et al., 2002; Sinha et al., 2000; Stennard et al., 
2003). However, T-box proteins form different quaternary structures (Coll et al., 2002; 
Muller and Herrmann, 1997; Zweier et al., 2007)and have different affinities for the 
number, orientation and specific sequence of these T-half sites which may help to 
confer functional specificity (Conlon et al., 2001; Ghosh et al., 2001; Lingbeek et al., 
2002; Sinha et al., 2000). In vitro studies show that Tbxl preferentially binds to a 
palindromie pair of T-half sites (Sinha et al., 2000; Zweier et al., 2007) although Tbxl 
also appears to be able to activate potential in vivo targets through a single, putative T- 
half site (Nowotschin et al., 2006; Xu et al., 2004).
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T-box transcription factors function as activators, repressors or both depending on the 
developmental context (Plageman and Yutzey, 2005). For instance, Tbxl and Tbx5 are 
transcriptional activators (Ataliotis et al., 2005; Bruneau et al., 2001; Hiroi et al., 2001; 
Plageman and Yutzey, 2004; Stoller and Epstein, 2005; Xu et al., 2004; Zaragoza et al., 
2004; Zweier et al., 2007) whereas Tbxl 5 and Tbxl 8 are transcriptional repressors 
(Farin et al., 2007). Tbx2, Tbx3 and Tbx20 contain both activation and repression 
domains (Carlson et al., 2001; He et al., 1999; Paxton et al., 2002; Plageman and 
Yutzey, 2004; Stennard et al., 2003).
Tbxl, Tbx2, Tbx3, Tbx5, Tbxl8 and Tbx20 are expressed in distinct but overlapping 
domains within cardiac progenitors and the heart and are involved in many aspects of 
vertebrate heart development including expansion of heart precursors, cardiac chamber 
formation and patterning, and conduction system, valve and septum formation 
(Hoogaars et al., 2007; Plageman and Yutzey, 2005). T-box proteins interact with each 
other and with other transcription factors such as Nkx2.5, Gata4 and Isll to co- 
ordinately regulate target genes (Brown et al., 2005; Farin et al., 2007; Garg et al., 2003; 
Hoogaars et al., 2007; Krause et al., 2004; Nowotschin et al., 2006; Stennard et al.,
2003; Takeuchi et al., 2005). For example, during cardiac chamber formation, Tbx2 
appears to compete with Tbx5 for interaction with Nkx2.5 to regulate target gene 
expression. Tbx5 interacts with Nkx2.5 to synergistically activate the target gene, Nppa 
whereas in non-chamber myocardium, Tbx2 interacts with Nkx2.5 to repress Nppa 
(Bruneau et al., 2001; Christoffels et al., 2004; Habets et al., 2002; Hiroi et al., 2001; 
Takeuchi et al., 2003). Thus, during heart development, the regulation of transcriptional 
targets by T-box genes is precisely controlled through their individual affinity for 
particular DNA sequences, their spatial and temporal expression and their interactions 
with other transcription factors.
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Figure 1.11 T-box transcription factor family and structure
(A) Phylogenetic tree of T-box genes subdivided into 5 families based on sequence 
analysis (Naiche et al 05). (B) Protein structure of members of the Tbxl subfamily. The 
T-box DNA binding domain is highly conserved within member  
 
domains (R). Tbx20 can 
function as an activator or repressor. The red boxes represent nuclear localisation 
signals identified within Tbxl and Tbxl 8. (Modified from (Plageman and Yutzey, 
2005)).
44
1.7 TBXl AND ITS ROLE IN DEVELOPMENT 
1.7.1 Specific requirements for Tbxl in development
Conventional mouse knockouts have demonstrated that Tbxl plays a critical role in the 
pathogenesis of structures affected in DGS. The time, tissue and dose-specific 
requirements for Tbxl throughout development have recently been elucidated through 
conditional ablation studies and the analysis of a series of alleles expressing various 
levels of Tbxl (Figure 1.12, Tables 1.1 and 1.2). These experiments have revealed that 
knocking out Tbxl at E7.5 recapitulates the germline deletion phenotype. Tbxl exhibits 
precise time-dependent roles in the development of each pharyngeal-derived structure 
and can be required at multiple stages throughout development of the same structure 
such as the thymus (Figure 1.12) (Xu et al., 2005). In addition, tissue-specific deletion 
studies in which Tbxl has been ablated from the pharyngeal epithelia (ectoderm and 
endoderm) (Zhang et al., 2005), pharyngeal endoderm (Arnold et al., 2006b) and 
pharyngeal mesoderm (Zhang et al., 2006) have emphasised the requirement for Tbxl in 
multiple tissues for normal pharyngeal development (Table 1.1). Tbxl expression 
within the mesoderm and endoderm is necessary for pharyngeal segmentation, NC 
migration, OFT, thymus and ear development (Arnold et al., 2006b; Zhang et al., 2006). 
Secondary palate morphogenesis solely relies on Tbxl expression in the pharyngeal 
epithelia. Also, it appears that Tbxl within the pharyngeal ectoderm is required for 
normal fourth PAA development (Arnold et al., 2006b; Zhang et al., 2005).
Reactivation of Tbxl within the mesoderm of hypomorphic embryos was also
carried out through Cre-mediated excision of the floxed Neo2 cassette contained within 
the Tbxl allele. Mesodermal reactivation of Tbxl rescues OFT alignment and septation 
defects, hypoplasia of the second pharyngeal arch and outer ear and third and sixth arch 
arteries anomalies demonstrating a cell-autonomous requirement for Tbxl in 
development of these structures (Zhang et al., 2006).
These studies have begun to characterise the tissue-specific roles for Tbxl in 
development. However, there has been no standardised approach to conducting these 
experiments. Different groups have carried out these tissue-specific deletion studies 
and thus, pharyngeal-derived defects have been investigated to different degrees. 
Strain-dependent tissue expression of the Foxgl-Cre driver has also made it difficult to 
be fully confident of the results (Arnold et al., 2006b; Zhang et al., 2005). Zhang et al 
(2005) showed that Foxgl-Cre drove expression in the mesoderm, endoderm and
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ectoderm whereas Arnold et al (2006) described Foxgl-Cre expression only within the 
endoderm in a different mouse strain. In addition, reactivation studies have not been 
conducted within the endoderm or ectoderm. Therefore, the precise roles which Tbxl 
plays within each tissue during development have yet to be clearly defined.
Tbxl function is extremely dose-sensitive, as both under and overexpression of Tbxl 
causes a DGS-like phenotype in mice (Funke et al., 2001 ; Hu et al., 2004; Jerome and 
Papaioannou, 2001; Liao et al., 2004; Lindsay et al., 2001; Merscher et al., 2001; Xu et 
al., 2004). Through analysis of nine different genotypes representing progressively 
lower levels of Tbxl mRNA, Zhang and Baldini (2007) demonstrated that different 
pharyngeal structures exhibit different sensitivities to altered Tbxl dosage (Table 1.2). 
Specifically, the penetrance and severity of thymic and PAA defects generally increase 
with decreasing Tbxl levels and the phenotype varies over a broad range of Tbxl doses. 
These structures are also the most dosage sensitive, with defects occurring even when 
Tbxl is expressed at 70% of wild type levels. In contrast, cleft palate is only present in 
TbxT^' mutants (Zhang and Baldini, 2007).
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Figure 1.12 Time requirements for Tbxl during development
Each pharyngeal structure or process analysed requires Tbxl at specific time intervals 
for normal development. The arrow indicates that the endpoint for TbxTs role in 
secondary palate development is unknown. (Modified from (Xu et al., 2005)).
Table 1.1 Tissue-specific requirements for Tbxl in development
Tissue-specific deletion of Tbxl
Endoderm and otic 
vesicle {Foxgl-Cre)
Mesoderm {Mespl-Cre)
Pharyngeal segmentation and 
arch artery development X X*
OFT septation and alignment X X*
Thymus X X
Thyroid X nd
Parathyroid X nd
Secondary palate X ✓
Ear - outer X X*
Ear - middle X nd
Ear - inner X X
Craniofacial bones X nd
Craniofacial muscles X X
Neural crest migration nd X
Fourth arch artery^ ✓ ✓
(Arnold et al., 2006b; Dastjerdi et al., 2007; Xu et al., 2007a; Xu et al., 2007b; Zhang et 
al., 2006)
Abbreviations: OFT, outflow tract; X represents defects in a particular structure or 
process; $/ represents no defects; nd, not determined
* Mesodermal reactivation of Tbxl in a Tbxl^^°^^' background partially or fully rescues 
defects in these structures (Zhang et al., 2006).
^Epithelial-specific (endoderm and ectoderm) deletion of Tbxl causes fourth arch artery 
defects (Zhang et al., 2005).
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Table 1.2 Tbxl dose-dependent phenotypes
Tbxl genotype
(% of wild type Tbxl expression)
Phenotype
Lethality Aortic arch Thymus OFT alignment and septation
Cleft
palate
Pharyngeal arch 
development
Neo2/+ (70%) low #(11% ) m. hypo 
(29%)
✓ ✓ ✓
Neo/+ (53%) low # m.hypo ✓ ✓ ✓
+/- (50%) low #  (38%) m.hypo 
(41%)
Alignment
defects
✓ ✓
Neo2/Neo2 (34%) 100% #  (100%) 
Most bilateral
s. hypo # ✓ Hypo 4* PA
Neo2/Neo (18.5%) 100% # aplasia Variable. 
Alignment & 
septation defects
✓
Neo2/- (15%) 100% # aplasia Incomplete and 
complete PTA
✓ No caudal arches but hypo 
4* pouch and 6^ PAA 
present
Neo/Neo (4%) 100% # aplasia PTA ✓ No caudal arches, pouches 
or PAAs
-/- (0%) 100% # aplasia PTA # No caudal arches, pouches 
or PAAs
00
(Lindsay et al., 1999; Xu et al., 2004; Zhang and Baldini, 2007)
Abbreviations: Neo, A PGKneo cassette inserted into Tbxl intron 5; Neo2, A floxed PGKneo cassette inserted into Tbx! intron 5; % represents defects 
in a structure, ✓ means no defects present, m. hypo, mild hypoplasia; s. hypo, severe hypoplasia; hypo 4* PA, hypoplastic 4* pharyngeal arch; PAA, 
pharyngeal arch artery; PTA, persistent truncus arteriosus.
1.7.2 Tbxl and pharyngeal segmentation
The pharyngeal apparatus develops in a cranial to caudal manner by the sequential 
addition of pharyngeal arches between E8 and El 0.5 within the mouse. However, the 
molecular pathways required for this process are not well characterised. Tbxl is 
expressed in an anterior-posterior and medial-lateral gradient within the pharyngeal 
endoderm so that it appears strongest within the most caudal and lateral pharyngeal 
segments as development proceeds, suggesting a role for Tbxl in pharyngeal growth 
(Vitelli et al., 2002a). Timed cell fate mapping studies also show a progressive increase 
in Tbxl levels in the caudal pharyngeal endoderm throughout pharyngeal development 
(Xu et al., 2005). Experiments have recently confirmed that Tbxl is indeed required for 
pharyngeal segmentation since deletion of Tbxl at timepoints prior to formation of the 
next arch only result in segmentation defects caudal to that arch (Xu et al., 2005). Tbxl 
has been proposed to regulate expansion of endodermal cells and there is a reduction in 
endodermal proliferation in TbxT^' mutants (Xu et al., 2005). In addition to the 
pharyngeal endoderm, Tbxl expression within the mesoderm also participates in the 
segmentation process (Zhang et al., 2006). Proliferation is also downregulated in this 
tissue and may be necessary for pharyngeal formation (Zhang et al., 2006). However, it 
is not clear as yet whether Tbxl also plays a role in regulating the patterning and 
morphogenetic events required for segmentation of the pharyngeal arches.
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1.7.3 Tbxl and heart development
Defects in the growth, alignment and septation of the outflow tract and formation and 
remodelling of the aortic arch arteries are the main heart malformations which occur in 
TbxV'' mice (Vitelli et ah, 2002a). In DGS patients, the aortic arch and OFT defects can 
occur together or in isolation. Similarly, these defects are separable in mice and have 
distinct time, tissue and dose requirements for Tbxl (Arnold et al., 2006b; Hu et al., 
2004; Jerome and Papaioannou, 2001; Liao et al., 2004; Lindsay et al., 2001; Merscher 
et al., 2001 ; Xu et al., 2004; Zhang et al., 2005; Zhang et al., 2006). In addition, mouse 
studies suggest that the high incidence of heart abnormalities in DiGeorge patients may 
be explained by the fact that arch artery and OFT development are more sensitive to 
altered Tbxl dosage than other pharyngeal arch derivatives (Hu et al., 2004; Zhang and 
Baldini, 2007).
In particular, development of the fourth PAAs is very sensitive to reduced Tbxl dosage. 
Arch artery defects occur even when Tbxl is expressed at 70% of normal levels and 
gradually increase in penetrance and severity as Tbxl levels decrease (Table 1.2)
(Zhang and Baldini, 2007). The particular sensitivity of fourth arch arteries to altered 
Tbxl levels may reflect the unique vascular morphology of these vessels (Bergwerff et 
al., 1999). Analysis of the fourth PAAs of Dfl/+  heterozygotes has shown that initial 
tube formation and endothelial cell differentiation are normal but at E l0.5 there is a lack 
of NC-derived vascular smooth muscle (VSM) lining the arch arteries (Lindsay and 
Baldini, 2001). NC migration appears to be normal, therefore, fourth arch artery defects 
were originally thought to occur as a result of the non cell-autonomous effects of Tbxl 
within the endoderm or mesoderm on NC differentiation (Lindsay and Baldini, 2001). 
However, recent studies indicate that ectodermal Tbxl plays the major role in fourth 
arch artery development (Table 1.1) (Arnold et al., 2006b; Zhang et al., 2005). 
Expression within the pharyngeal ectoderm correlates with the time requirement for 
Tbxl in PAA development between approximately E7.5 and E9.0 (Figure 1.12) (Xu et 
al., 2004; Zhang et al., 2005). Surprisingly, this means that Tbxl is necessary prior to 
fourth PAA formation, which occurs after E9.5. Given that Tbxl cells also contribute to 
the endothelia of the fourth arch arteries (Xu et al., 2005), it is possible that Tbxl 
expression within the ectoderm and/or endothelial precursor cells may affect the ability 
of endothelial cells to signal to NC, or alter the ability of NC to respond and 
differentiate later in development.
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The most common cardiovascular malformations found in DGS patients involve 
aberrant development of the OFT of the heart (Momma, 2007; Robin and Shprintzen, 
2005). Tbxl is essential for normal OFT development and is required cell- 
autonomously within the mesoderm for OFT growth, alignment and septation mediated 
in part by regulation of SHF expansion (Table 1.1) (Xu et al., 2004; Zhang et al., 2006). 
Analysis of SHF markers in TbxT^' embryos reveals that there is a reduction or loss of a 
subpopulation of SHF precursors (Kelly and Papaioannou, 2007). Endodermal deletion 
of Tbxl also results in OFT defects (Arnold et al., 2006b) implying that interaction 
between the mesoderm and endoderm is important for cardiac development. Tbxl is 
expressed within the SHF from the cardiac crescent stage and contributes cells to the 
OFT, right ventricle and even parts of the atria (Brown et al., 2004; Huynh et al., 2007; 
Maeda et al., 2006; Xu et al., 2005; Xu et al., 2004). However, to date, only OFT 
defects have been identified in TbxT^' mutants (Jerome and Papaioannou, 2001; Lindsay 
et al., 2001). Timed-deletion experiments show that Tbxl is required for normal OFT 
development between E8.5 and E9.5 (Figure 1.12) (Xu et al., 2005), coinciding with 
expression of Tbxl within the pharyngeal and splanchnic mesoderm (Chapman et al., 
1996; Lindsay et al., 2001). Cell fate mapping studies show that TTiJci-expressing 
precursors contribute extensively to the OFT specifically within this narrow time 
window, not only to the myocardial layer but also to the underlying endothelium of the 
OFT (Xu et al., 2005; Zhang and Baldini, 2007). Tbxl is only weakly expressed in part 
of the myocardial layer of the distal OFT at this stage (Vitelli et al., 2002a; Zhang and 
Baldini, 2007). Therefore, the results suggest that -expressing SHF precursors may 
give rise to both myocardial and endothelial tissues of the OFT (Zhang and Baldini, 
2007). This theory is supported by recent experiments demonstrating that 
multipotential Isll+  progenitor cells contained within the SHF can contribute to 
myocardial, endothelial and VSM cells of the heart (Moretti et al., 2006).
OFT alignment appears to be more sensitive to altered Tbxl dosage than OFT septation 
(Lindsay et al., 1999; Zhang and Baldini, 2007). Defects such as overriding aorta occur 
in heterozygous Tbxl mutants (Liao et al., 2004; Lindsay et al., 1999) whereas 
aortopulmonary septation defects become prevalent when Tbxl levels fall below 20% of 
wild type (Table 1.2) (Zhang and Baldini, 2007). SHF proliferation may be more 
sensitive to a reduction in Tbxl expression which would lead to a shorter OFT, looping 
defects and aberrant OFT alignment. The role of Tbxl in regulating OFT septation is 
less clear. NC distribution is abnormal within the pharyngeal arches of Tbxl mutants
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with OFT septation defects (Vitelli et al., 2002a; Xu et al., 2004; Zhang et al., 2006). 
However, it is not clear whether fewer NC cells invade the OFT or if Tbxl affects NC 
function within the endocardial cushions. In addition, defects in aortic sac 
morphogenesis have been identified in Tbxl mutants which may also contribute to a 
failure in OFT septation (Xu et al., 2004).
DGS patients exhibit a highly variable heart phenotype even though most patients have 
the same 22ql 1 deletion (Sullivan, 2004). Interestingly, Tbxl^^°^^^^^ hypomorphic 
mouse mutants which express Tbxl at 20% of wild type levels exhibit a very variable 
OFT phenotype ranging from no defects, to alignment defects, to complete PTA (Table 
1.2) (Zhang and Baldini, 2007). These results suggest that variability is affected by 
stochastic or epigenetic factors and this mouse mutant represents a better model for the 
OFT phenotype of DGS patients (Zhang and Baldini, 2007).
1.7.4 Tbxl and endocrine gland development
Thymus and parathyroid hypoplasia with associated immunodeficiency and 
hypocalcemia, respectively are common features of DGS. Hypothyroidism also occurs 
in patients with this syndrome (Robin and Shprintzen, 2005). The structures affected in 
DGS, the thymus, parathyroid and thyroid glands all derive from the pharyngeal 
endoderm. The thymus and parathyroid develop from a common primordium within the 
endoderm of the third pharyngeal pouch. The thyroid gland arises from endoderm 
lining the second arch which fuses with ultimobranchial bodies that form as 
outpocketings form the fourth pharyngeal pouch (Hilfer and Brown, 1984). In addition 
to the endoderm, NC also contributes to the connective tissue of the thymus and 
parathyroid glands from El 1.5 and is required for correct thymic morphogenesis (Jiang 
et al., 2000; Le Lievre and Le Douarin, 1975; Waldo et al., 1996; Yamazaki et al.,
2005).
In TbxT^' mice, development of all three endoderm-derived glands is affected. The 
thymus and parathyroid do not develop due to a failure in pharyngeal segmentation and 
patterning (Jerome and Papaioannou, 2001; Zhang and Baldini, 2007). The thyroid 
gland is hypoplastic in TbxT^' mice and does not form symmetrical lobes (Fagman et al., 
2007; Liao et al., 2004). Tbxl is not expressed in the thyroid itself but appears to be 
required non cell-autonomously to regulate its growth and position (Fagman et al.,
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2007). Defects in thymus and parathyroid gland morphogenesis also occur in Tbxl 
heterozygotes although penetrance of glandular defects depends on genetic background 
(Taddei et al., 2001). The thymus gland has been the most well studied of the endocrine 
organs affected by Tbxl mutations. Normal thymic development requires Tbxl early 
between E7.5 and E8.5 to regulate pharyngeal segmentation and thymic induction 
(Figure 1.12). Tbxl also plays another role later between E l0.5 and El 1.5 in thymic 
morphogenesis (Xu et al., 2005). Tissue-specific deletion experiments indicate that 
Tbxl functions in both the mesoderm and endoderm for normal thymus development 
(Table 1.1) (Arnold et al., 2006b; Zhang et al., 2006). In addition, the penetrance and 
severity of thymic defects varies over a wide range of Tbxl doses (70 to 20% of wild 
type levels) demonstrating the acute sensitivity of the thymus to altered Tbxl expression 
(Table 1.2) (Zhang and Baldini, 2007).
1.7.5 Tbxl and craniofacial development
DGS patients exhibit a range of craniofacial malformations including facial bone 
deformities, ear malformations and skeletal muscle hypotonia (Robin and Shprintzen, 
2005). Many of the structures affected derive from the pharyngeal arches which give 
rise to bones, muscles and connective tissue of the head and neck (Graham, 2003).
Pharyngeal mesoderm gives rise to branchiomeric muscles including the muscles of 
mastication (pharyngeal arch one), facial expression muscles (pharyngeal arch two) and 
muscles of the pharynx and larynx (caudal arches) (Couly et al., 1992; Hacker and 
Guthrie, 1998; Noden, 1983; Trainor et al., 1994). In TbxT^' embryos, expression of the 
myogenic determination genes, Myf5 and MyoD is sporadically activated within the 
pharyngeal mesoderm resulting in random, aberrant development of muscles derived 
from the first arch (Kelly et al., 2004). The caudal branchiomeric muscles fail to form 
in TbxT^' mutants (Kelly et al., 2004). Therefore, Tbxl is required for robust activation 
of branchiomeric myogenesis, a process which is relatively dosage-insensitive since 
pharyngeal derived muscles appear normally in hypomorphic mice expressing Tbxl at 
10% of wild type levels (Arnold et al., 2006b). Endoderm and mesoderm-specific 
deletion of Tbxl both cause defective MyoD expression and abnormal development of 
pharyngeal-derived muscles suggesting that Tbxl may be required to regulate 
interactions between the endoderm and mesoderm for normal muscle development 
(Table 1.1) (Arnold et al., 2006b; Dastjerdi et al., 2007).
53
Bones derived from the pharyngeal arches including those of the jaw, middle and outer 
ear and cartilages of the throat are all affected in Thxl'''’ mutants (Jerome and 
Papaioannou, 2001). In addition, non-pharyngeal derived craniofacial bones are also 
abnormal consistent with expression of Tbxl within the head mesenchyme as well as the 
pharyngeal arches (Jerome and Papaioannou, 2001). Craniofacial malformations occur 
in Tbxr^°^”^ ° mice expressing 25% of wild type Tbxl levels however, they are less 
severe than TbxT^' mice (Hu et al., 2004). In addition, cleft palate is particularly 
insensitive to altered Tbxl levels. Expression of as little as 4% of Tbxl wild type 
expression is sufficient to rescue palate defects (Table 1.2) (Zhang and Baldini, 2007).
1.7.6 Tbxl and ear development
DGS patients often exhibit external ear defects and hearing loss, of which a proportion 
is of the sensorineural type (Digilio et al., 1999; Reyes et al., 1999). There is one 
reported case of a patient with a TBXl mutation who also has a hearing impairment 
(Yagi et al., 2003). TbxT^' mice exhibit malformations of the outer, middle and inner 
ear ((Jerome and Papaioannou, 2001; Vitelli et al., 2003). Loss of Tbxl within the 
pharyngeal endoderm affects expansion of the first pharyngeal pouch and formation of 
pharyngeal arch one and two-derived middle and outer ear bones (Table 1.1) (Arnold et 
al., 2006b). Tbxl is also expressed within the otocyst and periotic mesenchyme of the 
inner ear (Raft et al., 2004; Vitelli et al., 2003). In TbxT^' mice, the otic vesicle is small 
and the vestibular and cochlear structures do not form (Jerome and Papaioannou, 2001 ; 
Moraes et al., 2005; Raft et al., 2004; Vitelli et al., 2003). Tissue-specific ablation 
studies have revealed that Tbxl plays a cell-autonomous role for contribution, 
proliferation and cell fate determination of a subpopulation of otic epithelial cells 
(Arnold et al., 2006a; Xu et al., 2007b). Tbxl may act to delimit the neurogenic domain 
in the otocyst by suppressing Delta-Notch signalling and Vg«7-mediated neural fate 
determination (Xu et al., 2007b). Tbxl also plays a non cell-autonomous role within the 
periotic mesenchyme for cochlear morphogenesis (Table 1.1) (Xu et al., 2007a; Xu et 
al., 2007b). Mesoderm-specific deletion of Tbxl causes reduced cell proliferation 
within the periotic mesenchyme affecting formation of the pericochlear capsule and 
subsequently, cochlear development (Xu et al., 2007a).
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1.7.7 Summary
Studies on multiple mouse mutants have revealed the precise dose, tissue and time 
requirements for Tbxl in development of different pharyngeal structures. These 
experiments have led to a better understanding of why certain malformations such as 
thymic and cardiovascular defects occur more frequently in DGS patients and the 
underlying mechanisms through which Tbxl functions during embryogenesis. 
Proliferation defects have been found in nearly all pharyngeal tissues in which Tbxl is 
expressed representing a common cellular process regulated by Tbxl. Differentiation 
and cell fate determination are other processes regulated by Tbxl. It still remains to be 
determined whether Tbxl also functions through additional mechanisms to control 
pharyngeal and heart development. In particular, given that NC plays an important role 
in the development of nearly all the structures affected in Tbxl mutants, a better 
analysis of the role of Tbxl in regulating NC function is required.
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1.8 MODIFIERS OF DIGEORGE SYNDROME
The developmental defects exhibited by Tbxl mutants, and the identification of TBXl 
mutations in DGS patients without a deletion, strongly suggests that this gene plays a 
major role in the aetiology of DGS. However, some of the defects exhibited by DGS 
patients such as renal and skeletal abnormalities are not present in Tbxl mutant mice 
(Robin and Shprintzen, 2005; Sullivan, 2004). Also, there are numerous DGS patients 
with rare 22ql 1 deletions that do not include TBXl (Amati et al., 1999; Rauch et al., 
1999; Rauch et al., 2005; Saitta et al., 1999; Weksberg et al., 2006). One possible 
explanation is that adjacent deletions may affect TBXl regulatory elements or cause 
changes in chromatin structure affecting TBXI expression. Alternatively, DGS may be a 
contiguous gene syndrome in which multiple genes within the region contribute to the 
phenotype.
The likelihood that DGS is a contiguous disorder is supported by findings implicating a 
role for the adaptor protein, Crkl. Mice homozygous for a mutation in the murine 
homologue, Crkl exhibit cardiovascular anomalies, thymic and parathyroid defects 
reminiscent of DGS (Guris et al., 2001). CRKL is contained within the typical 3Mb 
22ql 1 deleted region but not the 1.5Mb deletion of DGS patients so it may not be 
critical for the phenotype. However, double heterozygous Crkt''\TbxÜ'' mice display 
more severe cardiovascular defects than T b x f '  mice indicating an important role for 
Crkl in modifying the effects of Tbxl haploinsufficiency (Guris et al., 2006). Double 
heterozygous mutants exhibit an increased penetrance and severity of thymic, 
parathyroid, fourth PAA and OFT defects resulting from abnormal pharyngeal 
segmentation and patterning (Guris et al., 2006). These malformation may at least 
partly be caused by locally upregulated RA levels within the pharyngeal arches due to 
decreased expression of the RA metabolising enzymes, Cyp26al and Cyp26bl which 
are regulated in a dose-dependent manner by Crkl and/or Tbxl (Guris et al., 2006). In 
addition, Crkl mediates Fgf8 signalling through binding to Fgf receptors, Fgfrl and 
Fgfr2 (Moon et al., 2006). Double mutants {Crkll^^';Fgf8^^' and CrklT^';Fgf8^^') exhibit 
more severe cardiovascular, craniofacial and skeletal abnormalities than single mutants 
(Fg/8^^', Crkt^' or Crkr^') providing further evidence that haploinsufficiency of CRKL 
may contribute to the pathogenesis of DGS especially in the context of heterozygous 
TBXI expression.
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Other genes contained within the 3Mb TDR may also influence the clinical outcome in 
DGS patients. Neural crest-specific knockdown of chick Hira, a histone chaperone or 
Ufdll, a gene proposed to be involved in ubiquitin-mediated protein degradation, causes 
OFT septation defects (Farrell et al., 1999; Yamagishi et al., 2003a). In addition, 
attenuating Dgcr6 expression in chick neural crest results in DGS-like fourth PAA and 
OFT alignment defects and also appears to alter expression of Tbxl, Hira and Ufdll 
within the pharyngeal arches and heart (Hierck et al., 2004).
Furthermore, mouse mutants have implicated multiple 22ql 1 genes in the 
neurobehavioral phenotype of DGS. Dfl/+  mouse mutants (Paylor et al., 2001) as well 
as Tbxl (Paylor et al., 2006), Prodh (Gogos et al., 1999), ZdhhcS (Mukai et al., 2004) 
and Gnbll mutants (Paylor et al., 2006) ail exhibit deficits in prepulse inhibition (PPI), a 
sensorimotor gating defect associated with schizophrenia and found in 22ql 1 deletion 
syndrome patients (Sobin et al., 2005). In addition, Comt mouse mutants exhibit other 
behavioural phenotypes such as increased aggressiveness and anxiety (Gogos et al., 
1998).
These studies demonstrate that additional genes on chromosome 22ql 1 may contribute 
to the physical and neurological symptoms of DGS patients. However, in terms of the 
pharyngeal and cardiovascular defects, Tbxl is the only gene that has been shown to be 
haploinsufficient in both animal models and human patients and is therefore still the 
best candidate for the major clinical features in DGS patients.
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1.9 TBXI REGULATORS AND TARGETS
The importance of Tbxl in development has been well studied using numerous mouse 
models. However, the genetic pathways through which Tbxl functions have just begun 
to be elucidated. Determining the upstream regulators and downstream effectors of 
Tbxl is important not only for understanding the role of Tbxl in pharyngeal and heart 
development, but also, for determining which genes may act as modifiers of the 
extremely variable DGS phenotype in humans.
1.9.1 Potential Tbxl regulators
Studies of animal models with DGS-like phenotypes have led to the identification of 
potential Tbxl regulators. Shh is a signalling molecule which is expressed in the 
pharyngeal endoderm and ectoderm/endodermal boundaries (Helms et al., 1997; Wall 
and Hogan, 1995) and when disrupted results in pharyngeal and heart defects which are 
similar to Tbxl''' mice (Chiang et al., 1996; Litingtung et al., 1998; Washington Smoak 
et al., 2005). These defects include a single outflow tract arising from the right 
ventricle, great vessel anomalies and thymic hypoplasia (Fagman et al., 2004; Moore- 
Scott and Manley, 2005; Washington Smoak et al., 2005). Tbxl is down-regulated in 
the pharyngeal endoderm and mesoderm of Shh''' mutants at El 0.5 and ectopic 
expression of Shh is sufficient to induce Tbxl expression in chick (Garg et al., 2001). 
More recent studies have shown that Shh is required for maintenance of Tbxl 
expression rather than induction and may regulate Tbxl through Fox transcription 
factors (Goddeeris et al., 2007; Hu et al., 2004; Maeda et al., 2006; Yamagishi et al., 
2003b).
Two conserved Fox transcription factor binding sites located upstream of Tbxl are 
necessary to direct expression of a lacZ transgene to the pharyngeal endoderm, 
mesoderm, head mesenchyme and OFT domains (Hu et al., 2004; Maeda et al., 2006; 
Yamagishi et al., 2003b). In vitro experiments suggest that Foxa2, Foxcl and Foxc2 
can bind to these consensus enhancer elements and regulate Tbxl expression (Maeda et 
al., 2006; Yamagishi et al., 2003b). All three Fox genes are downregulated in Shh'^' 
mutants and are expressed in overlapping domains with Tbxl in the pharyngeal 
mesoderm (Hu et al., 2004; Seo and Kume, 2006; Yamagishi et al., 2003b). Foxa2 is 
also expressed in the pharyngeal endoderm (Hu et al., 2004; Yamagishi et al., 2003b).
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Foxcl and Foxc2 mutants have overlapping functions and exhibit OFT and arch artery 
defects similar to TbxF^' mice (Kume et ah, 1998; Kume et al., 2001; Seo and Kume, 
2006; Winnier et al., 1999). Tbxl is downregulated within the pharyngeal mesoderm of 
single and double Fox mutants and may play a role downstream in expansion of the 
SHF for contribution to the OFT (Seo and Kume, 2006; Yamagishi et al., 2003b). In 
addition, Foxa2 is downregulated in the pharyngeal mesoderm of Tbxl hypomorphic 
mice suggesting that a reinforcing autoregulatory loop may normally function in the 
SHF to amplify Tbxl expression (Hu et al., 2004). Together, these studies provide 
strong evidence that Fox transcription factors act upstream of Tbxl within the 
mesoderm. However, it remains to be determined whether Foxa2 also regulates Tbxl 
expression in the pharyngeal endoderm and what role this pathway may play in 
development.
Chordin, a Bmp antagonist secreted by the endoderm may also act upstream of Tbxl in 
development. Chordin'' mice recapitulate the TbxT^' phenotype; the caudal arches do 
not form and embryos have a small otic vesicle at E9.5 (Bachiller et al., 2003). Later in 
development, Chordin^' mutants have persistent truncus arteriosus, great vessel defects, 
craniofacial defects including cleft palate and hypo or aplastic thymus and parathyroid 
glands (Bachiller et al., 2003). All domains of Tbxl expression are downregulated in 
these mutants and Chordin is also sufficient to induce Tbxl expression ectopically in 
Xenopus (Bachiller et al., 2003). This data suggests that Bmp signalling plays a vital 
role upstream of Tbxl in development. However, the molecular mechanisms through 
which this pathway may regulate Tbxl are unknown.
Alterations in RA homeostasis can also lead to a DGS-like phenotype (Roberts et al., 
2006; Vermot et al., 2003) and recent studies have indicated that RA represses Tbxl 
expression (Roberts et al., 2005). In vitro experiments show that downregulation of 
Tbxl by RA is partly dependent on new protein synthesis suggesting that RA acts both 
directly and indirectly to regulate Tbxl (Roberts et al., 2005). Downstream effectors of 
RA in this pathway have yet to be identified and it remains to be confirmed if RA 
response elements (RAREs) identified upstream of Tbxl play a role in mediating the 
effects of RA (Roberts et al., 2005).
Vascular endothelial growth factor (Veg/), is an important signalling molecule required 
for cardiovascular development (Lambrechts and Carmeliet, 2004). Loss of a specific
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isoforai in mice, V eg f^  leads to craniofacial, cardiovascular and glandular defects 
reminiscent of DGS (Stalmans et al., 2003). Evidence for a genetic interaction between 
Vegf and Tbxl comes from experiments which show that Tbxl is downregulated in 
Feg/^^-deficient mice. In zebrafish, decreasing vegflevels enhance the PAA and 
cartilage defects induced by tbxl knockdown (Stalmans et al., 2003). In humans, 
specific promoter haplotypes of FEGF appear to correlate with increased risk of heart 
defects in DGS patients (Stalmans et al., 2003). These results suggest that VEGF may 
modulate the effects of TBXI disruption and contribute to the variability in expressivity 
observed in DGS.
1.9.2 Potential Tbxl targets
The signalling ligand, FgfS is one of the most well studied potential Tbxl targets. It is 
expressed within the pharyngeal endoderm, ectoderm and splanchnic mesoderm during 
mouse development, in domains overlapping with Tbxl (Hu et al., 2004; Lewandoski et 
al., 1997; Meyers et al., 1998; Park et al., 2006). Fgf8 is downregulated in the 
pharyngeal endoderm and splanchnic mesoderm of TbxV'' mice (Hu et al., 2004; Vitelli 
et al., 2002b; Zhang et al., 2006). Interestingly, Fgf8 is also downregulated in FoxcT^' 
;Foxc2'^' double mutants and Chrd^' mice, genes which potentially act upstream of Tbxl 
(Bachiller et al., 2003; Seo and Kume, 2006). FgfS hypomorphs exhibit a range of 
defects reminiscent of TbxT^' mutants and DGS including caudal pharyngeal 
hypoplasia, OFT and PAA defects, craniofacial abnormalities and small or absent 
thymus glands (Abu-Issa et al., 2002; Frank et al., 2002). Cre-mediated deletion of 
FgfS within Tbxl expression domains of the pharyngeal endoderm and mesoderm 
recapitulates the OFT defects exhibited by FgfS hypomorphs (Brown et al., 2004).
Also, Tbxl can regulate enhancer elements located upstream of FgfS in tissue culture 
assays (Hu et al., 2004). Together, these experiments suggest that FgfS represents a 
good candidate for a direct target gene acting downstream of Tbxl in pharyngeal and 
heart development. However, subsequent studies have indicated that Tbxl and FgfS 
may only interact in PAA development.
Tbxl^''\FgfS^'' compound heterozygotes exhibit an increased penetrance of fourth PAA 
defects compared to single heterozygotes (Vitelli et al., 2002b). Notably, no other 
cardiovascular, craniofacial or glandular defects are present in these double mutants 
(Vitelli et al., 2002b). In addition, FgfS knocked into the Tbxl locus only alters the
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PAA phenotype (Vitelli et al., 2006). Tamoxifen-induced ablation of FgfS within the 
pharyngeal endoderm of Tbxl heterozygotes ; F at E9.5 also increases
the penetrance of PAA defects (Vitelli et al., 2006). These experiments have led to the 
conclusion that the endoderm is the site of Tbxl and FgfS interaction in arch artery 
development. However, recent studies examining the tissue and time specific 
requirements for these genes in PAA development suggest that the interaction between 
Tbxl and FgfS in this process is more complex (Macatee et al., 2003; Park et al., 2006; 
Vitelli et al., 2006; Xu et al., 2005; Zhang et al., 2005). Firstly, conditional mutants 
have demonstrated that ectodermal FgfS is specifically required for fourth PAA 
development although a role for endodermal FgfS has not been ruled out (Macatee et 
al., 2003; Park et al., 2006). Tbxl is also required within the pharyngeal ectoderm for 
PAA development (Arnold et al., 2006b; Zhang et al., 2005). However, FgfS is robustly 
expressed in the ectoderm of TbxT^' mutants demonstrating it is unlikely that these two 
genes interact in this tissue (Arnold et al., 2006b; Zhang et al., 2005). In addition, Tbxl 
is required early in development, between E7.5 and E8.5, for development of the fourth 
arch artery (Xu et al., 2005). In contrast, reduction of FgfS expression within the 
endoderm of Tbxl heterozygotes at E9.5 is sufficient to increase PAA defects (Vitelli et 
al., 2006). Thus, it is still unclear whether FgfS is directly regulated by Tbxl.
In addition to FgfS, a number of other Fg/'ligands are downregulated in TbxT^' mutants. 
F gf 10 expression is diminished in the SHF domain and FgfS is downregulated in the 
pharyngeal endoderm of TbxT^' embryos (Aggarwal et al., 2006; Hu et al., 2004; Kelly 
et al., 2004; Kochilas et al., 2002; Vitelli et al., 2002b). Even though FgflO appears to 
be directly regulated by Tbxl in cell culture experiments (Xu et al., 2004), there is no 
evidence as yet to suggest an in vivo genetic interaction between FgflO and Tbxl 
(Aggarwal et al., 2006; Kelly and Papaioannou, 2007). A combination of double and 
triple knockout mutants between Tbxl, FgfS and F gfl0 in the mesoderm and Tbxl, FgfS 
and FgfS in the endoderm has not revealed any genetic interaction in pharyngeal or 
heart development (Aggarwal et al., 2006; Kelly and Papaioannou, 2007). Considering 
that additional F gf family members are also expressed in the pharyngeal region, for 
example Fgfl5 (Vincentz et al., 2005), Fgf4 (Niswander and Martin, 1992) and F gfl6 
(Wright et al., 2003), it is possible that functional redundancy among Fgfs may have 
affected analyses of epistasis with Tbxl. Furthermore, the Fg/'receptor, Fgfrl has 
recently been identified as downregulated in the pharyngeal endoderm and mesenchyme 
of Tbxl^^' and TbxT^' mutants and has been implicated in OFT development (Park et al.,
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2006). Overall, these studies suggest that Fgf signalling plays an important role 
downstream of Tbxl in development. However, the precise functions of each Fg/'ligand 
and receptor are still being investigated.
The transcription factor, Pitx2 represents another downstream target of Tbxl 
(Nowotschin et al., 2006). Pitx2 in involved in signalling pathways mediating left-right 
asymmetry during development and is left-asymmetrically expressed during 
development of the heart (Kitamura et al., 1999; Liu et al., 2002; Schweickert et al.,
2000). Mouse knockouts of Pitx2c, the left-asymmetrically expressed isoform of Pitx2, 
exhibit PAA abnormalities, VSD, atrial septal defects (ASD), atrioventricular (AV) 
valve and OFT alignment defects (Kitamura et al., 1999; Liu et al., 2001; Liu et al., 
2002). Analysis of the expression of Tbxl and Pitx2 during development has 
demonstrated that both genes are asymmetrically expressed in the left SHF and Pitx2 is 
downregulated in this domain in TbxT^' mutants (Nowotschin et al., 2006). Tbxl and 
Pitx2 appear to genetically interact during cardiovascular development with Tbxl^^' 
;Pitx2^^' double heterozygotes exhibiting more severe OFT alignment defects, VSD, 
ASD and AV valve defects than either heterozygote, alone. Furthermore, in vitro 
experiments show that Tbxl and Nkx2.5 synergistically activate a Pitx2 enhancer 
suggesting that Pitx2 is a direct target of Tbxl (Nowotschin et al., 2006). In contrast to 
the SHF, Tbxl appears to act downstream of Pitx2 during muscle development within 
the first pharyngeal arch (Shih et al., 2007). It is not known whether branchiomeric 
myogenesis is abnormal in Tbxl^^';Pitx2^^' mutants. However, these results highlight 
the fact that different interactions can occur between the same genes, depending on the 
tissue.
In order to identify additional targets of Tbxl, a microarray was carried out in our lab 
comparing the gene expression profile of Tbxl-mA\ mutants to wild type embryos.
This study identified a number of potential downstream Tbxl targets including Gbx2, 
Gcm2, Pax9 and the RA-catabolizing enzymes, Cyp26al, bl and cl (Ivins et al., 2005; 
Roberts et al., 2006).
Knockout mouse mutants of the transcription factor, Gbx2 display pharyngeal and heart 
defects reminiscent of DGS including craniofacial, great vessel and outflow tract 
anomalies (Byrd and Meyers, 2005). Gbx2 is down-regulated in both TbxP'' mice and 
Fgf8 hypomorphs and Tbxl and Gbx2 appear to genetically interact in PAA
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development (A. Calment and S. Ivins, pers.comm., (Byrd and Meyers, 2005)). In 
addition, compound Gbx2^^';Fgf8^^' heterozygotes display PAA defects not seen in 
single heterozygotes and also exhibit thymic anomalies (Byrd and Meyers, 2005). 
Altogether these results imply that Fg/8 and Gbx2 interact genetically and may be 
downstream of Tbxl.
RA is very important for pharyngeal development and dysregulation of RA levels 
recapitulates the DGS phenotype (see section 1.2.2). The Cyp26 family of retinoic acid 
metabolising enzymes consist of three genes, Cyp26al, Cyp26bl and Cyp26cl which 
encode enzymes required to catabolize the active retinoic acid metabolite to an inactive 
form (Fujii et al., 1997; White et al., 1996). In TbxF^' mutants, expression of the Cyp26 
genes is dysregulated in the pharyngeal region (Guris et al., 2006; Ivins et al., 2005; 
Roberts et al., 2006). Inhibition of Cyp26 enzyme function in the chick phenocopies 
DGS and results in caudal pharyngeal arch and arch artery defects, a hypoplastic otic 
vesicle and OFT defects similar to TbxT^' mice which are considered to occur as a result 
of the subsequent increase in RA levels within these embryos (Roberts et al., 2006). 
These results suggest that the Cyp26 genes act downstream of Tbxl in pharyngeal 
development however, it is unclear as yet whether they are direct or indirect targets.
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1.10 AIMS AND OVERVIEW
Animal models of gene present on homologous regions of 22ql 1 have revealed that 
several of these genes contained within chromosome 22ql 1 may function in pharyngeal 
and heart development, the main processes affected in DGS patients. Considering the 
highly variable phenotype and lack of a critical minimally deleted region, these findings 
suggest that DOS is a contiguous gene syndrome. However, the role of Tbxl in DGS 
appears to be particularly important. It is the only gene in this region that has been 
shown to be dose-sensitive in mouse development and the only gene in which mutations 
have been associated with DGS in humans. The extremely variable DGS phenotype can 
also be at least partly explained by the dosage effects of Tbxl and sequence variations in 
Tbxl regulators and downstream genes. While the developmental role of Tbxl has been 
extensively studied, the genetic pathways which lie downstream have yet to be fully 
characterised and may reveal additional genes which modify the DGS phenotype.
The overall aim of this project was to identify and characterise genes important in the 
development of structures affected in DGS, namely the pharyngeal apparatus and heart. 
Multiple approaches were taken in order to achieve this aim. First, a microarray 
analysis of -expressing cells was carried out to identify downstream targets of Tbxl 
(Chapter 3). This experiment required a novel technique to be optimised for isolation of 
Tbxl-lacZ expressing cells. To complement these studies, BAC recombineering 
experiments were also undertaken to generate a GFP-labelled Tbxl allele enabling 
easier isolation of Tbxl cells for future experiments (Chapter 4). One of the genes 
identified by microarray as a potential Tbxl target, Hesl, was further characterised. This 
revealed a previously unknown defect in craniofacial and cardiovascular development 
(Chapter 5). Finally, in a different approach to finding novel genes which may cause or 
modify a DGS-like phenotype, DGS patients without the typical deletion were 
investigated. FISH was used to map the breakpoint in DGS patients with t(l 1 ;22) 
translocations. This led to the identification of a potentially disrupted gene, H1C2, 
whose function was analysed using gene trap mouse models and which was shown to 
play a role in heart development (Chapter 6).
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CHAPTER 2. METHODS
2.1 REAGENTS
All reagents were of AnalaR grade and supplied by Sigma Aldrich or BDH unless 
otherwise stated. Solutions were made using milliQ water and autoclaved where 
appropriate.
2.2 STOCK SOLUTIONS
20 X SSC
FISH hybridisation buffer 
ST buffer 
IE  pH 8.0 
LB broth 
LB agar
NB buffer (10 x ) (Bioline)
lOmM dNTP
TAE buffer (10 x)
DNA ladder 
Loading buffer (6 x)
Tail lysis buffer
TBE buffer (5 x) 
Prehybridisation buffer
PBTX
TBTX
3 M NaCl, 0.3 M sodium citrate pH 7.0
50% FA, 10% dextran sulfate, 2 x SSC, 1 x PBS
0.05% Tween 20, 2 x SSC
10 mM Tris-HCl ph 8.0, 1 mM EOT A pH8.0
1% Bactotryptone, 0.5% Bactoyeast, 1% NaCl
2% Bactoagar, 1% Bactotryptone, 0.5% Bactoyeast,
1% NaCl
lOOmM Tris-HCl, 400 mM NaCl, 15 mM MgCL, 2.5 mM 
spermidine
10 mM dATP, 10 mM dCTP, 10 mM dGTP, 10 mM 
dTTP
0.4 M Tris-acetate, 10 mM EDTA pH 8.0 
50 ng/fxl DNA ladder in 1 x loading buffer 
10 mM Tris-HCl pH 7.5, 50 mM EDTA pH 8.0, 10% 
Ficoll 400, 0.4% Orange G
100 mM Tris-HCl pH 8.5, 5 mM EDTA pH 8.0, 0.2% 
SDS, 200 mM NaCl, 100 pig/ml proteinase K (added 
immediately prior to use)
0.45 M Tris-borate, 0.01 M EDTA pH 8.0 
50% formamide, 1.3 x 20xSSC, 5 mM EDTA pH 8, 
50pig/ml yeast RNA, 0.002% Tween 20, 0.5% CHAPS, 
100 |xg/ml heparin in water.
0.1%TritonX-100 in PBS
50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% TritonX- 
100, water.
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X-gal buffer 20 mM K3Fe(CN)6, 20 mM K4Fe(CN)6-3H20, 5 mM
EOT A, 2 mM MgCb, 0.02% NP40, 0.01% Deoxycholate, 
PBS. 1 mg/ml X-gal is added immediately prior to use.
2.3 MOUSE STRAINS, BREEDING AND GENOTYPING
2.3.1 Mouse strains
Dfl and Tbxl mice were obtained from Antonio Baldini, Baylor college of medicine, 
Houston, Texas, USA. The Dfl mice contain a 1.2 Mb deletion of chromosome 16 
(Lindsay et al., 1999) and the Tbxl mice contain a non-functional Tbxl allele which was 
generated by knocking in a lacZ reporter gene into exon 5 of Tbxl (Lindsay et al.,
2001). The mice were maintained on a C57B1/6 background.
Hesl mice were obtained from Francois Guillemot, National Institute for Medical 
Research, London, UK. The Hesl mouse was generated by replacing the first three 
exons with a PGK-«eo cassette (Ishibashi et al., 1995). The mice were maintained on a 
MFl background.
Hic2 gene trap (RRN127) mice were obtained from BayGenomics, University of 
California, San Francisco, USA, originally on a 129P2 background. The mice were 
crossed to a C57B1/6 background. Hic2 gene trap mice were generated by random 
integration of a pGTOLxf gene trap vector into intron 2 of Hic2.
TgTbxlfioxGFP mice were generated by Genoway (France) through pronuclear 
injection of fertilized C57B1/6 oocytes with a modified 76x7-containing RP23-35B9 
BAC. Mice were maintained on a C57B1/6 background.
Adult mice were paired overnight and the females were checked in the morning for the 
presence of a copulation plug. At midday, females with a copulation plug were 
considered to be at embryonic day (E) 0.5. Pregnant females were killed by cervical 
dislocation and the uterus was placed in DMEM + 25 mM HEPES for further 
dissection.
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2.3.2 DNA extraction
23,2,1 Tail biopsies
DNA was extracted from tail tips taken from pups aged approximately 10 days for 
genotyping. 3 mm tail tips were digested with 4 [xl 10 mg/ml proteinase K (Roche) in 
400 pi tail lysis buffer (see stock solutions) at 55°C overnight. For DNA precipitation, 
400 pi 100% isopropanol was added and samples were spun at 12 000 x g for 30 
minutes at 4°C. The DNA pellet was washed in 70% ethanol and spun at 12 000 x g for 
10 minutes at 4°C and finally the DNA pellet was resuspended in 200 pi TE pH 8.0. 2- 
4 pi was used for PCR.
2.3.2.2 Yolk sacs
As embryos were collected, corresponding yolk sacs were collected and mixed with 50 
pi PBS and 2 pi 10 mg/ml proteinase K (Roche) and incubated at 55°C overnight. The 
following day, the yolk sac DNA mix was heated at 100°C for 5 minutes to inactivate 
the proteinase K and then spun down at 12 000 x g for 5 minutes. 2pl was used for 
PCR.
2.3.3 Genotyping
Genotyping of embryos was carried out by PCR analysis of yolk sac or tail tip genomic 
DNA using the following primers.
Table 2.1 Mouse mutant genotyping primers
Mouse line Primer name Sequence Notes
Tbxl
(Lindsay et al. 2001)
TbxWTF3
TbxWTR3
TbxWTF3
TbxTARZR
AGTCTGGGGACTCTGGAAGG
AAGGCAGATCCTGCTACACC
AGTCTGGGGACTCTGGAAGG
TCGACTAGAGCTTGCGGAAC
wt allele 
mutant allele
Dfl
(Lindsay et al. 1999)
UFDTAR2F
UFDTAR2R
TCTTTGTCAGCAGTTCCCTTT
TGGGCAATTGTTTAATCTTCC
mutant allele
Hesl
(Ishibashi et al. 1995)
HeslWT-F
HeslWT-R
HeslpoiyA-F
Heslintron3-R
CCCCTTTGCAGTCATCAAAG
GCATTGCTCACTTACATCTTTC
GGGAGGATTGGGAAGACAAT
GGCGGAAGTCTGGAAGAAAT
wt allele 
mutant allele
Hic2 EN2-F
EN2-R
AACAAACTTGGCCTCACCAG
GCCAAGGCCATACAAGTGTT
mutant allele
TgTbxlfioxGFP GFPend_F 
Tbxl intron 1-R
CCACTACCTGAGCACCCAGT
GCCTGGAGAAAATCCACAGA
transgenic allele
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2.4 DNA AMPLIFICATION BY POLYMERASE CHAIN REACTION
2.4.1 Primer design
Primers were designed using the Primer3 program Oittp://primer3. sourceforge.net/) and 
ordered through Sigma. Forward and reverse PCR primers were designed on the 
following criteria: GC content approximately 50-60%, length between 20-30bp, absence 
of repeat sequences and similar melting temperatures (Tm). Primers were checked on 
the Sigma ordering website to ensure they would not anneal to one another.
2.4.2 PCR primers
Table 2.2 Analysis of FACS-enrichment of Tbxl cells
Label Primer name Sequence (5' to 3') Product size (bp)
GAPDH mGAPDH-F TGCACCACCAACTGCTTAG 175
mGAPDH-R GATGCAGGGATGATGTTC
Tbxl-lacZ IRESLACZ-F TCGGTGCACATGCTTTACAT 166
IRESLACZ-R g t t t t c c c a g t c a c g a c g t t
Tbxl-wt Ex4-F TTTGTGCCCGTAGATGACAA 238
Tbxlex6-R AATCGGGGCTGATATCTGTG
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Table 2.3 BAC Recombineering primers
Primer
label Primer name Sequence (5’ to 3’) Product size (bp)
a GFP-F ACGTAAACGGCCACAAGTTC 186
b GFP-R AAGTCGTGCTGCTTCATGTG
c Iresgfpl880-F GAGCAAAGACCCCAACGAGAA 1344 (-Kan), 3490 (+Kan)
d mTbxlexonl-2-R TGTCATCTACGGGCACAAAG
e mTbxlexonl-2-F TGAAGAAGAACCCGAAGGTG 271
f Exon4-IRES-R AGACCCCTAGGAATGCTCGT
g GFPend-F CCACTACCTGAGCACCCAGT 587
h Tbxl intron 1-R GCCTGGAGAAAATCCACAGA
i SNP55Kbup-F CACAATGGTGAGGTCTGTCG 212
j SNP55Kbup-R GACCTGGGTCCTTGTGAGAA
k SNPlOKbup-F CACATTCACCTCACAGGCTCT 242
1 SNPlOKbup-R CCTTTGCTGTCTGCATCTGA
m SNP50Kbdown-F CTGTGATATCAATGTTCAAGCAAG 240
n SNP50Kbdown-R GAAACAGAGAGCAAGCACCTC
0 pBACeamp-F CGATATCCCGCAAGAGGCCCGGCvA
GTACCGGCATAACCAAGCCTATGC
CTTCTTAGACGTCAGGTGGCAC 1121
P pBACeamp-R GGTGTGCGGTTGTATGCCTGCTGT
GGATTGCTGCTGTGTCCTGCTTATC
CCTCACGTTAAGGGATTTTGGTC
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2.4.3 PCR
Reactions were carried out in a final volume of 25 \i\ in PCR tubes. The following PCR 
mix and conditions were used for the majority of PCRs:
20-50 ng genomic DNA
1 X  NB buffer
200 pM each dNTP
1.5mM MgCli
0.8 (iM forward primer
0.8 pM reverse primer
1 U Taq Polymerase (Bioline)
In sterile, distilled water
The standard program used for most PCRs was 94°C for 2 minutes, followed by 30 
cycles of 94°C for 30 seconds, an annealing temperature dependent on the primers used 
(typically between 55-65°C) for 30 seconds and an elongation step of 72°C for 30 
seconds. An aliquot of each sample was checked by agarose gel electrophoresis.
2.4.4 Agarose gel electrophoresis
DNA was separated on a 1-2% agarose gel containing 0.5pg/ml ethidium bromide in 1 
X  TAE. An appropriate 100 bp or 1 Kb DNA ladder (Invitrogen) was also loaded. 
Samples were run in a l/6th volume of loading buffer and gels were electrophoresed at 
50-150V until the fragments had separated sufficiently. DNA was visualised by UV 
illumination.
2.5 SEQUENCING
2.5.1 Cycle sequencing
Cycle sequencing reactions were set up using BigDye Terminator v3.1 (Applied 
Biosystems) for running on the MegaBACE (Amersham Biosciences) which uses 
thedideoxynucleotide chain termination method for sequencing. Sequencing reactions 
were carried out in 10 /<1 reaction volumes as follows: 3 pi miniprep plasmid DNA, 
5pmol forward or reverse primer and sterile water were heated to 95°C for 5 minutes 
then 2 pi dilution buffer and 1 pi BigDye premix was added. The sequencing program 
used consisted of a dénaturation step of 95°C for 5 minutes then 36 cycles of 95°C for
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20 seconds, 50°C for 10 seconds and 60°C for 3 minutes. The reaction volume was 
topped up to 20 pi\ with sterile water.
Samples were sequenced by an in house sequencing facility. Files from the 
MegaBACE were downloaded in ABD format and checked using the Sequencher v4.2 
program.
2.6 REVERSE-TRANSCRIPTION-POLYMERASE CHAIN REACTION
2.6.1 RNA extraction
RNA was extracted from tissues using 1ml Trizol reagent (Invitrogen). The tissue was 
homogenized by passing the sample twice through a 25-gauge needle then the sample 
was left to sit at room temperature for 5 minutes to allow complete dissociation of 
nucleoprotein complexes. 200 pil of 49:1 chloroform:isoamyl alcohol was added to 
each sample and vortexed for 30 seconds. The samples were then left for 2 minutes at 
room temperature before being spun at 12 000 x g for 5 minutes at 4°C to separate the 
aqueous, RNA-containing phase from the organic phase. The aqueous phase was 
collected into another eppendorf tube and 500 (il ice-cold isopropanol was added and 
the samples incubated at -20°C for 1 hour to overnight. The sample was then 
centrifuged at 12 000 x g for 30 minutes at 4°C to pellet the RNA and subsequently the 
pellet was washed with 1 ml of 70% ethanol and spun again at 12 000 x g for 10 
minutes. Finally, the RNA pellet was resuspended in 50 pil RNAse-free water.
2.6.2 Reverse transcription (RT) and RT-PCR
cDNA was synthesized using 1-5 p,g total RNA which was added to 0.5 \i\ 500 ng/p,l 
random primers (Promega), 1 |il 10 mM dNTP and water to a final volume of 12 pil. 
This mixture was incubated at 65°C for 5 minutes then placed on ice. 4 pil 5 x reverse 
transcriptase buffer and 2 pil 100 mM DTT were added to the mix which was then 
heated to 25°C for 2 minutes. 1 pil 200 Units/pil Superscript reverse transcriptase II 
(Invitrogen) and water were added to a total volume of 20 \i\ and the mixture was 
incubated at 25°C for 10 minutes, 42°C for 50 minutes and finally, 70°C for 15 minutes 
to inactivate the reaction.
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2.7 CLONING
2.7.1 Plasmid mini-preps
IMAGE clone plasmid DNA was received as a culture streaked onto an agar slope 
(Geneservice, UK). On arrival, bacteria were streaked out onto LB plates containing 
the appropriate antibiotic and left to grow overnight at 37°C. A culture of 3ml LB broth 
containing the appropriate antibiotic was inoculated with one colony and incubated at 
37°C, shaking overnight. 15% glycerol stocks were prepared and stored at -80°C. 
Purified plasmid DNA was isolated using the Spin miniprep kit microcentrifuge 
protocol (Qiagen). Plasmid DNA was eluted in either water or Buffer EB. Bacterial 
artificial chromosomes (BACs) were received as either stab cultures (BAC PAC) or 
glycerol stocks (Invitrogen).
2.7.2 Digests
Digests of plasmid DNA were carried out in a total volume of 30 pil using 1-2 |ig 
plasmid DNA, 3 pil 10 x enzyme buffer, 0.3 pi 100 x BSA, 1-2 units of enzyme and 
water. The plasmids were digested at the appropriate temperature for optimal enzyme 
activity for 2 hours and then run on an agarose gel for analysis.
Digests of BAC DNA were carried out in a total volume of 50 pi using 20 pi BAC 
miniprep DNA, 5 pi 10 x enzyme buffer, 0.5 pi 100 x BSA, 1-2 units of enzyme and 
water. BACs were digested at the appropriate temperature for optimal enzyme activity 
for at least 2 hours and then run on an agarose gel for analysis.
2.7.3 Gel extraction
Gel extraction was carried out to isolate and purify DNA fragments from agarose gels. 
The Qiagen QlAquick gel extraction kit was used following the manufacturer’s 
instructions and DNA was eluted fi"om the column in 30 pi water.
2.7.4 De-phosphorylation of plasmids
Digested plasmids were de-phosphorylated to remove the phosphate groups from the 5’- 
ends to prevent self-ligation of the vector. The following components were mixed 
together: 30 pi gel-purified, digested plasmid DNA vector, 5 pi 10 x SAP buffer (USB), 
0.5 units Shrimp Alkaline phosphatase (SAP) (USB) and water to make a total volume 
of 50 pi. The mixture was incubated at 37°C for 1 hour, then at 65°C for a further 15 
minutes to inactivate SAP.
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2.7.5 Oligonucleotide annealing
To ligate oligonucleotides (oligos) into a vector, oligo ligation was carried out 
according to the following protocol: 2.5 pM each of two complementary oligos was 
added to 10 mM MgCb and 20 mM Tris-HCl pH7.5 in a final volume of 100 pi. The 
oligos were denatured at a few degrees below their melting temperature for 5 minutes 
and allowed to cool to room temperature for at least 10 minutes to allow annealing of 
the complementary oligos.
2.7.6 Ligation
Ligation of the plasmid vector and the annealed oligos was carried out by mixing 
together the following components: lOOng plasmid, 1 pi 10 x ligation buffer 
(Promega), 0.25-3 pi annealed oligos, 3 units T4 DNA ligase (Promega) and water to 
make a total volume of 10 pi. The vector and oligo were allowed to ligate overnight at 
4°C.
2.7.7 Transformation
Transformation of the plasmid DNA into subcloning efficiency DH5a competent cells 
(>10^ cfu/pg DNA, Gibco BRL) was carried out according to the following protocol: 3 
pi ligation reaction (from 2.7.6) or 1-10 ng plasmid DNA was added to 30 pi thawed 
DH5a competent cells and incubated on ice for 20 minutes. The cells were heat 
shocked by incubating at 37°C for 20 seconds and then placed back on ice. 900 pi LB 
broth was added and the cells were incubated at 37°C, shaking for 1 hour for 
expression. After expression, the cells were plated onto LB agar plates containing the 
appropriate antibiotic and incubated at 37°C overnight.
2.8 BAC RECOMBINEERING
2.8.1 Preparation of BAC DNA 
2.8.L1 BAC Maxiprep
Bacterial artificial chromosomes (BACs) were received as either stab cultures (BAC 
PAC) or glycerol stocks (Invitrogen). On arrival, bacteria were streaked out onto LB 
plates containing the appropriate antibiotic, either 20 pg/pl chloramphenicol or 15 pg/pl 
kanamycin and left to grow overnight at 37°C. A starter culture of 3ml LB broth with 
the appropriate antibiotic as above was inoculated with one colony and incubated at
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37°C, shaking overnight. 1 ml of the starter culture was transferred to a 2 L flask 
containing 500 ml LB broth with the appropriate antibiotic and incubated at 37°C, 
shaking overnight. 15% glycerol stocks were prepared and stored at -80°C.
Cells were harvested and the DNA was isolated using the maxiprep plasmid purification 
kit protocol for the isolation of low copy number plasmids (Qiagen), following 
manufacturer’s instructions. The final DNA pellet was dissolved in lOOpil TE pH 8.0. 
Quality and quantity of the BAC DNA was determined by spectrophotometric 
measurement of OD260/OD280 values.
2.8.1.2 BAC Miniprep
A culture of 2ml LB broth containing the appropriate antibiotic was inoculated with one 
colony and incubated at 32°C or 37°C, shaking overnight. The following day the 
culture was spun for 10 minutes at 400 x g and the pellet resuspended by vortexing in 
0.3 ml PI solution (see stock solutions). The DNA was lysed using 0.3 ml P2 solution 
in which the mixture was gently shaken and allowed to sit for 5 minutes at room 
temperature. Renaturation of BAC DNA was carried out by the slow addition of 0.3 ml 
P3 solution. The mixture was incubated on ice for 5 minutes then spun at 8000 x g for 
10 minutes at 4°C. The supernatant was transferred to another eppendorf tube 
containing 0.8 ml ice-cold isopropanol, mixed and incubated on ice for 5 minutes. The 
mixture was then spun for at 12000 x g for 15 minutes at 4°C. The DNA pellet was 
washed with 0.5 ml 70% ethanol and spun at 12000 x g for 5 minutes at 4°C. BAC 
DNA was resuspended by addition of 40 pi TE pH 8 without pipetting to prevent DNA 
shearing.
2.8.2 Making electrocompetent cells
EL250 or SW105 bacterial cells are modified BAC host strains that carry a defective 
prophage supplying functions which protect and recombine electroporated, linear DNA 
(Lee et al., 2001). These functions are under tight control of the temperature-sensitive X 
repressor so recombination functions can be transiently supplied by increasing the 
temperature to 42°C (Lee et al., 2001). EL250 cells were therefore maintained at 32°C.
To prepare electrocompetent cells, 2 ml overnight LB broth cultures were grown at 
32°C and then diluted 50-fold in LB broth and grown to an ODôoo 0.5-0.7. 10 ml 
cultures were induced for recombination gene expression by shifting the cells to 42°C
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for 15 minutes and then chilled on ice for 20 minutes. Cells were then spun at 5500 x g 
for 5 minutes at 4°C and washed with 1.5 ml ice-cold, sterile water which was repeated 
three times. Finally, cells were resuspended in 50 p,l ice-cold, sterile water and 
electroporated. For electroporation of BACs, the induction step was omitted.
2.8.3 Electroporation into EL250/SW105 cells
Transformation of DNA into EL250/SW105 cells was carried out by electroporating 
300 ng BAG DNA or linearised, plasmid DNA into 50 pil of ice-cold, competent cells in 
0.1 cm cuvettes in a Bio-Rad gene puiser set at 1.8kV. 1 ml of LB broth was added 
after electroporation and the cells were grown for 1.5 hours, shaking at 32°C and then 
plated onto LB agar plates containing the appropriate antibiotic.
2.8.4 Removal of the kanamycin/neomycin resistance genes
Prior to pronuclear injection of the recombined BAG into oocytes to generate transgenic 
mice, the kanamycin/neomycin selectable markers were removed. 2 ml LB broth 
overnight cultures were prepared from individual colonies, diluted 50-fold in LB 
medium and grown at 32°G to an ODôoo of 0.5. flpe expression in EL250/SW105 cells 
was induced by addition of 0.1% L-arabinose in LB medium and cells were incubated 
for 1 hour, shaking at 32®G. The bacterial cells were then diluted 10-fold in LB 
medium, grown for another hour and then serial dilutions were plated onto LB agar with 
20 ^g/pl chloramphenicol. The plates were incubated overnight at 32°G and the next 
day colonies were replica-plated onto LB agar plates containing 15 ptg/|il kanamycin to 
test for loss of kanamycin resistance and on chloramphenicol plates to allow recovery of 
kan-sensitive colonies.
2.8.5 Field Inversion Gel Electrophoresis (FIGE)
FIGE was used to separate large fragments of DNA obtained after digesting BAG DNA. 
FIGE works on the principle that by altering the electric field between spatially distinct 
electrodes, large DNA fragments are able to reorient and move at different speeds 
through the agarose gel allowing for better separation of large DNA molecules. There 
is a net downward migration of the DNA through the gel by using an asymmetric 
voltage. BAG DNA fragments were resolved by running the DNA in a 1% agarose gel 
containing 0.5 p-g/jxl ethidium bromide in 0.5 x TBE for 16 hours with a switch time of
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0.1-0.4 seconds, a 21% linear switch time ramp, a forward voltage of 180V and a 
reverse voltage of 120V. DNA fragments were visualised by UV illumination.
2.9 FLUORESCENT 77V 5 /r U  HYBRIDISATION (FISH)
2.9.1 Mammalian cell culture
Epstein Barr Virus (EBV)-transformed patient B-cell lymphoblastoid cell lines were 
cultured in RPMI 1640 medium with glutamax (Gibco) supplemented with 10% fetal 
calf serum and 1% penicillin/streptomycin (Gibco). Cells were maintained at 37°, 5% 
CO2 in a humidified atmosphere. Patient cell lines FN and FYl 198 were obtained from 
ECACC, Porton Down, UK and Dr James Lespinase, respectively.
2.9.2 Preparation of metaphase spreads
Metaphase spreads were prepared from 50ml patient cell cultures. Cells were spun 
down and resuspended in fresh culture medium 24 hours before harvesting. Mitotic 
arrest was induced by incubating a uniform cell suspension with colcemid (10 pg/pl) 
(Gibco) to a final concentration of 0.1 ml/10 ml for one hour at 37°C, 5% CO2 . Cells 
were subsequently spun down at 500 x g for 8 minutes and the supernatant removed.
The cell pellet was resuspended in 25-30 ml hypotonic 75 mM KCl to spread out the 
chromosomes and incubated at 37°C, 5% CO2 for 10 minutes. Cells were again spun at 
500 X  g for 8 minutes, supernatant discarded and cells were suspended in 25-30 ml fresh 
fixative solution (3:1 methanol:glacial acetic acid). This fixative wash step was 
repeated for a total of three times. The cell pellet was then resuspended in 3-5 ml 
fixative solution and stored at -20°C.
To make metaphase spreads, 1 ml of the cell suspension was spun at 2000 x g for 1 
minute and resuspended in 300 \i\ fresh fixative and dropped from 20-30cm onto glass 
slides that had been kept at -20°C and subsequently humidified. This enabled the 
chromosomes to spread out when the cells burst as they are dropped from above. Slides 
were then dried and a diamond marker was used to locate the drop. Finally the slides 
were flooded with fresh fix solution, left to dry and the metaphase spreads were stored 
at 4°C.
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2.9.3 Nick translation and precipitation of BAC probes
To obtain 300-500 bp labelled DNA fragments suitable for FISH, purified BAC DNA 
was nick translated using a nick translation kit (Vysis). The nick translation reaction 
incorporates a fluorescent label into the DNA probes by nicking the DNA using 
deoxyribonuclease I (DNase I) and then incorporating the fluorescent nucleotide into 
the DNA strand as it repairs the nicks using E. Coli DNA polymerase I.
Reactions were carried out in a total volume of 50 pi containing: 1 pg BAC DNA, 0.5 
nM dTTP, InM each of dATP, dCTP, dGTP, 1 x nick translation buffer, 5 units nick 
translation enzyme and nuclease-free water. The component were added in the above 
order, mixed by pipetting and incubated at 15°C for 8 hours then stopped by heating to 
70°C for 10 minutes.
Probes were precipitated using human Cot-1 DNA (Invitrogen) and herring testes DNA 
(Promega) in order to suppress cross-hybridisation to human repetititve DNA and 
remove unincorporated nucleotides. 20 pi of nick translated DNA was added to 6 pg 
Cot-1, 12 pg herring testes DNA and water to a total volume of 50 pi, mixed by 
pipetting and then 4 pi 3 M sodium acetate and 112 pi 100% ethanol were added. The 
mixture was put at -80°C for at least 40 minutes then centrifuged at 12 000 x g for 30 
minutes at 4 °C. The supernatant was removed and the pellet resuspended in 40 pi 
hybridisation buffer and incubated at 37°C for at least 2 hours. Probes were stored at - 
20T .
2.9.4 Fluorescence in situ hybridisation, washes and detection
Metaphase spread slides were incubated in 2 x SSC for 1 hour at 4°C then dehydrated in 
70% ethanol, 90% ethanol and 100% ethanol for 5 minutes each and left to air dry. 5 pi 
each of the precipitated, nick translated BAC probes were mixed with the 5 pi of the 
control BAC probe and pipetted onto the centre of the slide. A 22 x 22 mm coverslip 
was applied and sealed with a thick layer of vulcronising rubber solution (Weldtite). 
Slides were placed in a hybridisation chamber and denatured at 72°C for 2 minutes then 
incubated at 37 °C overnight in the dark.
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After incubation, the slides were kept in the dark, the coverslip was removed and slides 
were washed in ST buffer for 5 minutes at room temperature, 0.4 x SSC, 0.3% NP-40 at 
72°C for 2 minutes and then washed again in ST buffer twice for 5 minutes each. Slides 
were left to dry before applying vectastain mounting medium containing DAPI (Vector 
Labs) to stain chromosomal DNA. Coverslips were applied and sealed with nail polish. 
Slides were viewed under a Zeiss Axioskop fluorescent microscope and images were 
taken using a Photometries camera with Smartcapture software.
2.10 MICROARRAY
2.10.1 Fluorescent Activated Cell Sorting (FACS)
2.10. L I CMFDG labelling o f a single cell suspension
E9.5 embryos were dissected out in DMEM + 25 mM HEPES containing 10% PCS.
The embryos were staged by somite counting and embryos were separated
from Dfl/+, and wild type embryos. CMFDG loading was carried out using
the Detectagene green CMFDG lacZ gene expression kit (Molecular Probes). In order 
to reduce background fluorescence by blocking endogenous lysosomal p-galactosidase 
activity, the embryos were incubated in 0.3mM chloroquine diluted in DMEM + 25 mM 
HEPES containing 5% PCS and incubated at 37°C, 5% CO2 for 30 minutes. Following 
three rinses in PBS, embryos were incubated in 0.25% trypsin (Gibco) in PBS for 
approximately 30 minutes during which the embryos were dissociated into a single cell 
suspension by trituration every 5-10 minutes using plastic pipettes, starting with larger 
tips and moving down to smaller tips. The single cell suspension was spun down at 300 
X  g for 3 minutes and resuspended in pre-warmed (10 minutes at 37°C) 50 \iM 
CMDFG, 200 pM verapamil in 5% FCS/DMEM + 25 mM HEPES and incubated for 30 
minutes at 37°C, 5% CO2. The verapamil was used to inhibit efflux of the fluorescent, 
CMFDG-glutathione adduct from the cells. Following incubation, the cells were placed 
on ice and diluted to approximately 1-3 million cells/mL with 5%FCS/DMEM + 25 
mM hepes. 1 mM PETG was added to stop the reaction and 1.5 pM propidium iodide 
was added to identify dead cells. Cells were flow-sorted as soon as possible.
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2.10.1.2 FACS analysis
Single cell suspensions were sorted using the Beckman Coulter Epics Altra cell sorter 
(High Wycombe) and analysed using the Expo2 software (Beckman Coulter) or using 
the MoFlo cell sorter (Dakocytomation,Fort Collins, Colorado) and analysed using the 
Summit v4.11 software (Dakocytomation). Cells were gated on the basis of forward 
scatter and side scatter characteristics to exclude debris. Propidium Iodide (PI) was 
used as a viability stain to exclude all dead cells. Cells which were fluorescent for FDG 
above background were collected into 10%FCS/DMEM + 25 mM HEPES and placed 
on ice. At least 50000 events were acquired for analysis.
Sorted cells were immediately spun down at 300 x g for 4 minutes and resuspended in 
800 \i\ Trizol (Gibco BRL). The cells were then homogenized by passing them twice 
through a 25-gauge needle and stored at -80°C.
2.10.2 Microarray
2.10.2.1 RNA extraction
Sorted cell samples in Trizol were thawed and 250 pig/ml glycogen (Roche) or 50 
pg/mL Glycoblue (Ambion) was added as an RNA co-precipitant to improve yield. The 
sample was then vortexed at high speed for 10 seconds and the genomic DNA was 
sheared by passing the sample twice again through a 25-gauge needle. 160 pi of 49:1 
chloroform:isoamyl alcohol was added to each sample and vortexed for 30 seconds.
The samples were then spun at 12 000 x g for 5 minutes at 4°C to separate the aqueous, 
RNA-containing phase from the organic phase. The aqueous phase was collected into 
another eppendorf tube and 400 pi ice-cold isopropanol was added and the samples 
incubated at -20°C for 1 hour to overnight. The sample was then centrifuged at 12 000 
X  g for 30 minutes at 4°C to pellet the RNA and subsequently the pellet was washed 
with 200 pi 70% ethanol and spun again at 12 000 x g for 10 minutes. Finally, the RNA 
pellet was resuspended in 30 pi RNAse-free water.
2.10.2.2 RNA amplification
The Microarray Target Amplification kit (Roche) was used for the PCR-based random 
amplification of cDNA from small amounts of RNA, while still maintaining the relative
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gene expression profile of transcripts between samples. This protocol works by using a 
unique Target Amplification Sequence (TAS) primer with no known homology to any 
sequence in public databases to reverse-transcribe the total RNA population and also for 
the subsequent PCR amplification of cDNA.
2.10.2.2.1 First strand cDNA synthesis
RNA was amplified according to the instructions provided in the microarray target 
amplification kit. For first strand cDNA synthesis, the RNA sample or 50 ng control 
RNA was added to 50 pmol of the TAS-T7 Oligo (dT)24 primer and water to a final 
volume of 10.5 pi and incubated at 70°C for 10 minutes. The samples were then placed 
on ice and the following components added: 1 x reverse transcriptase buffer, 10 mM 
DTT, 1 mM dNTP mix and 25 units of reverse transcriptase enzyme mix to a total 
volume of 20 pi. Samples were vortexed and spun down in a centrifuge and then 
incubated in a thermal cycler at 42°C for 60 minutes.
2.10.2.2.2 Second-strand cDNA synthesis
The RNAiDNA hybrid was then denatured at 95°C for 5 minutes and the sample placed 
on ice. For second-strand cDNA synthesis, the following components were added: 0.5 
mM dNTP mix, 500 pmol TAS-(dN)io primer, 1 x Klenow reaction buffer, 13.5 pi 
water and 8 units Klenow enzyme to a total volume of 50 pi. The sample was vortexed 
and spun down in a centrifuge and then incubated in a thermal cycler at 37°C for 30 
minutes.
2.10.2.2.2 Purification o f double-stranded cDNA
To purify the double-stranded cDNA, the Microarray Target Purification kit (Roche) 
was used. 1.25 pi carrier RNA and 50 pi double-distilled water was added to each 
sample. 400 pi Binding Buffer + 4 pi p-mercaptoethanol (Sigma) and 200 pi 100% 
ethanol was then added and the sample was mixed before adding it to a High Pure filter 
tube and spinning at 6000 x g for 15 seconds. The flowthrough was discarded and 500 
pi wash buffer was added before spinning again at 6000 x g for 15 seconds. 300 pi 
wash buffer was then added and the samples were spun at 12 000 x g for 1 minute.
After discarding the wash buffer, the filter tube was put into a new collection tube and 
spun again at 12 000 x g for 1 minute to remove any residual wash buffer. Finally, the 
filter tube was placed in a new collection tube and the purified double-stranded cDNA
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was eluted with 50 pil Elution buffer B by incubating for 1 minute at room temperature 
and then spinning at 6000 x g for 1 minute.
2.10.2.2.4 First PCR (Optimisation) and second PCR (random amplification o f  entire 
mRNA population)
To determine the optimal number of cycles for amplification of each cDNA sample to 
ensure the reaction is in the exponential phase, an optimisation PCR was carried out.
The PCR reaction contained the following components: 12.5 pi purified ds cDNA, 50 
pmol TAS primer, 0.2 mM dNTP mix, 73 pi double distilled water, 1 x Expand PCR 
buffer and 5.25 units Expand enzyme mix to make a total volume of 100 pi. The 
following PCR conditions were used: the samples were denatured at 95°C for 2 minutes 
followed by 30 cycles of amplification consisting of a dénaturation at 95°C for 30 
seconds, annealing at 55°C for 30 seconds and elongation at 72®C for 3 minutes. 10 pi 
samples were removed at 16, 18, 21, 24, 27 and 30 cycles for analysis by agarose gel 
electrophoresis on a 1.2% agarose gel. The optimum cycle for amplification of each 
sample (in which the reaction was in the exponential phase) was determined as the cycle 
at which a visible smear of DNA could be seen within a range of 0.7 to 2.2 Kb. 
Following determination of optimal cycle number for each sample, PCR amplification 
was carried out as outlined in the protocol above.
2.10.2.2.5 Purification o f PCR product
The amplified PCR product was purified using the microarray target purification kit as 
outlined above for the purification of double-stranded cDNA. Purification was initiated 
by addition of 400 pi Binding buffer + 4 pi p-mercaptoethanol to the PCR product. The 
purified PCR product was eluted in 50 pi Elution buffer B. The concentration and 
purity of the PCR product was determined by measuring the absorbance at 260 nm on a 
Nanodrop spectrophotometer (Labtech International).
2.10,2,3 In vitro transcription
The Microarray RNA Target Synthesis kit (Roche) was used to generate Biotin-UTP 
labelled transcripts at a labelling density of 1:3. In a sterile tube, in vitro transcription 
components were added in the following order: Sterile, RNAse-free water, 4 pi NTP 
mix A (1:3 label density consisting of 25 mM ATP, 25 mM CTP, 25 mM GTP and 16.7 
mM UTP), 1.67 mM Biotin-UTP (Roche), 10 mM DTT, 300 ng purified, amplified
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PCR product, 1 X  transcription buffer and 3 \ii transcription enzyme blend to make a 
total of 20 pi. In vitro transcription was carried out by incubating at 37°C for 3 hours.
2.10.2.3.1 Purification o f Biotin-UTP labelled cRNA
The Affymetrix GeneChip sample cleanup module (Qiagen) was used to purify the 
Biotin-UTP labelled cRNA according to the following protocol: 60 pi of RNAse-free 
water was added to the cRNA and mixed by vortexing for 3 seconds. Then 350 pi IVT 
cRNA Binding buffer was added to the sample and mixed by vortexing followed by the 
addition of 250 pi 100% ethanol. The sample was added to the IVT cRNA Cleanup 
Spin column and centrifuged for 15 seconds at 8 000 x g. The spin column was then 
transferred to a new collection tube, washed with 500 pi IVT cRNA Wash buffer and 
spun for 15 seconds at 8 000 x g. The flow-through was discarded and the column 
washed with 500 pi 80% ethanol and then spun again for 15 seconds at 8 000 x g. After 
the flow-through was again discarded, the spin column was centrifuged for 5 minutes at 
12 000 X g to remove any residual wash buffer. Finally, the spin column was put into a 
new collection tube and the purified cRNA was eluted by spinning at 12 000 x g for 1 
minute after the addition of 11 pi of RNAse-free water to the spin column and spinning 
again after the addition of 10 pi RNAse-free water. The concentration and purity of the 
cRNA samples was determined by measuring the absorbance at 260 nm on a Nanodrop 
spectrophotometer (Labtech International).
2.10.2.4 Microarray hybridisation
Six Dfl/Tbxl^°^^ samples and six Tbxl^^‘^ ^  ^samples were hybridised onto MOE430 v2 
oligonucleotide array chips (Affymetrix) consisting of over 45000 probe sets 
representing over 34000 mouse genes. Purified, biotin-UTP labelled cRNA was 
fragmented and hybridised onto MOE430 v2 microarray chips according to Affymetrix 
protocols and this was carried out by the ICH Gene Microarray Centre (London UK). 
Arrays were scanned using the Affymetrix GeneChip Scanner and array images were 
captured using the Microarray Analysis Suite v5 software package (MAS, Affymetrix). 
The report files were examined to establish quality of the hybridisation.
2.10.2.5 Genespring analysis
Genespring software version 4.2.1 (Silicon Genetics) was used for the comparison of 
D fl/Tbxl’^ ^^and Tbxf^^°^^ microarrays. Per chip normalisation used the 50^ percentile
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of all measurements as a positive control for each sample. Measurements for each gene 
were divided by this synthetic positive control. The bottom tenth percentile was used as 
a test for correct background subtraction. Per gene normalisation was then carried out, 
for which all 7 6 x 7 samples were normalised to 1 and all Dfl/Tbxl^°^^samples were 
normalised to the samples. The data from the mouse MOE430 v.2 microarray
chips was then filtered to exclude genes with signals below the raw value of 22. 
Seventeen out of twenty D fl genes represented on the chip were expressed above 
threshold levels. Iterative analyses were then carried out on the normalised data to 
determine the appropriate filters to apply to identify the majority of hemizygously- 
expressed D fl genes. Fourteen out of 17 D fl genes were downregulated to 0.83 in 5 out 
of 6 chips hybridised with the Dfl/Tbxl^^^^^ target. The resulting gene list was 
statistically analysed using the non-parametric t-test (Wilcoxon-Mann- 
Whitney/Kruskal-Wallis test) with a p-value cutoff of 0.05 and the Benjamini and 
Hochberg False Discovery Rate multiple testing correction was applied. In addition, the 
reciprocal analysis was conducted on the filtered, normalised data to identify genes 
showing relative, normalised expression of 1.17 or more in 5 out of 6 chips hybridised 
with the Dfl/Tbxl^^^^taigQX. The resulting gene list was statistically analysed using the 
same t-test and multiple testing correction as above.
2.10.3 Quantitative Real Time PCR
RNA used for quantitative real time PCR was obtained from an independent pool of 
TbxD'^^^ and DfllTbxl^^^ cells isolated from 10 E9.5 Dfl/Tbxl^^"^ embryos and 26 E9.5 
TbxÜ'^°^^ embryos, ranging in somite number from 18 to 24. RNA collected from pools 
of TbxV'^''^ and Dfl/Tbxl'^''^ cells was extracted, amplified and in vitro transcribed as 
per sections (see Microarray sections 2.10.2.1, 2.10.2.2 and 2.10.2.3). However, for in 
vitro transcription, 200 ng purified, amplified PCR product was used with NTP mix D 
(25 mM ATP, 25 mM CTP, 25 mM GTP and 25 mM UTP (Roche)). The cRNA was 
purified according to section 2.10.2.3.1.
2.10.3.1 cDNA synthesis
cDNA was synthesized using 500 ng PCR-amplified and Dfl/Tbxl^^^^ cRNA
which was added to 0.5 pi 500 ng/pl random primers (Promega), 1 pi 10 mM dNTP and 
water to a final volume of 12 pi. This mixture was incubated at 65 °C for 5 minutes then 
placed on ice. 4 pi 5 x reverse transcriptase buffer and 2 pi 100 mM DTT were added to
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the mix, which was then heated to 25°C for 2 minutes. 1 pil 200 units/pil Superscript 
reverse transcriptase II (Invitrogen) and water were added to a total volume of 20 fxl and 
the mixture was incubated at 25°C for 10 minutes, 42°C for 50 minutes and finally,
70°C for 15 minutes to inactivate the reaction. 230 pil of water was added to dilute the 
cDNA.
2,10.3,2 Quantitative real time PCR
PCR primers were designed to span one or more exons. Some primer sequences were 
obtained from Primerbank (http://pga.mgh.harvard.edu/primerbank/index.html), a 
public database of PCR primers specifically designed for use in real time PCR (Wang 
and Seed 03). Primers were synthesized by Sigma-Aldrich (UK) and sequences are 
included below (Table 2.4)
Reactions were carried out using MicroAmp™ (Applied Biosystems) optical strips and 
caps. Each amplification reaction contained 12.5 pi 2 x SYBR green PCR master mix 
(QIAGEN), 0.4 pi 20 pm forward and reverse primers, 5 pi diluted cDNA and water in a 
total volume of 25pi. PCR conditions were 95°C for 15 minutes, followed by 40 cycles 
of 95°C for 15s and 60°C for 1 min at which stage fluorescence measurements were 
taken. . All reactions were performed in triplicate on an ABI PRISM 7000 Sequence 
Detection System (Applied Biosystems). Product specificity was determined by 
analysing dissociation curves. These curves highlight the melting temperature of the 
double-stranded product and the presence of primer dimers. The PCR products were 
also run on an agarose gel to check that the correct sized product was amplified. 
Expression values were determined using the DART-PCR analysis excel software 
which takes into account the amplification efficiency of each gene to obtain relative 
quantities (Peirson et al., 2003). Relative changes in gene expression were calculated 
by comparing the normalised expression values in Dfl/Tbxl^°^^ samples to the 
normalised expression values in samples. Expression values for each gene
were normalised to Gapdh expression. Each gene was analysed in 3 separate 
experiments and values were reported as the mean fold change in Dfl/Tbxl'^^^ cells 
relative to Tbxl^^^^^  ^cells which were designated a value of 1.
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2.10.3.3 qRT-PCR primers 
Table 2.4 qRT-PCR primers
Gene Primer name Sequence (5’ to 3’)
Product 
size (bp)
Prim erBank
accession
num ber
Plek PLEK-F
PLEK-R
ACAGCAGGACCACTTCTTCC
AGATACAAAGCCCCCAAGTC
168 na
Gbx2* GBX2-F
GBX2-R
ACAATTTGCCTGGTCAGACTG
CACCTCGCTGAGTTTGAGGG
236 6753952a3
Six2 SIX2-F
SIX2-R
CGTGCTTGATGAAGCGGTGTG
GATACCGAGCAGACCATTGTC
129 na
Dab2 DAB2-F
DAB2-R
GATGCCAATCAACTGTTGAACA
GGATCAGAAGATGCAGGCTG
166 na
Cyp26al CYP26A1-F
CYP26A1-R
CTCATCCAGAGGATGCTTCC
CAATCACAGTGCCTAGCCAG
119 na
Cyp26bl CYP26B1-F
CYP26B1-R
CTACCGCACTGTGCTGCAGA
ATCCTCACTGCGTGCCTGAC
159 na
Cyp26cl KCYP26C1-F
KCYP26C1-R
CAGCCATCACCAAAATCCAG
AACCGTCCAGTTCAAAGGTG
233 na
Nkx2.6* NKX2-6-F
NKX2-6-R
CTTTCTCGGTAGCTGACATTCTC
TCGCTGCTCTCAAACCATCC
142 3098520al
Cxcl4* CXCL4-F
CXCL4-R
AGCTCATAGCCACCCTGAAG
CATCGGAAGATTGCAGTTACA
175 na
Smad? SMAD7-F
SMAD7-R
GGCCGGATCTCAGGCATTC
TTGGGTATCTGGAGTAAGGAGG
153 6678778al
Cdhl CDHl-F
CDHl-R
CAGGTCTCCTCATGGCTTTGC
CTTCCGAAAAGAAGGCTGTCC
175 6753374al
Notch] N0TCH3-F
NOTCH3-R
CCACAGGTGTGAACTGTGAA
GATGCACACTCATTGATCTCC
153 na
Hesl HESl-F
HESl-R
CCTCTGAGCACAGAAAGTCATC
CAGAATGTCTGCCTTCTCTAGC
151 na
Ndufal3* NDUFA13-F
NDUFA13-R
ACGGCCCCATCGACTACAA
CCTGGTTCCACCTCATCATTCT
120 12963633al
Crb3* CRB3-F
CRB3-R
CACCGGACCCTTTCACAAATA
CCCACTGCTATAAGGAGGACT
130 29244038al
Sema3c SEMA3C-F
SEMA3C-R
GGAGGAAGGAGGTTAAACTG
ACCACTTGTCTGTCACAACG
191 na
S!it2* SLIT2-F
SLIT2-R
GGCAGACACTGTCCCTATCG
GTGTTGCGGGGGATATTCCT
154 30794374al
Lztfll LZTFLl-F
LZTFLl-R
GGATTTGCTAAAGGCCCAAGA
GTTTGGCTGCTGCTAGGTTCT
134 15277319a]
Isll ISLl-F
ISLl-R
GACATGATGGTGGTTTACAGGC
GCTGTTGGGTGTATCTGGGAG
209 31543007a]
Dsg2 DSG2-F
DSG2-R
CTGGTCAAGCAGCTAAAGTAACA
GCCACAACCTTTGCAGTGTA
154 22779879a2
Bmprla* BMPRIA-F
BMPRIA-R
CTCGTCGTTGTATTACAGGAGGA
ACTTGGCTCCAACTTACTTCATC
169 6753194a]
85
Gene Prim er name Sequence (5’ to 3*)
Product 
size (bp)
Prim erBank
accession
num ber
TbxlS TBX18-F
TBX18-R
ACCGTCTTCACAACTGTCACT
CCAAACCCATTCTGTTCCTCC
115 31560050a3
Tle4* TLE4-F
TLE4-R
TTTACAGGCTCAATACCACAGTC
TGCACAGATAGCATTTAGTCGTT
166 33859646al
Daaml DAAMl-F
DAAMl-R
GTAGAGACGGAGCTGGAGTATC
GAAGAACTCATCTGGCTGGA
203 na
Gsk3b GSK3B-F
GSK3B-R
TGGCAGCAAGGTAACCACAG
CGGTTCTTAAATCGCTTGTCCTG
189 9790077al
Pitxl* PITXl-F
PITXl-R
GAATCGTCCGACGCTGATCTG
GCTTGTGAAGTGAGTGCGTTG
153 6755070a2
Scml2* SCML2-F
SCML2-R
TGGAGCCAGGTTACGTCTAC
CCAACAGGTTGTATGTCTGATGA
90 18875336a3
FoxPl FOXPl-F
FOXPl-R
CAATGCAGCTTTACAGGCTTC
TGTCACTCTCGTTGCTGTTG
151 na
Socs3 S0CS3-F
S0CS3-R
GGAGCCCCTTTGTAGACTTC
GGAAACTTGCTGTGGGTGAC
237 na
Lrrl6 LRRC16-F
LRRC16-R
CAGGATCACCTCAACTCCTTAC
AATCCTTCAGTTGTTCATCCAC
237 na
Tmeffl TMEFFl-F
TMEFFl-R
GAGAACGTTGGGTGTGTATG
CATCTGTGTCTGTGCAGTGG
168 na
Fstll FSTLl-F
FSTLl-R
ATGACCTGTGATGGAAAGAATC
GCTGCAGACTCTGTGTGTACTG
212 na
Efnb2 EPHRINB2-F
EPHRINB2-R
GTGCCAGACAAGAGCCATGAA
GGTGCTAGAACCTGGATTTGG
169 31542597a2
Tbx20* TBX20-F
TBX20-R
AAACCCCTGGAACAATTTGTGG
CATCTCTTCGCTGGGGATGAT
171 12082750al
Pafahlb2* PAFAH1B2-F
PAFAH1B2-R
GCAGCTATTCCACATGCCG
CCGCCATATCTCGTACTGCT
156 6679199al
Dkkl* DKKl-F
DKKl-R
CTCATCAATTCCAACGCGATCA
GCCCTCATAGAGAACTCCCG
105 31542557al
Cxcll2* CXCL12-F
CXCL12-R
TGCATCAGTGACGGTAAACCA
TGCACACTTGTCTGTTGTTGTT
166 28386193a3
Suv39h2* SUV39H2-F
SUV39H2-R
ATCTACGAATGCAACTCAAGGTG
CCACAGCCATTGCTAGTTCTAA
110 31543790al
Prickle 1* PRICKLE 1-F 
PRICKLE 1-R
CAACATCACAGGGGCATCAG
GTGCAGCATGGAAGAGTTCA
138 na
Numb NUMB-F
NUMB-R
GATGCCAAGAAAGCTGAGAC
TCTTCTGGCTAAGAGCAGGA
216 na
Rhbdll* RHBDLl-F
RHBDLl-R
TTGCCCAGATCATCGTGTTCC
GGCATTGAACCCTAGCTGCT
182 21450189a3
Gapdh mGAPDH-F
mGAPDH-R
TGCACCACCAACTGCTTAG
GATGCAGGGATGATGTTC
175
mGAPDHb-F
mGAPDHb-R
CATGTTCCAGTATGACTCCACTC
GGCCTCACCCCATTTGATGT
136 6679937a2
mGAPDHc-F
mGAPDHc-R
TGACCACAGTCCATGCCATC
GACGGACACATTGGGGGTAG
203 6679937a3
na: not app icable
‘qRT-PCR experiments carried out by K. Pearce.
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2.11 EMBRYO ANALYSIS
2.11.1 Magnetic Resonance Imaging
Embryos were dissected out at E l5.5 and fixed for at least 3 days in 4% formaldehyde 
and 2 mM gadolinium-diethylenetriamine pentaacetic anhydride (Gd-DTPA Magnevist, 
Schering UK) in PBS at 4°C. Embryos were imaged by Shoumo Bhattacharya’s group 
at the Wellcome Trust Centre for Human Genetics, Oxford, UK. Multi-embryo 
magnetic resonance imaging (MRI) was carried out as described (Schneider et al.,
2004). Briefly, embryos were embedded in 1% agarose containing 2 mM Gd-DTPA in 
28mM nuclear magnetic resonance tubes. MRI measurements were performed using an 
11.7 Tesla (500 MHz) vertical magnet (Magnex Scientific, Oxon, UK) interfaced to a 
Bruker Avance console (Bruker Medical, Ettlingen, Germany) with a maximal gradient 
strength of 548 mTesla/m (Magenx Scientific, Oxon, UK), and quadrature-driven 
birdcage type coils with an inner diameter of 28 mm (Rapid Biomedical, Wurzburg, 
Germany). A 3D spoiled echo sequence (echo time 10 ms), a n il excitation pulse with 
rectangular pulse shape, (tc/2 = 100 ps) was used with a short repetition time (30 ms) to 
obtain strong Ti contrast. The field of view was 26 x 26 x 50 mm with a matrix size of 
608 X  608 X  1408 (bandwidth: 130 Hz/pixel), resulting in an experimental resolution of 
43 X  43 X  36 pm. The total experimental time was ~ 12.3 hours for 32 embryos with 
each phase encoding step being averaged four times (Schneider et al., 2004). Data was 
analysed using Amira 3.1 (TGS Europe, Merignac Cedex, France).
2.11.2 Whole Mount in situ Hybridisation
2,11.2.1 Dissection
Embryos for whole mount in situ hybridisation were dissected out into cold PBS and 
fixed overnight in 4% formaldehyde in PBS at 4°C. The next day, embryos were 
washed in 100% MeOH several times and stored at -20°C in 100% MeOH.
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2,11.2.2 Generation o f labelled riboprobe
2.11.2.2.1 Preparation o f the DNA template
Ipig of plasmid was digested with an appropriate enzyme to give a 5’ overhang and 
50ng was run on a 1% agarose gel to check digestion was complete. The digest was 
purified by diluting to 200 pil with H2O, adding an equal volume of phenol/chloroform 
(49:1 CHCbrlAA), vortexing and spinning in a centrifuge at 12000 x g for 5 minutes at 
4°C. The aqueous, upper layer was removed and placed in a new tube and an equal 
volume of chloroform:! AA (49:1) was added. The solution was then spun again as 
above, the upper layer removed and placed in a new tube. 1/10* volume of 3M NaOAc 
(pH 5.2) and 2.5 volumes of ice-cold 100% EtOH was added and the DNA was left to 
precipitate on ice for 30 minutes. The solution was spun in a centrifuge at 12 000 x g, 
4°C for 20 minutes and the DNA pellet was washed with ice-cold 70% EtOH and spun 
again at 12000 x g for 5 minutes. The DNA pellet was resuspended in 11.5pil H2O of 
which 1 pi was run on a 1% agarose gel to check the template before proceeding to the 
transcription reaction.
2.11.2.2.2 Probe Transcription
To generate DIG-labelled RNA transcripts the following components were added to an 
eppendorf tube in the following order: 4pl 5 X transcription buffer (Promega), 2pl O.IM 
DTT, 2pl DIG-labelled NTPs, 10.5pl (Ipg) linearised plasmid, 0.5pl Ribonuclease 
inhibitor (40U/pl) and 2pl SP6, T7 or T3 RNA polymerase (lOU/pl) (Promega). In 
vitro transcription was carried out by incubating for 2 hours at 37°C (or 40°C for SP6).
1 pi of the probe was run on a 1% agarose gel to check synthesis. An RNA band of 
approximately 10-fold greater intensity than the plasmid band indicated that 
approximately lOpg probe had been synthesised.
To purify the probe, the solution was diluted to 50pl with H2O, and the probe 
precipitated by adding 1/10* volume 3M sodium acetate (pH 5.2) and 2.5 volumes ice- 
cold 100% ethanol and incubating on ice for 30 minutes. The RNA probe was spun 
down at 12 000 x g for 5 minutes at 4°C, washed with ice-cold 70% ethanol, air-dried 
and resuspended in lOOpl H2O. 2pl probe was run on a 1% agarose gel to check 
purification and estimate concentration by comparing to a known concentration of DNA 
ladder.
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2.11.2.3 Pretreatment o f Embryos
Embryos for whole mount in situ hybridisation were dissected out into cold PBS and 
fixed overnight in 4% formaldehyde in PBS at 4°C. The next day embryos were 
washed in 100% MeOH several times and stored at -20°C in 100% MeOH. Embryos 
were then rehydrated by taking them back through a methanol series, washing in each 
solution for 20 minutes at room temperature. The embryos were then washed 3 x in 
PBTX for 10 minutes each and treated with lOpg/ml proteinase K in PBTX for 2-35 
minutes depending on the stage of embryo. Afterwards, embryos were washed 2 x in 
PBTX and re-fixed in 4% formaldehyde/0.2% glutaraldehyde in PBTX for 20 minutes 
at room temperature. Embryos were washed again 2 x in PBTX for 10 minutes each 
and finally transferred into 1-1.5 ml prehybridisation buffer. Embryos were stored at - 
20°C until required.
2.11.2.4 Probe Hybridisation
Embryos were incubated in prehybridisation solution (see stock solutions, section 2.2) 
at 68°C for at least 2 hours to overnight. 0.2-1.0 |ig/ml DIG-labelled probe was added 
to the prehybridisation solution and the embryos were incubated at 68°C, rocking 
overnight.
2.11.2.5 Post-hybridisation washes and Antibody Incubation
The probe was removed and embryos were rinsed in pre-warmed, prehybridisation 
buffer 2 x and washed 3 x in prehybridisation buffer at 68°C for at least 30 minutes 
each. The embryos were then washed in 1:1 prehybridisation bufferiTBTX for 20 
minutes at 68°C and rinsed 3 x in room temperature TBTX. TBTX washes were then 
carried out at room temperature 3 x for at least 30 minutes each. Embryos were then 
blocked in 20% sheep serum in TBTX for 2 -3 hours at room temperature and incubated 
in 1/2000 anti-DIG antibody (Boehringer) in 20% sheep serum/TBTX overnight at 4°C, 
rocking.
2.11.2.6 Post-Antibody Washes
The antibody solution was removed and the embryos washed 5 x with TBTX for at least 
1 hour each. The last wash was carried out overnight at 4°C.
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2.11.2.7 Histochemistry
The embryos were washed twice in TBST for 15 minutes each then washed 3 x in 
freshly made NTMT for 10 minutes each. The colour reaction was started by 
incubating the embryos in NBT/BCIP solution (Roche) or BM Purple staining solution 
(2ml BM Purple (Roche), 20pl 100 x levamisol, 20pd 10% Tween 20) in the dark. After 
colour had developed, the embryos were washed 2 x in TBTX, fixed in 4% 
formaldehyde in PBS for 1 hour at room temperature and stored in 0.1% formaldehyde 
in PBS at 4°C. Embryos were visualised and pictures taken using a Zeiss Stereo 
Lumar.V12 microscope.
2.11.2.8 In situ probes 
Table 2.5 In situ probes
Gene Source
Cyp26cl
Dab2
Gbx2
Gcm2
Gm603
Hesl
Hic2
Nkx2.6
Paxl
Raldh2
In house probe. Roberts et al. 2006 
IMAGE clone 3587226, Geneservice, UK 
Gift from Alex Joyner, Sloan-Kettering Institute, NY, USA 
Gift from Nancy Manley, University of Georgia, GA, USA 
IMAGE clone 6366969, Geneservice, UK 
PCR 552bp probe using primers HeslIS-F 
GAGAGGCTGCCAAGGTTTTT and HeslIS-R 
GTAATACGACTCACTATAGGGTCAAATAAACTTCCCCAA/ 
IMAGE clone 6851068, Geneservice, UK 
In house probe
Gift from Peter Gruss, Max-Planck Society, Munich, Germany 
Gift from Ursula Drager, Eunice Kennedy Shriver centre for 
Mental Retardation, Waltham, MA, USA
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2.11.3 X-gal staining of embryos
Embryos were dissected out and fixed for 30 to 60 minutes in 1% formaldehyde, 0.2% 
glutaraldehyde in PBS with 2 mM MgCl] at room temperature. Embryos were then 
washed twice in PBS with 2 mM MgCh and incubated in X-gal buffer (see stock 
solutions, section 2.2) with 1 mg/ml X-gal (Promega) at 37°C until the stain developed. 
Embryos were then rinsed in PBS and fixed overnight in 4% formaldehyde in PBS.
2.11.4 Intracardiac ink injection
Indian Ink (Pelikan) was injected into the outflow tract or aorta of embryos using a 
microinjection needle to visualise the pharyngeal arch arteries or great vessels of the 
heart.
2.11.5 Embedding and sectioning
2.11.5.1 Wax embedding and sectioning
Embryos were fixed overnight in 4% formaldehyde in PBS at 4°C. Following fixation, 
embryos were dehydrated to 100% ethanol by taking them through washes in 50% 
PBS:50% ethanol, 70% ethanol and 90% ethanol in H2O where each wash was at least 
30 minutes long. Embryos were then washed twice in Histoclear (Raymond A Lamb, 
Hull, UK) for 30 minutes each, then 50% Histoclear:50% wax for 20 minutes at 60°C 
and finally 3 x 40 minute (or longer) washes in wax at 60°C before embedding in wax 
and allowed to set. Sections were cut at 10 pm and placed on superfrost slides coated 
with Tespa. To remove the wax, sections were incubated in histoclear , then re­
hydrated through an ethanol series (2 x Histoclear for 10 minutes each, then 10 minute 
washes in 100% ethanol, 90%, 70%, 50%, 30% ethanol and finally H2O). Coverslips 
were mounted onto slides using DPX mounting media. Sections were visualised and 
pictures taken using a Zeiss Axiophot2 microscope.
2.11.5.2 OCT embedding and sectioning
Embryos were fixed in 4% formaldehyde in PBS for 2-3 hours, rinsed in PBS then left
to equilibrate in 20% sucrose in PBS overnight at 4°C. Embryos were transferred to
50% sucrose, 50% Optimal Cutting Temperature compound (OCT) and then frozen in
100% OCT on dry ice. OCT-embedded embryos were sectioned on a cryostat set at
approximately 22°C. Sections were cut at 10 pm thickness, collected onto Superfrost+
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glass slides and allowed to dry. GFP fluorescent TgTbxlfloxGFP sections were 
visualised and pictures taken using a Zeiss Stereo Lumar.V12 microscope.
2.11.6 Hematoxylin and eosin staining
Wax embedded sections were stained with hematoxylin and eosin to enable 
visualisation of the nuclei and cytoplasm. After removal of the wax as per section 
2.10.5.1, sections were stained in 100% hematoxylin (Raymond Lamb) solution until 
the desired stain was achieved. The sections were then rinsed in tap water and stained 
in eosin solution (Raymond Lamb), rinsed in tap water again and allowed to air dry. 
Coverslips were mounted onto slides using DPX mounting media.
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CHAPTER 3. MICROARRAY ANALYSIS OF T6%7-EXPRESSING 
CELLS
3.1 INTRODUCTION
Since the discovery of TBXl as the major candidate gene responsible for the primary 
symptoms of DCS, researchers have come a long way towards understanding the spatial 
and temporal requirement for Tbxl in development. However, the molecular pathways 
downstream of Tbxl have not yet been clearly defined. Some of the potential direct 
targets of Tbxl include the Fg/'ligands, Fgf8 and FgflO (Hu et al., 2004; Xu et al.,
2004)and the transcription factor, Pitx2c (Nowotschin et al., 2006).
In order to characterise the transcriptional networks downstream of Tbxl in 
development, a microarray was carried out in our lab comparing the genetic profile of 
dissected pharyngeal arches and adjacent tissues from E9.5 Dfl/Tbxf^^^ compound 
heterozygous embryos (also referred to as 716x7-null) to wild type embryos (Ivins et al.,
2005). A number of altered genes were identified giving an indication of the pathways 
potentially downstream of Tbxl and which could represent direct Tbxl targets.
However, since the tissues compared contained a number of different cell types, not all 
of which express Tbxl, the more subtle effects of altered Tbxl expression could have 
been masked by the gene expression profile of unaffected/non T6x7-expressing cells. 
Conversely, tissue loss may have resulted in apparent changes in gene expression due to 
absence of cells/anatomical differences between Tbxl null and wild type embryos. To 
minimise these problems, studies have used flow-sorting to obtain specific cell 
populations for microarray analysis (Bouchard et al., 2005; Kalajzic et al., 2005;
Kamath et al., 2005; Prall et al., 2007; Takasato et al., 2004), and experiments have 
shown this to be a valid method for analysing the genetic profile of defined cell 
subpopulations (Szaniszlo et al., 2004). Therefore, to try to overcome the limitations of 
the previous microarray, enrich for cell-autonomous effects and further define targets 
and downstream pathways important in pharyngeal and heart development, a method 
was optimised for isolating T6x7-expressing cells from Dfl/Tbxl'^^^and Tbxl^^^°^^ 
embryos for comparison by microarray.
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The Tbxl non-functional allele was generated by knocking a lacZ reporter gene into 
exon 5, which encodes the T-box DNA binding domain and therefore cells expressing 
this allele can be identified by using lacZ substrates. Fluorescent, lacZ substrates have 
been used previously to mark living cells for flow sorting (Brachvogel et al., 2005; 
Laugwitz et al., 2005). However, this method has never been used to isolate cells for 
whole genome analysis. The fluorescent lacZ substrate, CMFDG was used to label and 
flow-sort r^jc7-expressing cells from E9.5 compound heterozygous Dfl/TbxŸ^^^ and 
TbxÜ^^°^^ embryos and the gene expression profile of these two cell populations was 
compared by microarray analysis.
3.2 RESULTS
3.2.1 Isolation of JftjcZ-expressing ceils
In order to isolate T6x7-expressing cells from Tbxl-lacZ embryos, a single cell 
suspension was generated from the appropriate embryos. A procedure for the optimal 
labelling of Tbxl-lacZ cells was then developed using a fluorescent, lacZ substrate. 
C12FDG is a non-toxic, fluorogenic p-galactosidase substrate that has been used in 
numerous studies to label /acZ-expressing cells (Jasin and Zalamea, 1992; Peng et al., 
1993). C12FDG contains a 12-carbon lipophilic moiety covalently attached to 
Fluorescein Digalactoside (FDG), which allows for direct loading into cells by adding 
the substrate to the aqueous medium. The suitability of C12FDG as a fluorogenic 
substrate was tested in a single cell suspension of E9.5 embryonic cells. However, 
results were not consistent when using this substrate, since analysis by fluorescent 
activated cell sorting (FACS) often failed to demonstrate fluorescence above 
background levels. In addition, C12FDG gave high background fluorescence in control 
wild type cells that do not contain the lacZ gene.
An alternative fluorogenic substrate, 5-chloromethylfluorescein di-P-D- 
galactopyranoside (CMFDG) was therefore tested. CMFDG can also be directly loaded 
into cells, but once cleaved by P-galactosidase, it reacts with glutathione to form a 
membrane-impermeant adduct which means it is better retained within cells. CMFDG 
consistently showed high fluorescence above background (as analysed by FACS) when 
tested as a substrate in a single cell suspension made from mouse embryos. Therefore 
CMFDG was used to isolate T6x7-expressing cells {Dfl/Tbxl'°^^ and Tbxl^^^°^^) by 
FACS.
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E9.5 embryos were chosen for collection and analysis due to strong expression of Tbxl 
at this stage in the pharyngeal arches and surrounding tissues, and the requirement for 
Tbxl in development of the pharyngeal arch arteries and outflow tract at this timepoint 
(Xu et al., 2005). E9.5 embryos obtained from DflZ+rndXo, x Tbxl^^ °^^  ^female matings 
were collected and Dfl/Tbxl^^^^ embryos were separated by phenotype from the 
Tbxr^‘'"''^;Dfl/+;Wûd type embryo pool for subsequent dissociation into a single cell 
suspension. After staining with the fluorescent substrate, CMFDG, cells were collected 
based on fluorescence intensity (above background) and cell viability. FACS analysis 
showed that these cells constituted, on average, less than 1% of the total cell population 
obtained from E9.5 embryos (Figure 3.1 A, B). Cells which were gated as FDG- 
negative were run back through the cell sorter for re-analysis, confirming that no 
fluorescent cells were present in this population (Figure 3.1C). Due to the small sample 
size, the FDG-positive cells collected could not be re-analysed.
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Figure 3.1 Isolating Tbxl-lacZ  expressing cells by FACS
After cells from E9.5 embryos were loaded with the fluorescent substrate, CMFDG, 
Tbxl-lacZ  expressing cells were collected by FACS. Cells from a wild type embryo
(A) were used as a background control and subsequently, cells from Tbxl^ ^^ ^^ ^^  or
embryos were flow-sorted to isolate fluorescent, T bxl-lacZ  expressing 
cells which constituted approximately 0.6% of the total cell population (B - box G) . 
FDG-negative cells (B - box H) were re-anlaysed to ensure that no fluorescent cells 
were contained in this population (C). PI (Propidium Iodide) measures the amount of 
cell death and FDG is a measure of the fluorescence intensity.
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To analyse for enrichment of Tbxl-lacZ cells, FDG-negative cells were collected from 
the combined Tbxl^'^^^^\Dfl/+  ;Wi\d type flow sort and also from the Dfl/Tbxl^^^^ flow 
sort to compare to the FDG-positive cells (which should only be Dfl/Tbxl^^^^scad 
Tbxl^^^^^  ^cells). RNA was extracted, reverse-transcribed and amplified, then analysed 
for the presence of the Tbxl wild type and Tbxl-lacZ alleles. The Tbxl wild type allele 
was detected in the FDG-positive cell population containing Tbxl^^' cells and in the 
FDG-negative cell population containing Tbxl^^^°^ ,^ T>fl/+ and wild type cells (Figure
3.2). In contrast, the Tbxl-lacZ allele was only detected in FDG-positive cells (Figure
3.2). These results indicate that the FDG-positive cells collected were the Tbxl-lacZ  
expressing cells of interest consisting o f Tbxl^ '^ ^^ ‘^  ^and Dfl/Tbxl^^^^ cells.
Subsequently, RNA was extracted from these cells, amplified, labelled and hybridised 
onto microarray chips for gene expression analysis.
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Figure 3.2 Analysis of Tbxl-lacZ cell enrichment
The wild type Tbxl allele is present in both FDG-positive and FDG-negative cell 
populations. The T bxl-lacZ  allele representing rlfl/Tbxl^^^^^ cells and Tbxl^^^^^  ^cells is 
only present in FDG-positive cell populations.
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3.2.2 Microarray results
Microarray experiments were carried out using Affymetrix mouse MOE430 v2.0 arrays 
consisting of over 34 000 well characterised mouse genes, represented by over 45 000 
probe sets. Analysis of the microarray experiments was conducted using Genespring 
v4.2.1. Six replicate microarray experiments were carried out in total using RNA 
extracted from 3 pools of Dfl/Tbxl^°^^ cells and 3 pools of cells. Each pool of
cells was obtained from a group of E9.5 embryos ranging in somite number from 17s to 
25s. Pools of cells were used to minimise variation due to staging differences. 
Altogether, RNA was extracted from 38004 Dfl/Tbxl^^^^ cells sorted from a total of 71, 
E9.5 embryos and 57563 cells sorted from a total of approximately 89, E9.5
embryos. The average number of cells obtained per embryo was 535 cells per 
Dfl/Tbxl^°^^ embryo and 646 cells per Tbxl^^^^^^ embryo. Due to the limited number of 
cells obtained, PCR amplification was used to generate sufficient RNA for microarray 
analysis. Dfl/Tbxl^^^^ embryos were used instead of embryos so that the
hemizygously deleted D fl genes could be used as internal controls to assess the quality 
of the experiment. In addition, using Dfl/Tbxl^^^^^Qvdbryos to compare to Tbxl^^^°^^ 
embryos should allow for equivalent fluorescence intensity from the Tbxl-lacZ allele in 
both genotypes, ensuring the same cell populations were collected from Tbxl 
homozygous and heterozygous embryos.
Initially, 3 replicate microarrays were carried out for preliminary analysis of gene 
expression. The Dfl/Tbxl^^^^^and Tbxl^^^^^^ probes were made from pooled RNA 
collected from multiple sorts which were divided into 3 equal aliquots for RNA 
amplification and in vitro transcription. 17 out of the 20 D fl genes represented on the 
microarray chips were expressed above threshold detection levels (Genespring 
evaluated raw data value of 22). After applying filtering and statistical analyses to the 
data (Non-parametric t-test with a p value cutoff of 0.5 + the Benjamini and Hochberg 
False Discovery Rate multiple testing correction), 13 out of the 17 D fl genes were 
significantly down-regulated to 0.6 fold in 2 out of 3 Dfl/Tbxl^^^^ chips compared to 
Tbxl^^^°^^ chips indicating that the correct cells were isolated and that the microarray 
experiment was sensitive enough to detect down-regulation of genes expressed from 
only 1 allele in Tbxl^^^°^^ cells compared to Dfl/Tbxl^^^^ cells.
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Subsequently, 3 further microarrays were carried out to make a total of 6 replicate 
microarrays. The Dfl/Tbxl^°^^ and probes for the 4*microarray experiment
were made from pooled RNA collected from multiples sorts. The 4^ microarray 
experiment was kept separate from the last 2 experiments because cells were collected 
using a different machine, the MoFlo, which resulted in fewer cells per embryo 
(Dakocytomation - Ely Cambridge).
For the 5* and 6* microarray experiments, the Dfl/Tbxl^°^^ and Tbxl^^^°^^ probes were 
made from pooled RNA collected from multiple sorts carried out on the Beckman 
Coulter Epics Altra machine. The pooled RNA was divided into 2 equal aliquots for 
subsequent RNA amplification and in vitro transcription to make microarray probes.
3.2.2,1 D fl Genes
After combining all microarray chips into one Genespring experiment and applying 
filtering and statistical analyses to the data, 17 out of the 20 D fl genes represented on 
the MOE430v2.0 chips were expressed above threshold levels (Table 3.1). Iterative 
analyses were then carried out to determine the appropriate filters to apply to identify 
the majority of hemizygously-expressed Dfl genes. Fourteen out of those 17 D fl genes 
were down-regulated to at least 0.83 in 5 out of 6 Dfl/Tbxl^^^^ arrays compared to 
Tbxl^^^°^^ arrays, the filtering cut off applied to extract the majority of D fl genes. On 
average, these 14 genes were downregulated to 0.594 ± 0.09 indicating the sensitivity of 
the experiment in detecting downregulated genes (Table 3.1). In addition, the 
upregulation of Es2el is a known artifact resulting from ectopic activation of part of the 
gene located at the end of the Dfl deletion (Ivins et al., 2005).
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Table 3.1 Dfl genes analysed by microarray
Gene
Relative expression in 
DJl/Tbxl^‘'^  vs. cells
Dgcr6 0.517 ±0.068
ZdhhcS 0.663 ±0.140
Ranbpl 0.598 ± 0.095
Htf9c 0.549 ±0.104
D16h22s680e 0.563 ± 0.267
Arvcf 0.490 ±0.165
Comt 0.601 ±0.118
Txnrd2 0.531 ±0.054
Septin 5 0.568 ±0.167
Ufdll 0.459 ±0.091
Slc25al 0.639 ± 0.097
Cdc45l 0.694 ± 0.206
Prodh 0.632 ± 0.205
DgcrS 0.807 ±0.153
CldnS* 0.752 ± 0.478
Gnbll* 0.706 ± 0.325
Vpreb2 (L) 0.749 ± 0.704
Rtn4r (L) 0.977 ±0.631
Tbxl (L) 0.324 ± 0.344
Es2el 1.459 ±0.238
L indicates low signal strength
* These genes did not pass the filtering and statistical 
analysis applied
3.2.22 Dysregulated genes
Applying the same filtering and statistical analyses to the combined microarray as that 
used to identify 14 out of 17 hemizygous D fl genes resulted in a total of 1553 unique 
sequences which were downregulated to at least 0.83 in 5 out of 6 Dfl/Tbxl^^^^ arrays 
compared to arrays. Classification of these genes into gene ontology (GO)
categories revealed that the ratio of genes within each functional class was maintained 
in the dysregulated gene data set relative to genes across the entire microarray data set 
suggesting that there was no particular functional class which was more sensitive to 
altered Tbxl dosage (Table 3.2). Genes involved in translation comprised the only 
category which was perhaps overrepresented in the downregulated gene group (7% of 
downregulated genes vs. 4% of all microarray genes) (Table 3.2).
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In comparison to the number of downregulated genes identified in the microarray, fewer 
genes were found to be upregulated in Dfl/Tbxl^°^^ cells. When applying the reciprocal 
analysis to identify upregulated genes, only 171 genes passed the statistical filters used, 
increasing in expression to 1.17 in 5 out of 6 Dfl/Tbxl^°^^ chips. GO annotation showed 
that there appeared to be fewer genes associated with regulation of transcription while 
genes involved in transport and cell death were more predominant among upregulated 
genes in comparison to the microarray data as a whole (Table 3.2).
Table 3.2 Classification of genes into GO categories
MOE430v2 Downregulated Upregulated
transcripts transcripts transcripts
Unique 39000 1553 171
GO-annotated 27393 1029 109
GO category
Metabolic process 16636 (61%) 662 (64%) 67 (61%)
Signal transduction 5675 (21%) 204 (20%) 24 (22%)
Transcriptional regulation 4987(18%) 197(19%) 15(14%)
Transport 5454 (20%) 190(18%) 29 (27%)
Translation 1134 (4%) 73 (7%) 2(2%)
Cell cycle 1766 (6%) 71 (7%) 6 (5.5%)
Cell adhesion 1438 (5%) 61 (6%) 4 (4%)
Cell death 1547 (6%) 51 (5%) 10 (9%)
Cytoskeleton organisation and biogenesis 1207 (4%) 46 (4%) 6 (5.5%)
% values represent th 
annotated transcripts
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3.2.3 Validation of downregulated genes by qRT-PCR
The primary aim was to identify Tbxl targets, particularly genes which could be 
important in pharyngeal or heart development. Validation focused on downregulated 
genes because Tbxl has been demonstrated to be a transcriptional activator (Ataliotis et 
al., 2005; Stoller and Epstein, 2005; Xu et al., 2004). Quantitative, real-time PCR 
(qRT-PCR) was carried out to confirm gene expression changes using RNA amplified 
from an independent pool of Dfl/Tbxl^°^^mà. Tbxl^^^°^^ cells collected by FACS from 
10, E9.5 Dfl/Tbxf°^^ Qmhryos and 26, E9.5 embryos, ranging in somite
number from 18 to 24. Gapdh expression was not altered in Dfl/Tbx 1^^^ cqWs relative 
to Tbxl^^^°^^ QoWs in the microarray (1.019 ± 0.279) indicating that overall transcription 
was not changed. Gene expression levels were therefore normalised to Gapdh for 
subsequent qRT-PCR analysis. A proportion of the qRT-PCR experiments were carried 
out by Kerra Pearce, a research assistant in the lab (see section 2.10.3.3).
Previous microarray experiments carried out in the lab have compared the expression 
profile of E9.5 Dfl/Tbxl^°^^orc^ryos to wild type embryos by dissecting out the 
pharyngeal region and adjacent tissues corresponding to the major sites of Tbxl 
expression (Ivins et al., 2005). A number of genes identified as downregulated in 
Dfl/Tbxl^°^^ embryos by the previous microarray (Ivins et al., 2005; Roberts et al.,
2006) were chosen for further analysis to determine whether they were also 
downregulated specifically in -expressing cells. Seven genes were chosen based 
on their demonstrated role in pharyngeal and/or heart development (Gbx2, Six2, 
Cyp26al, Cyp26bl and Cyp26cl) (Abu-Abed et al., 2001; Byrd and Meyers, 2005; 
Kutejova et al., 2005; Roberts et al., 2006) or because they were significantly 
downregulated in both microarray experiments {Plek and Dab2). Most of these genes 
did not pass the filtering used in the present microarray experiment to identify 
downregulated genes (except for Plek and Dab2). However, more detailed analysis 
revealed that Gbx2, Six2 and Cyp26bl also appeared to be downregulated in 
Dfl/Tbxl^^^^ cells but the changes were not statistically significant. qRT-PCR is a more 
sensitive method of identifying small expression changes and was therefore used for 
analysis of the above genes. Plek, Gbx2, Six2, Cyp26al and Cyp26bl were verified as 
downregulated in Dfl/Tbxf°^^cells by this method (Figure 3.3). Dab2 expression was 
also downregulated in Tbxl null cells. However, the difference just failed to pass 
statistical significance (p = 0.059). Cyp26cl is downregulated in the pharyngeal region
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of D fî/T b x l‘^ ^^  embryos as analysed by qRT-PCR and in situ hybridisation (Roberts et 
al., 2006). However, the expression of this gene was not changed in Dfl/Tbxl^°^^ cells 
in comparison to Tbxl^^‘^ ^^  cells (Figure 3.3) suggesting possibly that alterations in the 
expression of this gene in Tbxl mutants may be due to expression changes not cell- 
autonomous to Tbxl cells.
Tbxl+/lacZ
D fl/T bxllacZ
s ax
/
G enes
Figure 3.3 Quantitative real time PCR of potential Tbxl targets
Average changes in gene expression in vs. 7^ 7x7 cells. Error bars
represent the standard error of n=3 experiments (except for Gbx2 where n=2). *P<0.05.
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Additional genes were selected for independent validation by qRT-PCR based on their 
expression pattern, known or potential function in pharyngeal or heart development and 
significant downregulation in the microarray experiments. Altogether, 34 putative, 
dovmstream Tbxl targets were analysed by qRT-PCR; 18 (53%) showed significant (p 
< 0.05) downregulation in Dfl/Tbxl^°^^ cells, consistent with the microarray results 
(Figure 3.4). Pitxl expression also appeared to be downregulated, but this difference 
was not statistically significant (p=0.078). In contrast to the microarray data, Rhbdl2 
was noted to be upregulated by qRT-PCR and 15 genes showed no appreciable changes 
in expression (Figure 3.4).
The most strikingly altered gene was Nkx2.6, whose expression was completely 
abolished in 76x7-null cells by qRT-PCR (Figure 3.4). This contrasts with microarray 
data in which Nkx2.6 was only downregulated to 0.694 ± 0.219. Other genes which 
were downregulated greater than 3-fold were NotchS and Hesl, which are involved in 
Notch signalling and Cxcl4, Smadl, Cdhl and Ndufal 3 which are novel genes whose 
role in pharyngeal or heart development have yet to be characterised. Downregulation 
of a number of genes with a known function in the pharyngeal apparatus or heart 
{SemaSc, IslI, Tbxl8, Bmprla, Dsg2) were also validated by qRT-PCR with SemaSc 
exhibiting the greatest downregulation to 0.360 ±0.170 in Tbxl-null cells. The 
remaining validated genes (Crb3, Slit2, Lztfll, Tle4 and Daaml) represent additional, 
novel factors which have not previously been shown to be involved in development of 
the pharyngeal system and its derivatives.
In general, qRT-PCR results of validated, downregulated genes revealed similar or 
slightly greater expression changes between Dfl/Tbxl^^‘^  ^cells and Tbxl^^'^^^ cells 
(Figure 3.5) consistent with reported studies of significantly greater fold changes by 
qRT-PCR vs. microarray (Dallas et al., 2005).
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Figure 3.4 Quantitative real-time PCR analysis of gene expression
^  Average changes in gene expression in Dfl/Tbxl^°^^ vs. cells. Error bars represent the standard error of n=3 experiments (except for Dsg2
g  where n=2). *P<0.05.
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Figure 3.5 Quantitative real time PCR results compared to microarray results
Average changes in gene expression in Dfl/Tbxl'^"^^ vs. cells. Error bars represent the standard error of n=3 experiments for qRT-PCR and
n=6 for microarray experiments.
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3.2.4 Whole mount in situ analysis of downregulated genes
While the microarray and qRT-PCR analyses of 27)jc7-expressing cells revealed 
quantitative gene expression changes, they gave no indication as to where in the embryo 
these changes occur. Therefore, whole mount in situ hybridisation (WISH) was carried 
out on putative Tbxl targets identified by the microarray to characterise the expression 
changes within TbxT^' embryos.
At E9.0-E9.5, Tbxl is expressed within the head mesenchyme, otic vesicle, pharyngeal 
arch ectoderm and endoderm, and within the second heart field domain consisting of the 
core mesoderm of each arch and the mesoderm dorsal to the heart (Chapman et al., 
1996). In situ hybridisation of dysregulated genes was carried out to identify the areas 
of overlapping expression with Tbxl and assess downregulation within these domains. 
Nkx2.6 and Dab2 were analysed by WISH and showed alterations in their expression 
patterns in Tbxl^^^^^^^^  ^embryos compared to stage-matched wild type embryos (Figure
3.<%.
Nkx2.6 is expressed in a restricted pattern in the pharyngeal arches of wild type 
embryos. At E9.5, Nkx2.6 is detected strongly in the caudal pharyngeal arch ectoderm, 
endoderm and mesoderm (Figure 3.6A, B) (Biben et al., 1998; Nikolova et al., 1997), 
tissues which also express Tbxl. Nkx2.6 is also expressed in the ectoderm overlying the 
second pharyngeal arch. In TbxT^' embryos at the same stage, Nkx2.6 expression is 
strikingly absent from all the caudal pharyngeal arch expression domains (endoderm, 
ectoderm and mesoderm) (Figure 3.6A, B). However, it is retained in the anterior 
portion of the second pharyngeal arch ectoderm, the only area in which Tbxl in not 
normally expressed at this timepoint (A.Calmont, pers. comm.). These results are 
consistent with the qRT-PCR data which indicated that Nkx2.6 expression is lost in 
D fl/Tbxl'‘’^  ^cells.
Dab2 expression was observed in the head and pharyngeal mesenchyme at E9.5 and is 
most strongly detected in a caudal region of pharyngeal arch two (Figure 3.6C). Even 
though Dab2 downregulation by qRT-PCR was not statistically significant, in situ 
hybridisation revealed that TbxT^' homozygotes exhibit loss of Dab2 expression, 
particularly within the second pharyngeal arch (Figure 3.6C).
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Preliminary WISH analysis of potential Tbxl targets identified by microarray has led to 
a better qualitative characterisation of the precise expression domains in which each 
gene is dysregulated. Further characterisation of other downregulated genes is currently 
underway in our lab and should give a better indication as to what role these genes may 
play in pharyngeal and heart development.
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Figure 3.6 Expression analysis of Nkx2.6 and Dab2
(A) Nkx2.6 expression at E9.5 is lost in the pharyngeal arches of TbxT^' mutants except 
in the pharyngeal ectoderm overlying pharyngeal arch two. (B) Coronal sections of the 
wild type and TbxT'' embryos in (A). (C) Dab2 expression at E9.5 in the second 
pharyngeal arch (arrow) of a wild type embryo and absent expression in TbxT^' mice. 
Abbreviations: ec, ectoderm; en, endoderm.
In summary, CMFDG-labelling of Tbxl-lacZ cells was effectively used to isolate 
D fl/Tbxf°^^and Tbxl^^ °^^^cells from E9.5 embryos. Microarray analysis of PCR- 
amplified RNA extracted from these cell populations has led to the identification of 
dysregulated genes representing potential Tbxl targets important in development of the 
pharyngeal apparatus and heart.
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3.3 DISCUSSION
3.3.1 Technical considerations
In this project, fluorescent labelling of /acZ-positive cells was optimised to isolate 
-expressing cells. Comparison of the gene expression profile of vs.
Dfl/Tbxl^^^^ cqWs has led to the identification of potential Tbxl targets which may play 
a role in pharyngeal and heart development and in the etiology of DOS.
Many groups have used GFP transgenic or knock-in animals to isolate pure cell 
populations for microarray analysis (Bryant et al., 1999; Covassin et al., 2006; Prall et 
al., 2007; Takasato et al., 2004; Von Stetina et al., 2007). However, it is more common 
for mouse mutants to contain a non-fluorescent, 6-galactosidase reporter which has been 
inserted into the gene of interest. Using the fluorogenic B-galactosidase substrate, 
CMFDG to label lacZ cells for isolation by FACS coupled with RNA extraction, 
amplification and microarray analysis has enabled the investigation of cell-specific gene 
expression profiles. This strategy is directly applicable for use with any B-galactosidase 
transgenic/knock-in mutant and is particularly useful for the many lacZ knock-in gene 
trap mouse lines.
After labelling, approximately 600 -positive cells were isolated per E9.5 embryo.
In comparison, GFP-positive cells collected from similar or even smaller-sized tissues 
generally yield a greater number of cells per embryo (1500 Nkx2.5+ cells per 21s heart 
tube, 5000-10000 Pax2+ cells per 4-6s midbrain/hindbrain region) (Bouchard et al., 
2005; Prall et al., 2007). This discrepancy between CMFDG-cells and GFP-cells may 
be due to the fluorescent labelling method used to mark lacZ cells, since the reagents 
used are known to cause cell death. For example, chloroquine is used to decrease 
background staining, but it has also been shown to be cytotoxic (Poot and 
Arttamangkul, 1997).
FACS analysis revealed that -expressing cells account for less than 1% of the total 
cell population obtained from E9.5 Tbxl^^^°^^ embryos or Dfl/Tbxl^^^^ embryos 
meaning that very small numbers of cells were collected from each flow sort.
Therefore, in order to generate enough RNA for microarray analysis, samples were 
pooled for each condition and RNA was amplified in independent aliquots to make 
microarray probes. Recent studies on the effects of pooling samples for microarray
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analysis demonstrate that this is advantageous if the biological variance is large, 
compared to the technical variance (Kendziorski et al., 2005; Kendziorski et al., 2003; 
Peng et al., 2003). In this microarray experiment, a combination of biological replicates 
and semi-technical replicates were used to assess differential gene expression. 
Considering the large numbers of embryos that were pooled to make microarray probes, 
several lines of evidence suggest_that an accurate gene expression profile was 
maintained for and Dfl/Tbxl^°^^ samples.
Amplification of starting RNA amounts was required to generate enough material to 
make microarray probes. In this study, the PCR exponential amplification method was 
used since several studies have shown that it requires only very small amounts of 
starting material, is reproducible and preserves abundance relationships (Iscove et al., 
2002; Ji et al., 2004; Klur et al., 2004). One study even concludes that it is in fact better 
than linear amplification, generating cRNA of higher quality (Klur et al., 2004). As 
discussed below, in this microarray experiment, analysis of the D fl genes (which act as 
positive controls) showed that quantitative relationships between Tbxl^^^°^^ and 
Dfl/Tbxl^°^^ samples appeared to be maintained.
3.3.2 Identification of differentially regulated genes
Compound heterozygous Dfl/Tbxl^°'^^ cells were used for comparison instead of
cells so that the haploid Dfl genes could be used as an internal control to 
test the sensitivity of the microarray experiment in detecting significantly down­
regulated genes. Our lab has shown previously that the Dfl genes are decreased to 
approximately 50% of wild type expression levels in Dfl/+  heterozygotes and they do 
not exhibit dosage compensation (where expression reverts to wild type levels) (Prescott 
et al., 2005). Also, the Dfl/+  mutant phenotype reflects Tbxl haploinsufficiency,
Dfl/+  arch artery defects can be rescued using a TBXl transgene and Dfl/+;Tbxl^^' 
compound heterozygotes are indistinguishable from TbxT^' homozygotes (Lindsay et 
al., 2001; Vitelli et al., 2002a). Thus, the heterozygous D fl deletion may be used to 
accurately represent a Tbxl mutant allele.
Using CMFDG-labelling to isolate 76x7-expressing cells meant that only cells 
containing the Tbxl-lacZ allele could be labelled and corresponding wild type cells 
could not be identified. Therefore, Dfl/Tbxl'^^^ cells could only be compared to
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heterozygous cells which potentially results in smaller gene expression
changes than if compared to the relevant wild type cells. Despite these limitations, 
analysis of the Dfl deleted genes demonstrated that this microarray experiment could 
distinguish between Dfl/Tbxl^°^^ cells and Tbxl^^^^^^ cells accurately. Fourteen of the 17 
hemizygously deleted D fl genes represented on the microarray chips were significantly 
down-regulated, displaying a mean relative expression level of 0.594 ± 0.090 in 
cells.
In addition to the Dfl genes, 1553 unique transcripts were also found to be 
downregulated in Dfl/Tbxl^°^^ cells. However, relatively few upregulated genes were 
detected. This is most likely due to the fact that Tbxl is a transcriptional activator 
(Ataliotis et al., 2005; Stoller and Epstein, 2005; Xu et al., 2004) and thus there is a bias 
towards downregulation of genes when Tbxl function is disrupted. Also, the relatively 
large number of downregulated genes identified in the microarray suggests that Tbxl 
may be required for maintenance or proliferation of a subpopulation of cells in which 
case any genes expressed in such a population would appear downregulated.
The microarray, qRT-PCR and WISH analysis identified a number of putative Tbxl 
targets including genes from a variety of functional categories and which represent 
members of different signalling pathways. These genes and the potential roles they may 
play in pharyngeal/heart development are summarised in Table 3.3. Expression results 
for a proportion of the genes were obtained from in situ hybridisation analyses carried 
out by a member of the lab, Irinna Papangeli. These results were generated during her 
Masters course in which I helped to design the research project and supervised the 
experiments.
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Table 3.3 Downregulated genes and their role in c evelopment
Gene
Molecular
Function Expression Animal model/Human mutations
Potential role in 
development References
Nkx2.6 transcription
factor
Pharyngeal 
endoderm, 
mesoderm and 
ectoderm, OFT
Nkx2.6^ '^ mice appear phenotypically normal 
but Nkx2.5' '^;Nkx2.6^ '^ double knockouts 
have more severe pharyngeal arch defects 
than Nkx2.5 mutants alone (there is a 
decrease in PE cells and pharyngeal pouches 
do not form). NKX2.6 mutations are 
associated with common arterial trunk.
Nkx2.6 may be required for 
proliferation and survival of 
PE cells.
(Biben et al., 1998; 
Heathcote et al., 2005; 
Nikolova et al., 1997; 
Tanaka et al., 2001; 
Tanaka et al., 2000)
Cxcl4 or Pf4 chemokine Liver,
megakaryocytes
Cxcl4^ '^ and Cxcl4' '^ mice exhibit increased 
platelet counts and reduced thrombus 
formation following injury.
Cxcl4 may play a role in 
angiogenesis. The Cxc 
family member, Cxcll2 is 
important for ventricular 
septum development.
(Gengrinovitch et al., 
1995; Keith Ho et al., 
2001; Nagasawa et al., 
1996; Struyf et al., 2007)
Smad? signal
transduction/
transcriptional
regulation
SHF and OFT^ mice are embryonic lethal and 
exhibit increased Tgfp signalling and altered 
B cell responses.
Embryonic lethality could 
indicate heart or vascular 
defects. SmadC^' mutants 
exhibit OFT defects.
(Galvin et al., 2000; Liu 
et al., 2007b; Luukko et 
al., 2001; Zwijsen et al., 
2000)
Cdhl cell adhesion pharyngeal
endoderm^
Cdhl'^' mice exhibit preimplantation defects. 
CDHl mutations are associated with cleft 
palate and skeletal defects.
The E-cad homologue, N-cad 
is required in actin cables for 
correct pharyngeal 
morphogenesis.
(Frebourg et al., 2006; 
Quinlan et al., 2004; 
Riethmacher et al., 1995)
Ndufal3 or 
Grim 19
NADH
dehydrogenase
activity
heart Griml9'^' embryos die prior to E9.5 due to 
gastrulation defects.
In Tbxl mutants, RA- 
homeostasis is disrupted 
leading to pharyngeal defects. 
Ndufal3 is induced by RA 
and could act downstream of 
this pathway in pharyngeal 
development.
(Angell et al., 2000; 
Huang et al., 2004; 
Kotarsky et al., 2007; 
Roberts et al., 2006)
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cm cell adhesion pharyngeal endoderm^ nd CrbS is required for formation of 
epithelial tight junctions and apicobasal 
polarity during development which 
could be important for correct 
pharyngeal morphogenesis.
(Chalmers et al., 2005; 
Lemmers et al., 2004)
Serna 3 c signal
transduction
pharyngeal endoderm, 
SHF, OFT
SemaSc^' mice exhibit OFT and 
PAA defects reminiscent of DGS.
SemaSc may act as a guidance/attraction 
cue for cardiac neural crest.
(Feiner et al., 2001)
Slitl guidance cue,
receptor
binding
pharyngeal endoderm^ Slit2' '^ mice exhibit perinatal 
lethality and defects in retinal axon 
guidance.
Embryonic lethality could indicate heart 
or vascular defects. Slit2 acts as a 
guidance cue for axons and a 
chemorepellent during cell migration. 
Drosophila slit acts as a guide to align 
myocardial cells during development.
(Nguyen Ba-Charvet et 
al., 1999; Plump et al., 
2002; Wu et al., 2001; 
Yuan et al., 1999)
Lztfll transcription
factor-like
nd nd nd
Isll transcription
factor
SHF Isir''' mice exhibit severe second 
heart field defects resulting in 
absence of the OFT, right ventricle 
and parts of the atria.
Isll is required for proliferation of SHF 
cells prior to differentiation and 
regulation of genes important in heart 
development such as Mef2c, Nkx2.5 and 
Shh.
(Gai et al., 2003a; Dodou 
et al., 2004; Lin et al., 
2006; Takeuchi et al., 
2005)
Dsg2 cell-cell 
adhesion
Endoderm, heart DsgT'' mutants exhibit early 
embryonic lethality at the 
implantation stage, and Dsg2 '' ES 
cells exhibit decreased 
proliferation. DSG2 mutations are 
associated with arrrhythmogenic 
right ventricular cardiomyopathy.
Dsg2 is required for cell adhesion which 
may be important during pharyngeal 
morphogenesis and heart development.
(Awad et al., 2006; 
Eshkind et al., 2002; 
Mahoney et al., 2002; 
Pilichou et al., 2006)
to
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Bmprla receptor/
signal
transduction
ubiquitous NC-specific knockouts exhibit OFT 
defects. Isll-cre specific knockouts (SHF 
&PE) exhibit OFT and atrioventricular 
septal defects and results in decreased 
Thx2 and Tbx3 in the A VC. BMPRIA 
mutations are associated with juvenile 
polyposis.
Mutations in Bmprll^ Bmp4 and Bmp 7 
also result in defects in OFT septation, in 
addition to arch artery defects, suggesting 
that Bmp signalling is important for OFT 
development.
(Delot et al., 2003; 
Dewulf et al., 1995; 
Howe et al., 2001; Liu et 
al., 2004; Stottmann et 
al., 2004; Yang et al., 
2007)
Tbxl8 transcription
factor
head
mesenchyme,
splanchnic
mesoderm
Tbxl8'^ ' mice exhibit craniofacial and 
skeletal defects in addition to defects in 
anterior-posterior somite polarity. Tbxl S' 
mutants also fail to form sinus horns and 
have defective caval veins.
Tbxl and Tbxl 8 may interact during 
formation of the craniofacial skeleton 
since both mutants exhibit occipital bone 
defects. In addition, Tbxl and Tbxl8 
could interact in the overlapping 
expression domain within the SHF during 
cardiovascular development.
(Bussen et al., 2004; 
Christoffels et al., 2006; 
Kraus et al., 2001)
Tle4 cofactor for 
transcription
pharyngeal
pouches*
Misexpression of Tle4 results in heart 
laterality defects in medaka embryos.
Tle4 is a corepressor for transcriptional 
repressors eg. Gbx2 and Hesl which are 
potential downstream targets of Tbxl.
(Bajoghli et al., 2007; 
Heimbucher et al., 2007; 
Koop et al., 1996; 
Nuthall et al., 2002)
Daaml actin
binding/actin
cytoskeletal
organisation
pharyngeal
endoderm*^
nd Daaml mediates actin cytoskeletal 
rearrangements and is involved in the 
non-canonical Wnt-signalling pathway in 
which multiple members such as Vangl2 
and Dvl2, exhibit roles in OFT 
development.
(Aspenstrom et al., 2006; 
Habas et al., 2001; 
Hamblet et al., 2002; 
Nakaya et al., 2004; 
Phillips et al., 2005; 
Phillips et al., 2007)
Gsk3^ signal
transduction/
kinase
ubiquitous Gsk3p^' mice exhibit cleft palate and 
skeletal defects. GskSp'' mice also die 
during midgestation prior to El4.5 due to 
liver degeneration.
Gsk3p is involved in the regulation of 
multiple signalling pathways, including 
Wnt and Shh signalling, which are 
important in pharyngeal and heart 
development.
(Hoeflich et al., 2000; 
Liu et al., 2007a)
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NotchS receptor/
transcription
factor
pharyngeal
endoderm^
NotchS'^' adult mice exhibit defects in VSMC 
maturation and arterial differentiation and 
also have a hypoplastic thymus. Transgenic 
mice overexpressing iVb^c/ii exhibit VSMC 
degeneration and impaired vascular 
mechanotransduction. NOTCHS mutations 
are associated with CADASIL, a type of 
adult-onset vascular dementia.
Tbxl and NotchS may interact in 
development of the thymus and 
during vascular smooth muscle 
development.
(Domenga et al., 2004; 
Dubroca et al., 2005; 
Joutel et al., 1996; 
Kitamoto et al., 2005; 
Ruchoux et al., 2003)
Hesl transcriptional
repressor
pharyngeal 
endoderm, SHF 
and pharyngeal 
mesenchyme.
HesV^' mutants exhibit DGS-like OFT, AA, 
palate and thymic defects. HesT^' mice also 
exhibit defects in neurogenesis, ear, pituitary 
gland, pancreas, kidney, lung and eye 
development.
H esl regulates multiple 
developmental processes including 
differentiation, and proliferation of 
progenitor cell populations.
(Ishibashi et al., 1995; Ito 
et al., 2000; Jensen et al., 
2000; Kaneta et al., 2000; 
Kita et al., 2007; Ohtsuka 
et al., 1999; Tomita et al., 
1999; Zheng et al., 2000)
Six2 transcription
factor
pharyngeal
arches*
Six2' '^ mice exhibit renal hypoplasia and 
perinatal lethality. Transgenic embryos 
overexpressing Six2 exhibit defects in 
pharyngeal arch 2-derived skeletal elements.
Six2 is required for maintenance and 
proliferation of the mesenchymal 
progenitor cell population in kidney 
development. Tbxl and Six2 may 
interact in formation of the second 
pharyngeal arch..
(Kutejova et al., 2005; 
Oliver et al., 1995; Self et 
al., 2006)
Dab2 cytoplasmic
adaptor
pharyngeal 
arches, strong 
expression in 
caudal region 
of 2nd 
pharyngeal 
arch*
Dab2'^' mice are embryonic lethal due to 
extraembryonic defects in which there is 
decreased proliferation at E5.5. Epiblast- 
specific Dab2 knockouts appear 
phenotypically normal but have some kidney 
defects.
Dab2 acts as an adaptor protein and 
is involved in signal transduction and 
cell positioning control which may 
be important in pharyngeal 
morphogenesis.
(Hocevar et al., 2001; 
Morris et al., 2002; Yang 
et al., 2002)
Plek signalling
factor
nd nd Plek causes reorganisation of the 
actin cytoskeleton.
(Ma and Abrams, 1999)
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Cyp26al Retinoic acid 
metabolizing 
enzyme
pharyngeal
pouches*
Cyp26aV^' mice exhibit defects in kidney, 
urogenital tract, hindgut, vertebrae and brain 
development. Knockdown of all Cyp26 
genes in chick causes a DGS-like phenotype.
Cyp26al is required to maintain the 
correct RA levels during 
development.
(Abu-Abed et al., 2001; 
de Roos et al., 1999; 
Roberts et al., 2006)
Cyp26bl Retinoic acid 
metabolizing 
enzyme
pharyngeal 
endoderm and 
ectoderm
Cyp26br'' mice exhibit DGS-like palate, 
thymic, OFT and A A defects. Knockdown of 
all Cyp26 genes in chick causes a DGS-like 
phenotype.
Cyp26bl is required to maintain the 
correct RA levels during 
development.
K. Yashiro pers comm., 
(MacLean et al., 2001; 
Roberts et al., 2006)
Gbx2 transcription
factor
pharyngeal 
endoderm, 
ectoderm and 
mesoderm^
Gbx2' '^ mutants exhibit DGS-like palate, OFT 
and PAA defects. Tbxl^ '^;Gbx2^ '^ mutants 
exhibit increased penetrance of PAA defects.
Gbx2 and Tbxl could interact in 
patterning the neural crest during 
pharyngeal arch development.
(Byrd and Meyers, 
2005)S. Ivins and A. 
Calmont, pers. comm.
*Expression within a specific pharyngeal tissue not yet determined 
^Expression analysis carried out by I. Papangeli 
^A. Calmont, pers. comm.
Abbreviations: ES, embryonic stem; NC, neural crest; nd, not determined; OFT, outflow tract; PE, pharyngeal endoderm; PAA, pharyngeal arch artery; 
SHF, second heart field
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The primary defect in Tbxl'^' homozygous mutants is considered to be failure of 
pharyngeal segmentation, which leads to craniofacial, glandular and cardiovascular 
malformations. However, Tbxl is expressed in multiple tissues of the pharyngeal 
system within the endoderm, ectoderm, and core mesoderm which has made it difficult 
to determine the role that Tbxl plays within each tissue during pharyngeal development. 
Evidence from tissue-specific deletion studies suggests that Tbxl is required in both the 
mesoderm and pharyngeal epithelia for development of the majority of structures 
affected in TbxT^' mutants since deletion within either tissue recapitulates most of the 
TbxT^' phenotype (Arnold et al., 2006b; Zhang et al., 2006). However, Tbxl is required 
exclusively in the pharyngeal epithelia for secondary palate and fourth PAA 
development (Arnold et al., 2006b; Zhang et al., 2005; Zhang et al., 2006).
Reactivation experiments have also revealed that OFT, second pharyngeal arch and 
third and sixth PAA development are dependent on mesodermal expression of Tbxl 
(Zhang et al., 2006). Similar “restoration of function” experiments will need to be 
conducted to better define the requirement for Tbxl in the pharyngeal endoderm and 
ectoderm.
It is clear from these studies that Tbxl plays cell-autonomous and non cell-autonomous 
roles in pharyngeal development, but, in order to mediate interactions between tissues, 
Tbxl may regulate the expression of genes encoding signalling factors. To date, the 
only characterised, downstream targets of Tbxl which could act in this manner are 
members of the Fgf signalling pathway. Fgf3, FgfS and FgflO are secreted fibroblast 
growth factors which are downregulated in the pharyngeal region of TbxF^' embryos 
(Aggarwal et al., 2006; Arnold et al., 2006b; Hu et al., 2004; Xu et al., 2004; Zhang et 
al., 2005). Fgf8 and Tbxl interact genetically in development of the fourth arch artery 
(Vitelli et al., 2002b; Vitelli et al., 2006). However, due to possible functional 
redundancy between the Fgf ligands, it has been difficult to determine if they play a role 
in other aspects of pharyngeal development, downstream of Tbxl (Aggarwal et al., 
2006). Tissue-specific ablation of Fg/"signalling in Tbxl mutants may clarify the 
genetic interaction between these pathways, but other signalling factors are most likely 
also involved in mediating tissue interactions regulated by Tbxl.
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In this microarray, the signalling effectors, SemaSc and Slit2 were identified as 
dysregulated in Tbxl null cells. Both genes are expressed in the pharyngeal endoderm 
and SemaSc is also present in the SHF. SIU2 and SemaSc have been previously 
demonstrated to act as guidance cues for axons (Bagnard et al., 1998; Koppel et al., 
1997; Nguyen Ba-Charvet et al., 1999; Plump et al., 2002). In addition, Slit2 can act as 
a chemorepellent during cell migration (Wu et al., 2001) and Drosophila Slit has been 
shown to play a role in aligning myocardial cells at the midline during heart tube 
development (Qian et al., 2005). It is possible that in the context of pharyngeal 
morphogenesis, these genes may act to regulate NC cell migration for proper arch artery 
and OFT development or possibly, SIU2 could regulate endodermal cell movements in 
formation of the pharyngeal pouches.
One of the general mechanisms through which Tbxl acts to regulate development is by 
controlling cell proliferation. Tbxl has been shown to be required to maintain cell 
proliferation in the pharyngeal endoderm, mesoderm and otic vesicle (Vitelli et al.,
2003; Xu et al., 2005; Xu et al., 2004; Zhang et al., 2006). A number of genes 
identified in the microarray could act downstream of Tbxl in this process, including 
Nkx2.6, Gbx2, Isll and Hesl. Mouse mutants for these genes all show defects in cell 
proliferation (Cai et al., 2003a; Murata et al., 2005; Tanaka et al., 2001; Waters and 
Lewandoski, 2006).
In addition to proliferation, Tbxl may also be required for correct cell migration in the 
formation of the pharyngeal arches. The pharyngeal apparatus develops in a cranial to 
caudal manner and forms initially as outpocketings of the pharyngeal endoderm, which 
moves towards the surface ectoderm. These tissues come into close contact and expand 
along the proximodistal axis to form the pharyngeal pouches and clefts separating each 
pharyngeal arch (Graham and Smith, 2001). Quinlan et al. have demonstrated that the 
formation of actin cables within the pharyngeal endoderm linked via N-Cadherin 
adherens junctions plays an important role in this process (Quinlan et al., 2004). Given 
that cell adhesion molecules and genes involved in cytoskeletal rearrangement such as 
Cdhl, CrbS, Daaml, Dab2 and Plek were verified as downregulated in Dfl/Tbxl^^^^ 
cells, it would be interesting to investigate whether Tbxl also plays a direct role in 
mediating cell shape changes and cell migration in pharyngeal morphogenesis.
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In an effort to identify transcriptional targets of Tbxl, a novel approach was undertaken 
to isolate -expressing cells from mutant embryos by labelling Tbxl-lacZ cells with 
a fluorogenic, p-galactosidase substrate. Gene expression analysis of PCR-amplified 
RNA from these cells has led to the identification of novel Tbxl targets (and the 
elucidation of genetic pathways) which may play important roles in pharyngeal and 
heart development.
3.3.3 Future experiments
Microarray analysis is an excellent tool for investigating global gene expression 
changes caused by disruption of a transcription factor. In this project, confining the 
analysis to -expressing cells has allowed for enrichment of cell autonomous 
effects. However, Tbxl is expressed in multiple cell types within the pharyngeal region 
which were all included in the microarray and this method gives no indication as to 
where the changes occur in vivo or whether dysregulated genes are primary or 
secondary targets.
WISH analysis of the dysregulated genes can be used to address the first issue and 
currently, the lab is carrying out in situ experiments on the potential Tbxl targets 
identified by the microarray in order to prioritise genes for further investigation. In situ 
analysis should determine whether genes are downregulated in multiple or a subset of 
Tbxl expression domains, the degree of downregulation and whether genes are also 
altered in adjacent n o n - - e x p r e s s i n g  tissues such as the neural crest, which also 
plays an important role in pharyngeal development.
Another disadvantage of including multiple Tbxl cell types in the microarray analysis is 
that changes which occur only in a subdomain may be masked by no changes in other 
716x7-expressing tissues. For example, Fgf8, which has been shown to genetically 
interact with Tbxl (Vitelli et al., 2002b; Vitelli et al., 2006) was not identified as 
dysregulated in this microarray. This may be because while Fgf8 is downregulated in 
the pharyngeal endoderm and SHF of TbxT^' mutants, Fg/8 expression within the 
pharyngeal ectoderm, in an area overlapping with Tbxl, remains robust (Arnold et al., 
2006b; Zhang et al., 2005; Zhang et al., 2006). Future microarrays may overcome this 
problem by focusing on only one Tbxl domain for analysis. This could be achieved if 
the enhancer elements required for Tbxl expression within a particular tissue are
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discovered. Subsequently, transgenic mice expressing GFP under control of these 
regulatory elements could be used for isolation of homogeneous Tbxl cell populations. 
In order to distinguish between direct and indirect targets of Tbxl, the results from this 
microarray need to be combined with an experiment such as ChlP-chip, in which 
chromatin immunoprécipitation is coupled with microarray analysis. This method 
would involve using formaldehyde to crosslink Tbxl with its genomic DNA binding 
sites followed by immunoprécipitation with a Tbxl antibody. The regions bound by 
Tbxl could then be used as a probe on genomic DNA microarrays. Results from ChlP- 
chip could be compared to the gene expression analysis to determine if any identified 
genomic DNA binding sites for TBXl occur within the vicinity of dysregulated genes.
In addition to determining whether genes are direct or indirect targets of Tbxl, in vivo 
functional studies should be undertaken to confirm a role for potential targets in 
pharyngeal and/or heart development. This could be achieved by generating knockout 
or conditionally mutant mouse models or by using antisense morpholino 
oligonucleotides in zebrafish or chick. Furthermore, to test whether genes act in the 
same pathway as Tbxl, epistatic interactions will need to be analysed in animal models 
by crossing mouse mutants or using double morpholino injections in zebrafish. Tissue- 
specific roles for putative Tbxl targets could be examined by conditional deletion of 
genes and/or restoration of gene function in a mutant Tbxl background. These 
experiments would help to define the requirement for a particular gene downstream of 
Tbxl and in development.
These studies will provide the basis for investigating the molecular mechanisms through 
which Tbxl acts to regulate pharyngeal and heart development.
119
CHAPTER 4. TBXl BAC RECOMBINEERING
4.1 INTRODUCTION
At present, -expressing cells can be isolated from Tbxl-lacZ mice using the mutant 
Tbxl-lacZ allele which can be identified by using a fluorescent lacZ substrate. Labelled 
cells can then be collected by FACS. However, there are a number of disadvantages to 
isolating cells by this method. Firstly, corresponding wild type cells cannot be 
identified because they cannot be labelled. In addition, treating the cells with CMFDG 
and other chemicals in this protocol may potentially interfere with normal cell function 
and gene expression and is also time-consuming. In fact, the chemical chloroquine, 
which is used to reduce background caused by lysosomal enzyme activity, has been 
shown to decrease cell viability (Poot and Arttamangkul, 1997).
In order to overcome these limitations, recombination-mediated genetic engineering of 
bacterial artificial chromosomes (BAG recombineering) was used to generate a 
transgenic mouse carrying a GFP-labelled Tbxl allele. BAG recombineering is a 
method of modifying large genomic fragments of DNA using phage-based homologous 
recombination. In the past, genetic engineering by homologous recombination required 
the use of restriction enzymes, ligase and large regions (hundreds of base pairs) of 
homology. By incorporating a prophage with recombination functions into bacterial 
cells, scientists developed a more efficient and simple method of modifying BAGs and 
PAGs which requires less than 50bp homology (Figure 4.1 A) (Lee et al., 2001; Muyrers 
et al., 2001 ; Yu et al., 2000). Lee and colleagues introduced a defective "k prophage into 
the BAG host strain, DHIOB for use in BAG recombineering (Lee et al., 2001). The "k 
prophage has the recombination genes, gam, bet and exo whose expression is under 
control of a temperature sensitive repressor, X-cI857. Exo encodes an exonuclease 
which digests the 5’ ends of linear dsDNA then bet attaches to the 3’ overhangs and 
mediates annealing to complementary sequences of DNA in the host cell. Gam is 
required to prevent the RecBGD activity of the host cell which would degrade the linear 
targeting cassette. Normally, the cells are maintained at 32°G and the repressor is active 
but when the cells are shifted to 42°G for 15 minutes, the recombination genes are 
expressed and homologous recombination can occur between the target DNA and the 
BAG (Figure 4.IB) (Lee et al., 2001; Yu et al., 2000).
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Additional genes including cre,flpe and the galactose operon have also been introduced 
into the BAC host strains to make modifying BAC DNA even easier (Lee et a l, 2001; 
Warming et al., 2005). BAC recombineering has thus made it possible to modify large 
pieces of DNA efficiently and has made constructing gene targeting vectors for the 
production of transgenic mice much easier. Recombineering can be used to introduce 
reporter genes, subclone out regions of genomic DNA by gap repair and even introduce 
point mutations. This system was used to modify the Tbxl gene within a BAC.
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Figure 4.1 BAC recombineering to generate a moditled allele
(A) A linear targeting cassette containing 40 -  50bp homology arms is introduced into 
cells containing the BAC of interest. (B) The defective prophage contains gam, bet and 
exo genes which are under control of the Pl promoter and the temperature-sensitive 
repressor, c l857. Arabinose-inducible Cre or Flp recombinase genes are also contained 
in the defective prophage. Phage-mediated homologous recombination is induced by 
shifting the cells to 42°C. The phage recombination exonuclease, X-Exo, digests the 5’ 
ends of the targeting cassette leaving 3’ overhangs. X-Beta then binds to the 3’ 
overhangs and mediates annealing to complementary ssDNA in the cell resulting in a 
recombinant BAC. Modified from (Copeland et al., 2001)
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4.2 RESULTS
4.2.1 BAC recombineering
The aim of this project was to generate transgenic mice carrying an additional labelled, 
reversible, mutant Tbxl allele (TgTbxlfloxGFP) by inserting a floxed IRES2-eGFP 
sequence into intron 1 of Tbxl within a BAC (Figure 4.2). Introducing an IRES2-eGFP 
sequence (containing a poly A signal and downstream of a splice acceptor) within the 
first intron of Tbxl, after the first coding exon should generate either a null mutant 
allele or at least a hypomorphic allele, much like gene trap insertions (Stanford et al., 
2001).
Producing TgTbxlfloxGFP mice by pronuclear injection of oocytes should generate 
phenotypically normal mice, depending on the insertion site, since the allele is mutant 
but it is contained within a BAC, which inserts randomly into the murine genome.
Cells still express endogenous, wild type Tbxl thus negating the null phenotype of the 
mutant transgene. In any event, mice with an extra copy of Tbxl should be 
phenotypically normal since mice expressing up to four copies of a BAC containing 
Tbxl plus three other genes (Gnbll, Gplbfi and Cdcrell) are phenotypically normal as 
well (Lindsay et al., 2001; Zhang and Baldini, 2007). The rationale behind modifying a 
Tbxl BAC to make transgenic animals for future studies lies in experiments which have 
shown that using a 140kb PAC containing Tbxl is sufficient to rescue the arch artery 
defects present in D/7/+ mouse mutants (Lindsay et al., 2001). This implies that the 
140kb region including the Tbxl gene contains regulatory elements which are sufficient 
for normal Tbxl function at least in the tissues required for proper arch artery 
development.
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Targeting construct pIRES2-eGFP
50bp T bxl intron 1 
homology arm
SA 1RES GFP Kan/Neo 50bp Tb x l intron 1 
hom ology arm
...........2* ’
TgTbxlfloxGFP allele
1 SA 1RES
3 4 5 6 7
Tbxl
^  Homologous recombination
CH29-595C10 
BAC
GFP Kan/Neo
Translational start Splice Acceptor ^  loxP
—  5’ Tbxl intron 1 homology arm 
' 3’ Tbxl intron 1 homology arm
FRT
Figure 4.2 Generation of the TgTbxlfloxGFP allele
The targeting construct was generated by cloning loxP sites, FRT sites and Tbxl-m\xon 
1 homology arms into the pIRES2-eGFP vector. Electroporation of this vector into 
competent bacterial cells containing the CH29-595C10 BAC and induction of 
homologous recombination resulted in the recombined BAC containing a floxed IRES2- 
eOFP within intron 1 of Tbxl.
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4.2,L1 Generation of the Tbxl targeting vector
To incorporate a floxed IRES2-eGFP into intron 1 of Tbxl, a targeting vector for 
homologous recombination was generated (Figure 4.2). The pIRES2-eGFP plasmid 
vector was used as the backbone. FRT sites were ligated in cis into the vector to 
surround the kanamycin/neomycin resistance genes and were ligated into the Bsal and 
Aflll site using the following 5 ' -phosphorylated oligos which contained an Xbal site to 
test for incorporation of the oligo:
BsalF 5’-CCACTGAAGTTCCTATACTTTCTAGAGAATAGGAACTTC-3’
BsaIR 5’-GTGGGAAGTTCCTATTCTCTAGAAAGTATAGGAACTTCA-3’ 
AflIIFRT-F2 5’-TTAAGAAGTTCCTATACTTTCTAGAGAATAGGAACTTC-3’ 
AflIIFRT-R2 5’-TTAAGAAGTTCCTATTCTCTAGAAAGTATAGGAACTTC-3’
LoxP sites were ligated in the same orientation into the vector to surround the IRES- 
eGFP sequence and a splice acceptor site was also ligated upstream of the IRES-eGFP 
to ensure it would not be spliced out after incorporation into intron 1. A loxP-splice 
acceptor oligo was ligated into the EcoRI/SacII sites within the multiple cloning site 
region upstream of IRES2-eGFP using the following 5 ' -phosphorylated oligos 
containing a Sail site to test for incorporation: 
loxpSA-F
5’AATTATAACTTCGTATAGCATACATTATACGAAGTTATGTCGACAGGGTTT
CCTTGACAATATCATACTTATCCTGTCCCTTTTTTTTCCACAGGC-3’
loxpSA-R
5’CTGTGGAAAAAAAAGGGACAGGATAAGTATGATATTGTCAAGGAAACCC
TGTCGACATAACTTCGTATAATGTATGCTATACGAAGTTAT-3’
Another loxP site was ligated into the Notl site downstream of the IRES-eGFP sequence 
using the following 5’-phosphorylated oligos containing a PstI site to test for 
incorporation:
NotlLoxP-F
5’GGCCGCATAACTTCGTATAGCATACATTATACGAAGTTATCTGCAGGC-3’
NotlLoxp-R
5’GGCCGCCTGCAGATAACTTCGTATAATGTATGCTATACGAAGTTATGC-3’
125
The vector was sequenced using primer c, Iresgfpl880-F (Figure 4.4) to ensure the FRT 
sequence ligated into the Aflll site and the loxP sequence ligated into the Notl site were 
in the correct orientation in relation to the other FRT and loxP sites.
Finally, 50bp of homologous Tbxl intron 1 sequences were ligated into the Bsal s\\q 
and Nhel/Xhol site within the multiple cloning site region to ensure the vector would be 
targeted into Tbxl. Both sets of oligos contained an Nrul site to test for incorporation 
and to linearise the vector and remove unwanted vector sequence before homologous 
recombination into intron 1 of Tbxl. The following 5’-phosphorylated oligos were used 
for ligation:
Bsaltbxl intron 1-F
5’CCACACCAGCTCCGTGGCCAAGGAGGCTCAGGGCCTGTTTGCAAAGCCTT
CTCGCGA-3’
Bsaltbx 1 intron 1 -R
5’GTGGTCGCGAGAAGGCTTTGCAAACAGGCCCTGAGCCTCCTTGGCCACGG
AGCTGGT-3’
Nheltbx 1 intron 1 -F
5’CTAGCTCGCGAGAGGGAAAAAGGAACAATTGCAGATGCTCCCGATTTGAC
CAGTAGACC-3’
Xholtbx 1 intron 1 -R
5’TCGAGGTCTACTGGTCAAATCGGGAGCATCTGCAATTGTTCCTTTTTCCCT
CTCGCGAG-3’
The targeting vector was linearised by digesting with Nrul in preparation for 
electroporation into the target BAG.
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4,2.1.2 Tbxl BAC Recombineering of CH29-595C10
The Tbxl BAG, CH29-595C10 was transfomed by electroporation into EL250 cells, a 
competent cell line containing temperature-inducible recombination genes and an 
arabinose-inducible flpe gene (Lee et al., 2001; Yu et al., 2000). Digestion by Hindlll 
and Notl was carried out to determine the normal digestion pattern of the BAG (Figure 
4.3A). Originally, four 76x7-containing BAGs, generated from different mouse strains, 
were obtained. GH29-595G10, generated from a NOD mouse strain, was chosen for 
subsequent recombineering experiments so that the transgene could potentially be 
distinguished from the G57B1/6 host strain, by SNP-based PGR.
The pTamp vector (Lee et al., 2001) was used to try to remove the loxP site present in 
the GH29-595G10 BAG vector backbone, pTARBAG2.1. Removal of the loxP site was 
necessary to prevent it from interfering with the loxP sites contained within the 
targeting vector. BamHI digestion of the pTamp vector (Lee et al., 2001) was used to 
release the ampicillin cassette and pBeloBAGl 1 vector sequences flanking the loxP site. 
This linear DNA was then used as a targeting vector to replace the loxP site and was 
electroporated into EL250 cells containing the BAG. Subsequent recombined BAGs 
were isolated by selecting for û/w/?-resistant colonies (Lee et al., 2001).
The targeting vector was linearized by digesting with Nrul. EL250 cells carrying the 
modified GH29-595G10 Tbxl BAG were shifted to 42°G for 15 minutes to induce the 
recombination genes, exo, bet and gam and then electroporated with the linearized 
targeting vector. Kanamycin-resistant colonies were selected the next day and Hindlll 
and Notl restriction digests confirmed the integrity of the BAG.
The kanamycin/neomycin selection cassette was removed to prevent it from interfering 
with Tbxl function. To induce recombination between the FRT sites surrounding the 
kan/neo gene, Flp recombinase was activated in EL250 cells carrying the GH29-595G10 
BAG, by addition of L-arabinose. Fifty chloramphenicol-resistant colonies were picked 
and replica-plated onto kanamycin plates to test for loss of resistance. Forty-nine out of 
fifty colonies were kanamycin-sensitive indicating that the FRT sites were functional. 
Restriction digest and FIGE gel electrophoresis of several clones were carried out again 
to assess the integrity of the BAG (Figure 4.3B). A different digest pattern was 
apparent for the recombined BAGs compared to the original GH29-595G10 BAG.
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However, this was assumed to be due to the deletions and insertions incorporated into 
the BAG by the above recombination steps. This recombined BAG was sent to 
Poly Gene and used for pronuciear injection into mouse oocytes to generate transgenic 
mice carrying a reversible, rZ)x7-null/hypomorphic allele.
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Figure 4.3 BAG recombineering of CH29-595C10
(A) Hindlll and Notl digests of BAGs containing Tbxl prior to recombineering. (B) 
Hindlll and Notl digests of the T^jc/floxOF? GH29-595G10 BAG before and after 
removal of the kan selection cassette looks the same (4 and 7 are clone numbers). 
However, the digestion pattern of the recombined GH29-595G10 BAG (B) appears 
different to the unmodified BAG (A). The bands in (A) labelled by the black and red 
arrows do not appear in (B). Note that the gels were run for different lengths of time.
According to PolyOene, a total of 199 injected zygotes were transferred to 9 foster 
mothers, leading to the birth of 49 pups, from which tail biopsies were collected for 
genotyping. Twenty-five of the 49 pups were positive for the GFP vector sequence as 
analysed by PGR. Fourteen potential TgTbxlfloxGFP founders were mated with 
G57B1/6 wild type mice to collect litters and test for fluorescence of the transgene. 
Five, E9.5 litters were collected from potential TgTbxlfloxGFP mice (#10, 11, 28, 42 
and 44). However, none of the embryos were fluorescent within the expected Tbxl- 
expressing regions of the pharyngeal apparatus, head mesenchyme or otic vesicle. In 
order to determine whether the insert was being expressed, RT-PGR analysis was 
carried out on one of the litters obtained from TgTbxlfloxGFP x wildtype matings 
using primers spanning the region from Tbxl exon 1 to the 1RES sequence of the insert 
using primers e and f (Figure 4.4). A band of approximately 200bp was amplified.
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However, the PCR should have yielded a product of 271 bp, indicating that this band 
was either a non-specific product or that part of the insert had been deleted.
To confirm that the recombined BAG contained all of the Tbxl regulatory regions and 
to determine why the TgTbxlfloxGFP mice did not fluoresce, PCR analysis of 
sequences 55Kb and 10Kb upstream of the recombined Tbxl BAG used for 
electroporation was carried out (primers i,j and k,l. Figure 4.4). In comparison to the 
original GH29-595G10 BAG, which contained regions 10Kb and 55Kb upstream of 
Tbxl, the recombined GH29-595G10 containing the IRES2-eGFP insert was missing 
the 10Kb upstream region (Figure 4.5). This data, together with the altered digest 
pattern of the recombined BAG compared to the original BAG suggested that the BAG 
had aberrantly rearranged at some point during construction of the modified Tbxl allele. 
This rearrangement had led to disruption of upstream regulatory sequences and this is 
presumably why the transgene did not fluoresce.
Re-analysis of the steps during which the previous BAG, GH29-595G10, may have 
rearranged identified the “Tamping” step as the most probable cause of aberrant 
rearrangement. Many BAG vector backbones contain a loxP site which needs to be 
removed to prevent it from interfering with any loxP sites contained within the targeting 
cassette. The pTamp vector contains an ampicillin gene flanked by arms homologous to 
pBeloBAGl 1 vector regions surrounding the endogenous loxP site. This vector can be 
used to replace the endogenous loxP site by gene targeting. However, the pTamp 
plasmid is only applicable for use with BAGs contained within the vector, pBeloBAGl 1 
(Lee et al., 2001). The BAG used for engineering (GH29-595G10) is contained within 
the pTARBAG2.1 vector which has different sequences flanking its loxP site, therefore, 
this is the most likely step at which rearrangement occurred.
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Figure 4.4 PCR primers used to assess BAC integrity
PCR primers located upstream and downstream of Tbxl and also within the modified 
Tbxl allele were used to analyse TgTbxlfloxGFP BAC integrity and for genotyping. 
Primers are represented by the labelled black arrows. The sequences for primers a to n 
are located in section 2.4.2, Table 2.3.
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Figure 4.5 PCR analysis of genomic DNA surrounding Tbxl
The presence of genomic DNA 10Kb and 55Kb upstream of Tbxl was analysed in 
recombined, TbxIfloxGFP CH29-595C10 BACs. The 10Kb upstream region was 
missing in recombined TbxIfloxGFP CH29-595C10 BACs. The 55Kb upstream region 
was present in all recombined BACs. Genomic tail tip DNA and the chromosome 11 
BAC, RPl 1-4N9 were used as positive and negative controls, respectively.
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4.2.2 Re-engineering the TgTbxlfloxGFP allele
To re-engineer the TgTbxlfloxGFP allele, a different BAC containing Tbxl was used as 
the starting point, one for which the entire sequence had already been deposited into 
Genbank. RP23-35B9 (AC 133574) was chosen so that BAC integrity could be closely 
monitored with respect to in silico restriction digest patterns. Tbxl is located at the 
centre of this 168Kb BAC with at least 80Kb of genomic DNA either side of the 
transcript. First, a PCR-amplified ampicillin gene flanked by arms homologous to the 
sequences surrounding the pBACe3.6 loxP site (the vector backbone of RP23-35B9) 
was incorporated into the BAC to replace the endogenous BAC loxP site. The 
ampcillin gene was amplified from the pTamp vector (Lee et al., 2001) using primers 
o,p, Table 2.3, section 2.4.2). Recombined BACs were isolated by selecting for 
ampicillin-resistant colonies and Hindlll and Notl digests were carried out to confirm 
the integrity of the BAC. Once again, the Nrul-digested IRES-GFP insert generated 
previously was engineered into the RP23-35B9 BAC by electroporating the linearised 
targeting vector into the RP23-35B9 BAC contained within SW105 cells and selecting 
for kanamycin-resistant colonies the next day. SW105 cells were derived from the 
EL250 temperature inducible competent cell strain. However, they also contain a gal 
operon for use in galKpostive/negative selection (Warming et al., 2005). A Hindlll 
digest confirmed the integrity of the BAC (Figure 4.6A). In addition, PCR analysis of 
up and downstream regions of Tbxl within the modified RP23-35B9 BAC confirmed 
that these regions had not deleted (primers i,j;k,l;m,n. Figure 4.4, Figure 4.6B)
The kanamycin/neomycin selection cassette was removed prior to pronuciear injection 
by inducing Flp in SW105 cells carrying the modified RP23-35B9 BAC by addition of 
L-arabinose and cells were plated onto chloramphenicol and kanamycin plates to test 
for loss of kanamycin-resistance. 24 chloramphenicol-resistant colonies were then 
replica-plated onto kanamycin plates to confirm loss of kanamycin-resistance. A Sail 
digest confirmed BAC integrity, matching the predicted, in silico digestion pattern 
(Figure 4.6C). Finally, a PCR using primers spanning a part of the insert and exon 2 of 
Tbxl (primers c,d, Figure 4.4) confirmed that the kanamycin selection cassette had been 
removed, giving PCR products of the correct, predicted size (Figure 4.6D).
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Figure 4.6 Re-engineering the modified Tbxl allele in RP23-35B9
(A) The Hindlll digestion pattern of TbxIfloxGFP RP23-35B9 BACs, K l, K3 and K4 
matches the original RP23-35B9 digest pattern. (B) PCR analysis shows that regions of 
genomic DNA, 10Kb and 55Kb upstream and 50Kb downstream of Tbxl are present in 
the TbxIfloxGFP BACs, K l, K3 and K4 plus another RP23-35B9 recombinant, PI. (C) 
The Sail digestion pattern of the K3 recombinant before and after removal of the kan 
selection cassette matches the predicted, in silico digest pattern. (D) PCR analysis of the 
TbxIfloxGFP RP23-35B9 recombinant before and after removal of the kan selection 
cassette using primers spanning the 1RES sequence of the insert and Tbxl exon 2.
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4.2.3 Generation of TgTbxlfloxGFP mice
The modified RP23-35B9 BAC, named TgTbxlfloxGFP was sent to Genoway for 
pronuciear injection of oocytes. Genoway reimplanted 47 injected embryos into 2 
pseudopregnant mothers, resulting in 14 viable pups which were tested for presence of 
the transgene. Genoway also conducted a Southern blot analysis using a GFP probe 
which determined that 2 animals contained the transgene. According to the signal 
intensity, it was estimated that founder #36523 contained more than 10 copies of the 
transgene and founder #36853 harboured at least 1 copy (Figure 4.7).
Exi
Enginetrtd Tbxl k)cu$
Ex2 Ek6  PmI
4 - ...... — 0------ L
2 ‘ t -
'3FP prob«
rOTj-(MfN
»nm
(A 0).
i *
kb
10
IP
i s
ro »r> »- O  M
TO > I
10
8
6
5
- 3
10-
8 -
6 -
5-
< T g
3 -
Pcil d igest/probe GFP Pcil digest / probe GFP
Figure 4.7 Southern blot analysis of TgTbxlfloxGFP mice
After Pcil digestion of genomic DNA, a GFP probe was used to detect a 6.2Kb DNA 
fragment containing the transgene. Fourteen potential founders were analysed but only 
2, #36523 and #36853 contained the transgene (red arrows). The intensity of the signal 
was compared to known copies of the transgene (0, 5 and 10 copies) to determine the 
copy number in the founder animals. (Conducted by Genoway).
133
These 2 male animals, #36523 and #36853 were obtained from Genoway and mated to 
wild type C57B1/6 females to assess fluorescence of the transgene in embryonic litters. 
Embryos were collected at E9.5, a timepoint at which Tbxl is normally expressed at 
high levels within embryonic tissues (Chapman et al., 1996). Tbxl is normally 
expressed at this stage in the head mesenchyme, otic vesicle and pharyngeal endoderm 
and ectoderm. It is also detected within SHF domains consisting of the core mesoderm 
of the pharyngeal arches and the splanchnic mesoderm and Tbxl is also expressed 
within the distal OFT (Figure 4.8A and B). Two E9.5 litters were collected from 
wildtype matings to founder #36523. However, none of the embryos were fluorescent. 
One E9.5 litter was analysed from a wildtype mating to the founder #36853, reported to 
contain at least 1 copy of the transgene. FI embryos were found to express GFP within 
the 76x7-expressing domains of the pharyngeal apparatus and otic vesicle (Fig 4.8C,C’- 
F,F’). The transgene appeared to be expressed in all of the pharyngeal pouches at this 
stage and in the pharyngeal ectoderm surrounding caudal arches three and four (Figure 
4.8C’, E’ and F’) The transgene was also expressed within the pharyngeal mesoderm of 
arches three and four and in the splanchnic mesoderm dorsal to the heart within the SHF 
(Figure 4.8D’, E’ and F’). The transgene did not recapitulate the entire expression 
pattern of Tbxl since it was not expressed (at least at a detectable level by fluorescence) 
within the head mesenchyme, core pharyngeal mesoderm of arches one and two or 
OFT. Genotyping confirmed that the fluorescent embryos contained the transgene 
expressing GFP within intron 1 of Tbxl. Furthermore, analysis of an E9.5 litter of 
embryos obtained from a wild type C57B1/6 female mated to an FI TgTbxlfloxGFP 
male confirmed that there was successful transmission of the transgene. All the F2 
TgTbxlfloxGFP/+ heterozygous embryos were fluorescent within the same Tbxl 
domains as seen in the FI generation.
These results demonstrate that the BAC recombineering experiments carried out to 
generate a Tbxl allele expressing GFP were successful and produced a TgTbxlfloxGFP 
mouse which will be a valuable tool for use in future experiments to study the role of 
Tbxl in development.
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BFigure 4.8 GFP expression in TgTbxlfloxGFP embryos
(A, B) Expression of Tbxl at E9.5 shown by X-gal staining of embryos. Tbxl
is expressed in the head mesenchyme (black arrowhead), otic vesicle (white arrow), 
core pharyngeal mesoderm and splanchnic mesoderm (yellow arrowhead), pharyngeal 
endoderm (red arrowhead) and outflow tract (black arrow). (C, D) Expression of the 
TgTbxlfloxGFP transgene detected by fluorescence at E9.5 within the otic vesicle 
(white arrow), splanchnic mesoderm (yellow arrowhead) and pharyngeal endoderm (red 
arrowhead). A lateral (C) and frontal (D) brightfield view and the corresponding view 
of fluorescent tissues (C% D ) The dotted circle represents the position of the outflow 
tract. (E, F) Cryosections of E9.5 TgTbxlfloxGFP embryos. Brightfield views of 
sagittal (E) and coronal (F) sections and the corresponding views of fluorescent tissues 
(E \ F’). Fluorescence is also detected in the pharyngeal ectoderm in coronal sections 
(F% white arrowhead).
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4.3 DISCUSSION AND FUTURE DIRECTIONS
4.3.1 Analysis of TgTbxlfloxGFP mice
BAC recombineering is a relatively quick and simple method of modifying genetic loci 
while retaining all the regulatory elements required for correct transgene expression. 
This approach was used to generate a transgenic mouse carrying a modified Tbxl allele 
in which a floxed IRES2-eGFP vector was inserted into intron 1 of Tbxl.
One founder TgTbxlfloxGFP mouse was obtained which appears to express the 
transgene within a subpopulation of -expressing cells. At E9.5, the 
TgTbxlfloxGFP allele is expressed in the otic vesicle, pharyngeal endoderm and 
ectoderm and the pharyngeal mesoderm/splanchnic mesoderm of caudal pharyngeal 
arches three and four. Loss of the more rostral head mesenchyme and pharyngeal 
mesoderm expression may have occurred secondary to positional effects of transgene 
integration or because the mesodermal enhancer required for this expression is located 
outside the BAC. However, experiments by another group have indicated that multiple 
Fox cis elements contained within the 13 kb region directly upstream of the translational 
start site of Tbxl are sufficient to direct expression of a lacZ reporter in most 
endogenous Tbxl expression domains (Hu et al., 2004; Maeda et al., 2006; Yamagishi 
et al., 2003b). More precisely, a 200bp fragment (-12.8kb to -12.6kb) plus a l.Skb 
fragment (-S.lkb to -6.6kb) containing 2 conserved Fox binding sites upstream of the 
translational start site of Tbxl could recapitulate the head mesenchyme, pharyngeal 
mesoderm, pharyngeal endoderm and OFT expression of Tbxl assessed at E9.5 by lacZ 
expression (Hu et al., 2004; Maeda et al., 2006; Yamagishi et al., 2003b).
In TgTbxlfloxGFP mice, transgene expression does not fully recapitulate endogenous 
Tbxl expression, which could be due to a number of different reasons. One possibility 
is that the transgene could be expressed in the core pharyngeal mesoderm and head 
mesenchyme but at insufficient levels to be detected by fluorescence. One way of 
determining whether the transgene is expressed in these tissues would be to amplify the 
signal using the Biotin-Avidin system. A rabbit anti-GFP antibody could be used 
followed by a biotinylated anti-rabbit antibody and finally, a peroxidase conjugated 
avidin applied for detection. This series of steps provides a more sensitive method of 
detecting expression due to the amplification of binding sites.
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The copy number of the transgene may also have affected expression within the head 
mesenchyme and pharyngeal mesoderm. The original founder animal tested contained 
only one copy of the transgene. However, additional copies may be required for 
detection in all Tbxl expression domains, as has been noted for other Tbxl transgenes 
(Maeda et al., 2006).
Alternatively, some of the Fox enhancer elements or other cfj-regulatory regions 
identified upstream of Tbxl may have been lost (Hu et al., 2004; Maeda et al., 2006; 
Yamagishi et al., 2003b). Future experiments should determine whether these sites 
were lost during the injection and homologous recombination into mouse genomic 
DNA. Considering that the BAC DNA was injected by Genoway without first 
linearizing the vector, it is not clear how the BAC integrated into the genome. A 
proportion of the regulatory regions controlling Tbxl expression may have been lost. If 
these required Fox elements or other regulatory regions are found to be missing, the 
expression of the TgTbxlfloxGFP transgene could mean that additional regulatory 
elements can direct Tbxl expression in the pharyngeal endoderm and the more caudal 
domains of the pharyngeal ectoderm and SHF. It is also possible that insertion of the 
IRES2-eGFP fragment into intron 1 of Tbxl disrupted an enhancer or activated a 
repressor element leading to an altered expression pattern. Rearrangement of the BAC 
during integration may also have altered the position of important regulatory elements. 
In addition, silencing of some Tbxl expression domains could have occurred depending 
on the integration site.
In order to distinguish between these possibilities and assess the integrity of the 
transgene, real-time PCR could be used to analyse the copy number of regulatory 
sequences surrounding Tbxl, which should be contained within the transgene. Also, 
Southern blot analysis could be used to determine if transgene fragments are missing or 
have rearranged. Functional studies of the TgTbxlfloxGFP mice could also be carried 
out. TgTbxlfloxGFP mice could be bred to TbxF'^^ animals to generate
gTbx 1 floxGFP mice so that transgene rescue of the TbxF’’^^^ ’'^  {=TbxT^') 
mutant phenotype could be assessed. The TbxF’^  ^allele was generated by knocking in 
an IRES-Cre construct into the T-box DNA binding domain of Tbxl and it is expressed 
in all endogenous Tbxl expression domains (Huynh et al., 2007). Cre-mediated 
recombination of the TgTbxlfloxGFP allele should occur in expression domains in 
which both Cre and the transgene overlap. This recombination should allow removal of
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the IRES2-eGFP from intron 1 of Tbxl, restoring frill length Tbxl expression. Analysis 
of the extent of phenotypic rescue would begin to indicate if the transgene is expressed 
in all Tbxl domains. If, for example, the transgene was not expressed within the head 
mesenchyme and core mesoderm of the first and second pharyngeal arches then the 
branchiomeric myogenesis defect and second pharyngeal arch hypoplasia exhibited by 
TbxT^' mutants (caused by loss of Tbxl expression in the mesoderm) may still be 
present.
The loss of Tbxl in a sub-mesodermal domain may be quite fortuitous in that it should 
allow the function of Tbxl in the caudal mesodermal domain to be distinguished from 
its role in more rostral mesoderm. The difference in Tbxl function between these two 
regions is exemplified by regulation of Pitx2 which is considered to be downstream of 
Tbxl in the SHF (Nowotschin et al., 2006) however, it is upstream of Tbxl in the first 
pharyngeal arch mesoderm (Shih et al., 2007).
4.3.2 Identification of Tbxl target genes
TgTbxlfloxGFP mice could also be crossed to Tbxl'^ '^" '^" mutants to generate 
T&Jc7'”^ ' '^”‘^'”;TgTbxlfloxGFP mice to investigate genetic pathways downstream of Tbxl. 
The Tbxl' '^ '^" allele was generated by knocking in a tamoxifen-inducible Cre into the 
DNA binding domain of Tbxl (Xu et al., 2004). 77jx7'”"' '^”"'”;TgTbxlfloxGFP embryos 
will effectively be homozygous null for functional Tbxl (equivalent in phenotype to 
TbxT^' or Dfl/Tbxl^°^^omhryos). GFP-positive cells (effectively TbxT^') could be 
isolated by FACS. Following sorting, these cells could be split into two portions, one of 
which is treated with tamoxifen to induce Cre-mediated recombination of the 
TgTbxlfloxGFP allele, restoring Tbxl function to these cells. Comparing the gene 
expression profile between the tamoxifen-treated and carrier-treated Tbxl cells should 
further enrich for direct Tbxl targets because RNA can be extracted soon after 
tamoxifen induction of recombination, thus enriching for immediate early response 
genes. In addition, this experiment allows a within-group comparison to be carried out, 
reducing the effects of variability among different embryos. Results from these studies 
could be compared to the microarray data for further validation of potential Tbxl 
targets.
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After tamoxifen treatment, time needs to be allowed for Cre-mediated recombination of 
the TgTbxlfloxGFP allele and subsequent protein expression of functional Tbxl to take 
place before RNA can be extracted for expression analysis. In order to determine the 
correct time to extract RNA, a preliminary experiment could be carried out in which 
RNA or genomic DNA is extracted from tamoxifen-treated cells at various timepoints 
after addition of tamoxifen. RT-PCR or PCR analysis could then be carried out to test 
for recombination of the transgenic allele. In addition, protein could also be extracted at 
various timepoints after tamoxifen injection to test for presence of the functional Tbxl 
protein by Western analysis. These preliminary experiments could be used to identify 
the timepoint at which RNA should be extracted after Tbxl protein production. This is 
important as the shorter the time after Tbxl production, the greater the enrichment for 
direct Tbxl targets.
4.3.3 Additional Tbxl BACs
While this transgenic mouse enables further analysis of the role of Tbxl in 
development, other BACs/transgenic mice are being constructed in our lab which will 
enable even better analysis of the genetic pathways downstream of Tbxl. Incorporating 
a mutated form of the ligand binding domain of the human estrogen receptor (ER) 
downstream of Cre recombinase has been successfully used to control the time of 
recombination in various tissues (Monvoisin et al., 2006; Yajima et al., 2006).
Normally, the Cre-ER fusion protein is retained in the cytoplasm within a HSP90 
complex and is inactive. However, upon addition of tamoxifen, a synthetic ER ligand, 
the HSP90 complex is disrupted and the Cre recombinase protein is translocated to the 
nucleus where it can act to induce recombination at its target sites (Feil et al., 1997). 
BAC recombineering has been used in our lab to fuse the estrogen receptor to the last 
exon of Tbxl which should enable temporal control of Tbxl activity. These transgenic 
mice will enable better identification of immediate, early response genes upon Tbxl 
activation since transcription of Tbxl does not need to occur.
In conclusion, the generation of TgTbxlfloxGFP mice will enable further direct 
downstream targets of Tbxl to be identified providing a valuable resource to study the 
role of Tbxl in development.
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CHAPTER 5. FUNCTIONAL ANALYSIS OF H E Sl IN 
DEVELOPMENT
5.1 INTRODUCTION
The microarray of Dfl/Tbxl^°^^ cells vs. cells identified a number of potential
Tbxl targets including Notch3 and Hesl, genes encoding transcription factors involved 
in the Notch signalling pathway. NotchS is a receptor and transcription factor, while 
Hesl is a transcriptional repressor and effector of Notch signalling. Both genes were 
significantly downregulated in Tbxl-nuW cells by greater than 3 fold to 0.249 ±0.103 
and 0.261 ± 0.093, respectively, according to qRT-PCR. Notch3'^' mutant embryos 
appear phenotypically normal. However, adults exhibit vascular abnormalities 
(Domenga et al., 2004). Notch3 expression within the pharyngeal apparatus overlaps 
with other Notch receptors, thus there is a possibility that functional redundancy affects 
analysis of the role of Notch3 in embryogenesis (Kitamoto et al., 2005). HesT^' mutants 
exhibit a large range of abnormalities demonstrating the importance of this gene during 
development. Hesl is required for normal neurogenesis, pituitary gland, eye, ear, 
thymus, lung and pancreas development (Ishibashi et al., 1995; Ito et al., 2000; Jensen 
et al., 2000; Kaneta et al., 2000; Raetzman et al., 2007; Tomita et al., 1999; Tomita et 
al., 1996; Zheng et al., 2000; Zhu et al., 2006; Zine et al., 2001).
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5.2 RESULTS
5.2.1 Analysis of Hesl expression
Reports of Hesl expression during development show that Hesl is present within the 
pharyngeal arches between embryonic days E8.5 to E9.5 at least (Barsi et ah, 2005; 
Hamada et ah, 1999; Koop et ah, 1996). However, the role of Hesl in this structure has 
not been well characterised. In situ hybridisation analysis at E9.5 revealed that Hesl is 
expressed in an overlapping fashion with Tbxl, in the pharyngeal mesenchyme, the 
endoderm lining the pharyngeal pouches and the splanchnic mesoderm within the SHF 
domain (Figure 5.1). Hesl appeared downregulated within all of these domains in 
TbxT '^ mutant embryos at the same stage. These results show that Hesl is diminished 
in cell lineages important for pharyngeal and cardiovascular development suggesting 
that Hesl may play a role downstream of Tbxl in the morphology of structures affected 
in Tbxl mutants.
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Figure 5.1 In situ hybridisation of Hesl in wild type and Tbxl''' embryos at E9.5
(A) Hesl expression within the pharyngeal mesenchyme (black arrow), endoderm 
(black arrowhead) and second heart field (red arrowhead) within wild type embryos is 
downregulated in TbxT '^ embryos. (B) Coronal sections and (C) transverse sections 
demonstrating downregulation of Hesl within the pharyngeal mesenchyme (black 
arrow), endoderm (black arrowhead) and second heart field (red arrowhead) of TbxT'' 
embryos. Abbreviations: a, arch.
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5.2.2 Hesl and analysis of lethality
According to the original study of the Hesl mouse knockout phenotype, a proportion of 
Hesl'^' homozygotes are embryonic lethal commencing at age E l2.5 (Ishibashi et ah, 
1995). In this study, Hesl'^' embryos collected at El 4.5-El 5.5 on an MFl background 
were also underrepresented according to the expected Mendelian ratios (Table 5.1) and 
dead Hesl'^' embryos were often found at this stage which had either resorbed, or had 
neurulation defects as previously described (Ishibashi et al., 1995). In the analysis of 
embryos at earlier stages, it was noted that some Hesl'^' homozygotes exhibit 
haemorrhage throughout the body at El 1.5 (n=2 out of 7) (Figure 5.2) which has not 
been previously reported. These observations suggest that vascular defects may be 
partly responsible for the embryonic lethality of Hesl'^' mutants from E l2.5.
The phenotype of Hesl'^' mutants was also assessed on a mixed MFl;C57Bl/6 
background. Hesl'^' embryos on this background were present in normal Mendelian 
ratios at E l5.5 (Table 5.1) and brain and neural tube defects were not observed at this 
stage in contrast to H esl"  mice maintained on a pure MFl background. This suggests 
that the C57B1/6 genetic background may play a protective role against vascular and 
neurulation defects caused by the Hesl mutation.
Table 5.1 Frequency of genotypes obtained at E14.5-E15.5 from Hesl 
intercrosses
Strain n wild ty\idH est^' Hesl'^'
MFl
MFl;C57Bl/6
110
80
92(84%) 18(16%)* 
57(71%) 23 (29%)
‘p < 0.05 Statistics based on Chi squared test.
Hes1*^-IBr
L
Figure 5.2 Vascular defects in Hesl'^' mouse mutants
(A) A control Hesl^^' embryo at El 1.5 (B) A H esl"  mutant exhibiting haemorrhaging 
throughout the body (arrowheads in B).
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5.2.3 H esl mutants exhibit defects in multiple organs
The gross morphology of the whole embryo, including the cardiovascular system was 
investigated at E14.5 to E15.5 to determine whether Hesl mutants exhibited any DGS- 
like abnormalities. A combination of MRI scanning and conventional histological 
methods were used to analyse the phenotype of Hesl mutants on both a pure MFl 
background and a mixed MF1;C57B16 background to determine whether strain 
differences would affect the phenotypes observed.
Hesl'^' mice have previously been shown to exhibit defects in multiple organs and MRI 
scanning of El 5.5 Hesl'^’ homozygotes detected some of the reported defects in eye, 
pancreas and thymus development (Jensen et al., 2000; Kaneta et al., 2000; Tomita et 
al., 1999; Tomita et al., 1996) (Table 5.2). Ail Hesl'^' embryos regardless of genetic 
background had absent eyes and a hypoplastic or aplastic pancreas (Figure 5.3B, D). 
Hesl'^' mutants also exhibited hypo/aplasia of one or both thymic lobes (n = 23/23, 
100% MF1;C57B16 and n = 13/15, 87% M Fl) (Figure 5.3F), a phenotype which is very 
similar to that seen in Tbxl mutants (Jerome and Papaioannou, 2001 ; Lindsay et al., 
2001; Merscher et al., 2001).
Table 5.2 Developmental defects identified by MRI in E15.5 Hesl'^' mutants
Strain Genotype n
Pancreatic 
Eye defects hypo/aplasia
Thymic
hypo/aplasia
MFl Hesl-'' 15 15(100%) 15 (100%) 13 (87%)
Hesl*'- 15 0 0 0
Wild type 2 0 0 0
MFl;C57Bl/6 H e s r 23 23 (100%) 23 (100%) 23 (100%)
HesH^- 21 0 0 0
Wild type 7 0 0 0
143
»Figure 5.3 Morphological defects detected in E15.5 embryos by MRI
Transverse MRI scans show that mutants are missing eyes (compare black
arrows in (B) to (A)), and exhibit pancreatic hypo/aplasia (small dark spots indicated by 
red arrow in (D) which are absent in (C)) as well as thymic hypo/aplasia (asterisks in 
(F) compared to (E)). Abbreviations: th, thymic lobe.
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5.2.4 Analysis of pharyngeal and heart development in H esl mutant embryos
5,2.4.1 H esl mutants exhibit pharyngeal arch artery defects
Tbxl is required in the pharyngeal apparatus for correct growth and remodelling of the 
pharyngeal arch arteries. These initially form as bilaterally symmetric vessels which 
pass through each pharyngeal arch and remodel during embryogenesis to form part of 
the aorta and great vessels of the heart. To examine the potential role of Hesl 
downstream of Tbxl in pharyngeal development, the pharyngeal arch arteries were 
analysed at E l0.5. At this stage, Tbxl^^' heterozygous embryos exhibit fourth arch 
artery hypo/aplasia (Jerome and Papaioannou, 2001; Lindsay et al., 2001; Merscher et 
al., 2001). Intracardiac ink injection was carried out to visualise the arch arteries in 
stage-matched wild type, Hesl^^' and HesT^' mutant embryos. These experiments 
revealed that 5/27 (19%) HesT^' embryos analysed on an MFl background had an arch 
artery defect including hypo/aplasia of the fourth arch artery, persistent first and second 
arch arteries and hypoplastic sixth arch arteries (Figure 5.4D-F; Table 5.3). In addition, 
the same range of pharyngeal arch artery defects also occurred in a smaller proportion 
of Hesl^^' mutant embryos (5/42, 12%) (Figure 5.4B, C; Table 5.3), although these 
involved hypoplasia rather than aplasia and no sixth arch artery defects were found. In 
comparison, wild type control embryos (Figure 5.4A) did not exhibit pharyngeal arch 
artery defects except for one embryo which may possibly have had a unilateral, 
hypoplastic fourth arch artery (1/67, 1%) (Table 5.3).
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Figure 5.4 Intracardiac ink injection of E10.5 Hesl mutants
(A) In wild type embryos, bilateral pairs of caudal arch arteries R3-R6 and L3-L6 are 
present at E l0.5. A proportion of Hesl^^' mutants have hypoplasia of the fourth arch 
artery (arrow in B) and persistent first and second arch arteries (C). mutants also
exhibit fourth arch artery aplasia (arrow in D), persistent first and second arch arteries 
(E) and sixth arch artery hypoplasia (arrow in F). Abbreviations: L, left; R, right.
Table 5.3 Frequency of pharyngeal arch artery defects in E10.5 Hesl mutants
PAA WT Hesl^' H esl'-
Ink Injection
Abnormal 1st . 1 (pers) 1 (pers)
2nd - 1 (pers) 2 (pers)
3rd - - -
4th 1 5 (hypo/ap) 3 (hypo/ap)
6th - - 1 (hypo)
Total abnormal 1 5* 5**
Normal 66 37 22
Total embryos (93) 67 42 27
Percentage of embryos 
with arch artery 
abnormalities 1% 12% 19%
Abbreviations: PA A, pharyngeal arch artery; WT wild type 
* Significantly different from WT (Fisher's exact test, p<0.05) 
** Significantly different from WT (Fisher's exact test, p<0.01)
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5.2.4.2 H esl mutants exhibit cardiovascular and craniofacial defects
In addition to the previously reported morphological defects mentioned above, a 
proportion of El 5.5 Hesl'^' embryos also exhibited cardiovascular defects including 
great vessel and outflow tract alignment defects (5/23, 22% MF1;B16 and 2/15 (13%) 
M Fl) (Table 5.4). Normally in wild type embryos at this stage, the right fourth 
pharyngeal arch artery has remodelled and forms part of the right subclavian artery and 
the left fourth arch artery forms part of the aortic arch. The right sixth arch artery has 
regressed and the left sixth arch artery forms the ductus arteriosus connecting the 
pulmonary trunk to the descending aorta (Figure 5.5A, B, E). Arch artery defects in 
Hesl'^' mutants (4/23 (17% MF1;B16) and 1/15 (7% MFl), Table 5.4) included right­
sided aortic arch (RAA) (Figure 5.5C, F, G), interruption of the aortic arch type B 
(lAA-B) (Figure 5.50) in which the connection between the left common carotid and 
left subclavian artery is missing, and isolation of the right subclavian artery (I-RSCA) 
(Figure 5.5H) in which the right subclavian branched off the pulmonary artery instead 
of connecting to the right common carotid artery. RAA and lAA-B represent loss of the 
left fourth arch artery and persistence of the right fourth arch artery and I-RSCA occurs 
due to aberrant remodelling of the right fourth arch artery. In addition, some embryos 
exhibited right-sided ductus arteriosus (Figure 5.5D, F), a manifestation of loss of the 
left sixth arch artery and persistence of the right sixth arch artery. The phenotype of 
these Hesl'^' embryos is consistent with the earlier arch artery defects observed at 
E10.5.
In addition to great vessel abnormalities, defects in outflow tract alignment were also 
observed in Hesl'^' homozygotes (2/23 (9% MF1;B16) and 1/15 (7% M Fl)) (Table 5.4; 
Figure 5.6). These outflow tract defects included double outlet right ventricle (DORV) 
(Figure 5.6D, F) in which both the aorta and pulmonary trunk arose from the right 
ventricle or an overriding aorta and both of these defects were accompanied by a VSD 
(Figure 5.6B).
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Table 5.4 Frequency of cardiovascular and craniofacial defects in £15.5 H esl 
mutants
Strain Genotype n CV defect
Great vessel 
defect OFT defect Cleft Palate
MFl Hesl'- 15 2(13%) 1 (7%) 1 (7%) 9 (60%)
Hesl"'- 15 l ‘ (7%) 0 0 0
Wild type 2 0 0 0 0
MFl;C57Bl/6 Hesr'’ 23 5 (22%) 4(17%) 2(9%) 9 (39%)
HesV'- 21 0 0 0 1(5%)
Wild type 7 0 0 0 0
* Dextroposition of the heart 
CV-cardiovascular, OFT-outflow tract
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Figure 5.5 Great vessel defects in E15.5 Hesl'^' mutants 
(A-D) Transverse MRI scans. (E-H) Intracardiac ink injection. (A, B) In wild type 
(wt) embryos, the aortic arch (A) and pulmonary trunk (B) pass to the left of the 
trachea. (C, D) In some HesT^'i-/-) mutants, the aortic arch (C) and pulmonary trunk 
(D) pass to the right of the trachea. (E) Intracardiac ink injection of a wild type embryo 
displaying normal great vessel morphology (F-H) H esl' ' mutants with right-sided 
aortic arch and right-sided ductus arteriosus (F), interruption of the aortic arch type B 
and a right-sided aortic arch (G), and isolation of the right subclavian artery (H). 
Abbreviations: aoa, aortic arch; da, ductus arteriosus; Icc, left common carotid; Isca, left 
subclavian artery; pt, pulmonary trunk; rcc, right common carotid; rsca, right subclavian 
artery; rv, right ventricle. Asterisks denote missing segments.
wt '  ^ , ' wt
-W:;
Figure 5.6 Outflow tract and ventricular septal defects in E15.5 Hesl'^' mutants 
(A-B) Transverse MRI scans. (C-F) Transverse histological sections. (A) In wild type 
embryos the interventricular septum separates the right and left ventricles. (B) H esl " 
mutants exhibit a ventricular septal defect. (C, E) Consecutive transverse sections of a 
wild type embryo in which the pulmonary trunk arises from the right ventricle (C) and 
the aorta joins the left ventricle (E). (D, F) Consecutive sections of a H esH ' embryo 
with DORV in which both the aorta and pulmonary trunk arise from the right ventricle. 
Abbreviations: ao, aorta; ivs, interventricular septum; Iv, left ventricle; pt, pulmonary 
trunk; tv, right ventricle; vsd, ventricular septal defect.
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Craniofacial abnormalities were also observed in H esl"  mutant embryos. A previously 
unreported phenotype was the presence of cleft palate in 39% (9/23) of mutants
on a MFl ;C57Bl/6 background and 60% (9/15) of HesV^' embryos on an MFl 
background (Table 5.4). The secondary palatal shelves appeared to have rotated but 
they did not meet in the midline in mutants compared to wild type embryos at
the same stage (Figure 5.7).
In contrast to the pharyngeal arch artery defects detected in Hesl^^' embryos at E l0.5, 
no great vessel abnormalities were found in later stage Hesl^^' heterozygotes at E l5.5 
indicating that these pharyngeal arch artery defects may largely recover later in 
development. Flowever, one MFl;C57Bl/6 Hesl^^' embryo was slightly growth delayed 
in comparison to its littermates and had a cleft palate and another, MFl Hesl^^' embryo 
had dextroposition of the heart (Table 5.4) suggesting that a small proportion of Hesl 
heterozygotes may exhibit some type of phenotypic abnormality.
In conclusion, MRI and histological analysis has revealed that HesH' mutants exhibit 
cardiovascular, thymic and secondary palate defects which are highly reminiscent of 
those observed in Tbxl mutant mice and further implicates Hesl as a downstream target 
of Tbxl in pharyngeal and heart development.
Figure 5.7 Craniofacial defects in E l5.5 HesT '^ mutants
(A, B) Sagittal MRI sections. (C, D) Transverse histological sections. (A, C) In wild 
type (wt) embryos the palatal shelves are fused. (B, D) HesH' (-/-) mutants exhibit cleft 
palate where the palatal shelves do not meet in the midline. Abbreviations: ps, palatal 
shelf; t, tongue. Asterisks indicate missing segments.
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5.2.5 Analysis of epistasis between Tbxl and H esl in pharyngeal arch artery 
development
Given the evidence presented for Hesl as a potential Tbxl target, Tbxl^^' mice were 
crossed with Hesl^^' mice to determine whether Tbxl and Hesl interact within the same 
genetic pathway in pharyngeal arch artery development. Genotyping of PIO litters 
obtained from these matings indicated that Tbxl^^';Hesl^^' mice were slightly 
underrepresented according to expected Mendelian ratios but values did not reach 
statistical significance (%2=5.67; 0.15>P>0.1) (Table 5.5).
Table 5.5 Frequency of genotypes obtained from Hesl^^' \  Tbxl^ '^ matings
Stage Wild type HesI*'- Tbxl*'- H esl*';Tbxt' Total
PIO 38 (30) 32 (30) 29 (30) 20(30) 119
Numbers in parentheses indicate the expected number of mice per genotype 
rounded to the nearest whole number
Embryos were collected from Tbxl^^' x Hesl^^' and Hesl^^';Tbxl^^' x Hesl^^';Tbxl^^' 
matings at E10.5-E11.5 to examine the pharyngeal arch arteries by intracardiac ink 
injection on the mixed MFl;C57Bl/6 background. All Tbxl^^' embryos (5/5, 100%) had 
a fourth arch artery defect at E l0.5 consistent with previous reports (Jerome and 
Papaioannou, 2001; Lindsay and Baldini, 2001; Lindsay et al., 2001; Merscher et al., 
2001). In comparison, 80% (8/10) of Hesl^^';Tbxl^^' transheterozygotes exhibited a 
fourth pharyngeal arch artery defect (Table 5.6). There was no difference between 
Tbxl^^' and Hesl^^';Tbxl^^' mutants in terms of the severity of the fourth pharyngeal 
arch artery defect. Numbers of absent vs. hypoplastic arch arteries or the number of 
bilateral vs. unilateral cases were equivalent (Table 5.6). No defects were seen in 
development of any of the other arch arteries in Hesl^^';Tbxl^^' embryos in comparison 
to the TbxH^' or Hesl^^' embryos collected on this background (Table 5.6). All Tbxl'^' 
embryos exhibited a severe defect in pharyngeal formation in which none of the caudal 
arches or arch arteries formed. This phenotype was consistent with or without a Hesl 
heterozygous mutation (Table 5.6).
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Table 5.6 Frequency of fourth arch artery defects at E10.5-E11.5
Genotype Abnormal/T otaf
Right fourth arch artery 
hypoplastic absent
Left fourth arch artery 
hypoplastic absent
Bilateral
defects
Wild type 0/1 0 0 0 0 0
H est'- 0/3 0 0 0 0 0
Tbxt'- 5/5 1 3 0 5 4
HesT'- 1/6 1 0 0 0 0
TbxT'- 3/3*’ - - - - -
H esl" ';Tbxr 8/10= 2 5 1 6 6
HesH'-'JbxH- 3/3*’ - - - - -
Hesr-\Tbxr'- 0/1 0 0 0 0 0
“Embryos with fourth arch artery defects generated from Hesl ' x Tbxl ' and Hesl ';TbxH ' x 
HesH ';Tbxt^' matings
*’A11 TbxT '^ embryos were missing the caudal arch arteries
®One, HesH^'.TbxH^’ embryos which did not have a fourth arch artery defect appeared 
to be growth delayed
These results indicate that the incidence and severity of pharyngeal arch artery 
malformations is not altered in Tbxl^^' or Tbxl'^' embryos by reducing the dosage of 
Hesl by half. One Tbxl^^'iHesl'^' embryo was obtained from the above matings. It did 
not exhibit any pharyngeal arch artery defects despite the further reduction in Hesl gene 
dosage (Table 5.6).
Tbxl^^' mice exhibit a strain-dependent recovery from the fully penetrant fourth arch 
artery defects present at E l0.5. Subsequently, depending on the genetic background, 
only 30-50% of Tbxl^^' mice at term exhibit a fourth arch artery-derived great vessel 
abnormality (Lindsay and Baldini, 2001; Taddei et al., 2001). The Tbxl^^';Hesr^' 
embryo and one Hesl^^';Tbxl^^' embryo (1/10) with no arch artery defect appeared to be 
slightly older (~ El 1.5) compared to most of the Tbxl^^' mutants analysed in the litters 
obtained. Therefore, strain-dependent rescue at this later stage may account for the lack 
of phenotype in these embryos.
To investigate the effect of Hesl on this recovery phenotype, the fourth pharyngeal arch 
arteries were examined from E l0.5 to E l2.5 in embryos collected from Hesl^^' x 
Tbxl^^' matings (Table 5.7). At El 0.5, all Tbxl^^' embryos regardless of Hesl 
genotype, exhibited fourth arch artery abnormalities. By El 1.5 approximately 40% (2/5) 
of Hesl^^';Tbxl^^' embryos had fourth arch artery hypo/aplasia compared to 25% (2/ 8) 
of Tbxl^^' mice (Table 5.7). At E l2.5, the percentage of embryos with abnormal arch
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arteries had decreased even further in both Hesl^^';Tbxl^^' and Tbxl^^' mutants to 8% (n 
= 1 of 12) and 14% (n = 1 of 7), respectively (Table 5.7). This data shows that 
decreasing the dosage of Hesl does not appear to significantly affect the penetrance of 
the pharyngeal arch artery defects in Tbxl^^' mutants during embryogenesis. However, 
larger numbers of embryos may be needed to clarity these results.
The penetrance of the arch artery defects in Tbxl^^' heterozygotes at El 1.5 appears to be 
decreased compared to the reported penetrance in Tbxl^^' mice on a C57B16 x 
129SvEvBrd background (Lindsay and Baldini, 2001). One possibility is that this may 
be due to the mixed MFl;C57Bl/6 background on which these embryos were analysed.
Table 5.7 Frequency of fourth arch artery defects in embryos generated from 
Hesl^ '^ X TbxH '^ matings from E10.5 to E12.5
Genotype E10.5 E11.5 E12.5
Wild type 0/1* 0/1 0/11
HesH^' 0/2 0/5 0/8
TbxH^- 4/4 (100%) 2/8 (25%) 1/7 (14%)
Hesr^-\TbxH'- 3/3 (100%) 2/5 (40%) 1/12(8%)
* AbnormaET otal
Altogether, the results so far suggest that Hesl and Tbxl do not interact genetically in 
development of the arch arteries. There was no change in the type or severity of 
cardiovascular defects apparent in Hesl^^';Tbxl^^' embryos compared to Tbxl^^' 
heterozygotes. Nor was there any significant increase in the penetrance of arch artery 
defects in double heterozygotes later in development relative to Tbxl heterozygotes. 
There appeared to be a loss of double heterozygotes neonatally, although this did not 
reach statistical significance. However, due to the phenotypic variability among Hesl 
and Tbxl mutants and the effect of genetic background, it is still possible that an 
epistatic interaction between Hesl and Tbxl in arch artery development was masked in 
the small numbers of embryos examined. Furthermore, Tbxl and Hesl may genetically 
interact in other biological processes such as outflow tract, thymus and/or craniofacial 
development which were not investigated in these experiments.
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5.2.6 Analysis of pharyngeal arch patterning
To better characterise the pharyngeal phenotype o f Hesl'^' mutants and begin to dissect 
out the mechanisms underlying the pharyngeal defects, markers of pharyngeal 
patterning were analysed by WISH. Tbxl mutants exhibit thymic, thyroid and 
parathyroid defects which occur due to aberrant development of the pharyngeal 
apparatus (Jerome and Papaioannou, 2001; Lindsay et al., 2001; Merscher et al., 2001). 
Thymic hypo/aplasia was clearly evident in HesT^' embryos at E l5.5. However, 
parathyroid defects at this stage were difficult to assess. Expression analysis has shown 
that Gcm2, a marker of parathyroid precursor cells in third pouch endoderm is absent 
from the presumptive third pharyngeal pouch in TbxT^' mutant embryos at E l0.5 (Ivins 
et al., 2005). Expression of this parathyroid marker was analysed in HesT^' mutants to 
assess whether there were any parathyroid defects similar to those seen in Tbxl mutants. 
Gcm2 was not found to be downregulated in HesT^' mutants (n = 7) when compared to 
wild type embryos at E10.5 (Figure 5.8A). Thus, unlike TbxT^' mutants it does not 
appear that HesT^' embryos exhibit any defects in parathyroid development at E10.5.
The expression of Paxl was used to assess whether the pharyngeal arches were 
correctly patterned. Paxl is normally expressed within the pharyngeal pouch endoderm 
separating each pharyngeal arch (Neubuser et al., 1995). In TbxT^' heterozygotes, Paxl 
has been reported to be downregulated in the fourth pharyngeal pouch (Guris et al.,
2006) and in TbxT^' mutants, Paxl expression could be detected only in the first 
pharyngeal pouch revealing a lack of caudal pharyngeal patterning (Guris et al., 2006; 
Jerome and Papaioannou, 2001). In one HesT^' embryos at E l0.5 (1/6), expression of 
Paxl between the second and third pouches was expanded medially within the 
pharyngeal endoderm indicating a failure of Paxl to discretely localise to the lateral 
endoderm within the pharyngeal pouches (Figure 5.8B, C).
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Figure 5.8 Pharyngeal patterning in Hesl'^' mutants
(A) Whole mount in situ hybridisation shows no change in expression of Gcm2, a 
marker for parathyroid precursors, between wild type (wt) and Hesl'^' (-/-) embryos at 
El 0.5 (see arrows). (B, C) Expression of the pharyngeal pouch marker, Paxl is 
continuous between pharyngeal arches 2 and 3 in a HesI'^' embryo (arrow in B). (C) 
Coronal sections of the corresponding embryos in B show that expression of Paxl 
extends medially into the endoderm lining pharyngeal arch 3 (arrow in C). 
Abbreviations: a, arch.
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5.2.7 Analysis of Tbxl targets in Hesl mutants
To investigate whether disruption of similar pathways may underlie the pharyngeal and 
heart defects seen in Tbxl and Hesl mouse mutants, expression of -regulated genes 
was examined in HesT^' embryos.
The homeobox transcription factor, Gbx2 is downregulated in the pharyngeal endoderm, 
ectoderm and SHF of TbxT^' mutants ((Ivins et al., 2005), A. Calmont, pers. comm.). 
Knockout mouse models of Gbx2 have also demonstrated a role for this gene in 
pharyngeal development (Byrd and Meyers, 2005). Gbx2'^' mutants exhibit great vessel 
and OFT defects highly reminiscent of the Tbxl mutant phenotype implying that Gbx2 
may act downstream of Tbxl in formation of the pharyngeal arch arteries and OFT. At 
E9.5, Gbx2 expression in wild type embryos was detected in the pharyngeal ectoderm 
overlying pharyngeal arch one and in the endoderm and ectoderm of the caudal arches 
(Figure 5.9A, B). However, in HesT^' mutants (n=2) at the same stage, expression 
within the caudal ectoderm was diminished (Figure 5.9A, B). Later, at E l0.5, Gbx2 
expression in wild type embryos was observed within the ectoderm of the first 
pharyngeal arch and in the endoderm lining the caudal pharyngeal arches (Figure 5.9C, 
D), Ivins et al 05). In contrast, in a proportion of HesT^' mutants (n=2 out of 6) at the 
same stage, expression of Gbx2 in the caudal pharyngeal endoderm was absent similar 
to that seen in TbxT^' embryos (Figure 5.9C, D). In addition, Gbx2 appeared to be 
upregulated within the second pharyngeal arch ectoderm of HesT^' embryos (Figure 
5.9C, D). These results suggest that Gbx2 may lie downstream of Tbxl and Hesl in a 
common pathway required for proper development of the pharyngeal apparatus.
In TbxT^' mutants, expression of the Cyp26 genes is dysregulated in the pharyngeal 
region (Guris et al., 2006; Ivins et al., 2005; Roberts et al., 2006) and knockdown of 
Cyp26 enzyme function in the chick phenocopies the Tbxl mouse mutant (Roberts et 
al., 2006). The Cyp26 family of retinoic acid metabolising enzymes consist of three 
genes, Cyp26al, Cyp26bl and Cyp26cl which encode enzymes required to catabolize 
the active retinoic acid metabolite to an inactive form (Fujii et al., 1997; White et al., 
1996; White et al., 2000). All three Cyp26 genes are expressed within the pharyngeal 
region in both complementary and overlapping domains (de Roos et al., 1999; MacLean 
et al., 2001; Roberts et al., 2006; Tahayato et al., 2003)and they play an important role 
in regulating levels of retinoic acid for normal development of the pharyngeal apparatus
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and heart (Abu-Abed et al., 2001; Roberts et al., 2006; Uehara et al., 2007; Yashiro et 
al., 2004)(K. Yahiro, pers. comm.).
In a preliminary analysis of Cyp26 gene expression in Hesl'^' mutants, Cyp26cl 
expression was examined. In Tbxl'^' embryos, Cyp26cl expression is downregulated in 
the peri-otic mesenchyme, otic vesicle, epibranchial placodes and pharyngeal endoderm 
but is expanded within the first pharyngeal arch mesenchyme (Roberts et al 06). In 
embryos at E9.5 (n = 3), Cyp26cl expression was also dysregulated, but in 
contrast to Tbxl'^' mutants, Cyp26cl was expanded into the second pharyngeal arch of 
mutant embryos and was also ectopically expressed within the caudal 
pharyngeal ectoderm overlying pharyngeal arches three and four (Figure 5.9E, G, H).
In addition to the Cyp26 gene expression changes which occur in Tbxl'^' mutants, 
Raldh2, the main gene required for synthesis of retinoic acid is upregulated in the head 
mesenchyme of Tbxl'^' mutants and shifted anteriorly within the splanchnic mesoderm 
(Guris et al., 2006; Ivins et al., 2005). Analysis of Raldh2 expression in Hesl'^' 
embryos at E9.5 ( n = 2) did not reveal any changes in expression compared to wild 
type embryos (Figure 5.9F).
Examination of genes required to maintain the correct levels of retinoic acid for normal 
development has shown that retinoic acid levels may be altered in the pharyngeal region 
of Hesl'^' mouse mutants however, expression changes appear to be different to those 
which occur in Tbxl'^' embryos.
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Figure 5.9 Expression of potential Tbxl targets in HesT^' mutants 
(A-D) In a proportion of Hesl'^' mutants at E9.5, Gbx2 expression is downregulated in 
the caudal pharyngeal ectoderm overlying pharyngeal arch 3 (arrows in A and B) 
whereas later at E l0.5, Gbx2 is lost in the caudal pharyngeal endoderm (arrowheads in 
C and D) but upregulated in the second arch ectoderm (arrows in C and D). (B, D) 
Coronal sections of the embryos in A and C, respectively. (E, G, H) Cyp26cl 
expression is expanded in Hesl'^' embryos at E9.5 (arrows in E) into pharyngeal arch 2 
(arrows in G) and Cyp26cl is also ectopically expressed in the ectoderm overlying 
pharyngeal arches 3 and 4 (arrows in H). (G, H) Sagittal and coronal sections of 
Cyp26cl in situ hybridisations, respectively. (F) Raldh2 expression is not altered in 
HesT^' mutants at E9.5 (arrows in F).
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5.3 DISCUSSION
5.3.1 The role of Hes and Hey genes in development 
5,3. LI Hes and Hey transcription factors
Hairy and enhancer of split 1 {Hesl) is one of the mammalian homologues of the Hairy 
and Enhancer-of-split [E(spl)] type genes in Drosophila which act as effectors of the 
Notch signalling pathway (Fischer and Gessler, 2007). The Notch signalling pathway is 
an evolutionarily conserved signalling mechanism which plays a critical role in multiple 
aspects of development, regulating diverse cellular processes such as proliferation, 
differentiation, cell fate and apoptosis (Bolos et al., 2007).
The canonical Notch pathway is activated through intercellular interactions between 
transmembrane-bound Delta and Jagged ligands and Notch receptors (Bolos et al.,
2007) (Figure 5.10A). Upon ligand binding, the transmembrane-bound type I Notch 
receptors undergo proteolytic cleavage to release the Notch intracellular domain 
(NICD) which is translocated to the nucleus where it interacts with the DNA binding 
transactivator, Rbp-J (also known as Su(H) in Drosophila) converting it from a 
repressor into an activator. Together with the coactivator, MAML, this complex acts to 
regulate target genes such as the Hes and Hey family of transcriptional repressors, the 
most well characterised effectors of the Notch pathway (Iso et al., 2003).
In mammals there are seven Hes genes {Hesl-7), (Akazawa et al., 1992; Bae et al.,
2000; Bessho et al., 2001; Hirata et al., 2000; Ishibashi et al., 1993; Koyano-Nakagawa 
et al., 2000; Pissarra et al., 2000; Sasai et al., 1992) and three Hey genes {Heyl, Hey2 
and HeyL) (otherwise known as Herp2, 1, 3; Hesrl, 2, 3\ Hrtl, 2, 3 or Chf2, 1) (Iso et 
al., 2001a; Kokubo et al., 1999; Leimeister et al., 1999; Nakagawa et al., 1999; Steidl et 
al., 2000; Zhong et al., 2000). Both families primarily act as transcriptional repressors 
and are composed of three conserved domains: a basic helix-loop-helix (bHLH) DNA 
binding domain, an Orange domain that regulates the selection of heterodimer partners 
(Dawson et al., 1995; Taelman et al., 2004) and a C-terminal WRPW domain for Hes 
members or YRPW domain for Hey family members (Figure 5.1 OB) (Fischer and 
Gessler, 2007).
Hes and Hey family members can form homo- or heterodimers with one another 
(Fischer et al., 2007; Iso et al., 2001b; Leimeister et al., 2000; Van Wayenbergh et al.,
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2003). Both family members function to actively repress transcription by binding to E- 
Box (CANNTG) consensus sites or N-box (CACNAG) sequences (Akazawa et al., 
1992; Iso et al., 2003; Iso et al., 2001b; Ohsako et al., 1994; Sasai et al., 1992). In Hes 
family members, the C-terminal WRPW domain acts to repress transcription by 
recruiting Tie corepressors (Grbavec and Stifani, 1996; Paroush et al., 1994) whereas 
Hey family members primarily act to repress transcription through their bHLH domain 
and recruit different corepressors including N-CoR, mSin3A and HDACl (Fischer et 
al., 2002; Iso et al., 2001b). Hes and Hey transcription factors can also repress 
transcription in a passive manner by forming non-functional heterodimers with E-box 
binding bHLH factors, preventing DNA binding (Hirata et al., 2000; Sasai et al., 1992; 
Sun et al., 2001).
Figure 5.10 Notch signalling
(A) Transmembrane Notch ligands on neighbouring cells bind to Notch receptors, 
inducing proteolytic cleavage. The Notch intracellular domain (NICD) is translocated 
to the nucleus where it binds to the transcription factor, Rbp-J turning it from a 
repressor into an activator. Coactivators such as MAML are then recruited to the 
complex to induce transcription of targets such as Hes and Hey genes. (B) Hes and Hey 
transcription factors contain three conserved domains. Both families contain an N- 
terminal basic helix-loop-helix (bHLH) domain and an Orange (Or) domain. Hes and 
Hey family members differ in their C-terminal domains. Hes members have a WRPW 
(W) motif and Hey members contain a YRPW (Y) motif and a TE(I/V)GAF (T) 
peptide. Numbers represent the amino acid content of each domain. (Fischer and 
Gessler, 2007).
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53.1.2 The roles o f H esl in development
Hesl is the most extensively studied member of the Hes gene family. Hesl knockout 
mice exhibit a multitude of defects in brain, neural tube, endocrine gland, sensory organ 
and gut formation, representing the diverse roles that Hesl plays in development, in 
maintaining proliferation, regulating differentiation and controlling binary cell fate 
decisions. Depending on the time and tissue in which Hesl is expressed, it can act to 
regulate one or more of these processes through Notch-dependent or independent 
pathways (Kageyama et al., 2007).
5.3.1.2.1 Hesl regulates the maintenance o f progenitors
Hesl functions to regulate the maintenance of progenitor cell populations in 
development. In the nervous system, Hesl, with HesS and Hes5 act to maintain neural 
stem cells and prevent premature neurogenesis by repressing the expression of 
proneural genes such as Mashl and Ngn2 (Hatakeyama et al., 2004; Ishibashi et al., 
1993; Ohtsuka et al., 1999; Ohtsuka et al., 2001). Similarly, Hesl is required to 
maintain progenitor cells in the eye (Lee et al., 2005; Tomita et al., 1996), pituitary 
gland (Kita et al., 2007; Raetzman et al., 2007), pancreas (Jensen et al., 2000) and 
thymus (Tomita et al., 1999) by inhibiting the expression of pro-differentiation genes 
(Jensen et al., 2000; Kita et al., 2007; Raetzman et al., 2007; Tomita et al., 1999; Tomita 
et al., 1996). However, Hesl may also directly regulate proliferation as it has also been 
shown to repress expression of the cyclin-dependent kinase inhibitor,/727(X//?7^ which 
was found to be upregulated in the brain and thymus of Hesl'^' mice (Murata et al., 
2005).
Hesl also acts to regulate boundary formation between the mid and hindbrain (Baek et 
al., 2006). High, persistent levels of Hesl within the boundary are required not only to 
prevent neuronal differentiation but also to suppress proliferation (Baek et al., 2006). 
Downregulation of proliferation in this tissue is thought to occur through repression of 
cell-cycle regulators such as E2F-1 or PCNA (Baek et al., 2006; Castella et al., 2000; 
Hartman et al., 2004; Strom et al., 2000). In contrast, compartment cells express 
variable levels of Hesl, which the authors propose may be necessary for sustained 
proliferation (Baek et al., 2006).
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5.3.1.2.2 Hesl regulates the timing o f  differentiation
Hesl also functions to regulate the timing of differentiation. In Hesl'^' mice, neural stem 
cells prematurely differentiate into neurons which become depleted and this occurs at 
the expense of later cell types such as oligodendrocytes and astrocytes (Hatakeyama et 
al., 2004). Hesl has been found to be required to maintain progenitor cells for a correct 
period of time during development to allow differentiation into late-arising neuronal cell 
lineages (Hatakeyama et al., 2004).
5.3.1.2.3 Hesl controls binary cell fate decisions
Hesl regulates binary cell fate decisions during development of the nervous system, 
pituitary gland and gut. In the nervous system, Hesl promotes the differentiation of 
neural stem cells into astrocytes over neuronal cells by repressing proneural genes and 
acting through the Lif signalling pathway to induce astrocyte-specific genes 
(Hatakeyama et al., 2004; Ishibashi et al., 1995; Kamakura et al., 2004; Ohtsuka et al., 
1999; Ohtsuka et al., 2001). Throughout development of the digestive system, Hesl has 
also been found to regulate enterocyte versus non-enterocyte cell fate in the intestine 
(Jensen et al., 2000; Suzuki et al., 2005) and biliary epithelial cell versus hepatocyte 
lineage in the liver (Kodama et al., 2004). Furthermore, in addition to its role in 
maintenance of progenitor cells in the pituitary gland, Hesl also functions to specify 
intermediate versus anterior lobe formation in the pituitary (Kita et al., 2007; Raetzman 
et al., 2007).
5.3.1.2.4 Hesl functions as a molecular oscillator
The formation of somites along the anterior-posterior axis of vertebrate embryos is 
precisely controlled by the segmentation clock in which synchronised, oscillatory 
expression of genes in the pre-somitic mesoderm (PSM) regulates the timing of somite 
development (Andrade et al., 2007). Both Hesl and Hes7 have been shown to exhibit 
cyclical gene expression in the PSM (Bessho et al., 2001; Jouve et al., 2000). However, 
only Hes7 appears to play an important role in regulating the segmentation clock in 
mice (Bessho et al., 2001; Hirata et al., 2004) since Hesl'^' mutants do not exhibit any 
defects in somitogenesis.
Interestingly, Hesl has also been found to exhibit oscillatory expression upon serum 
stimulation within multiple, different cell types in culture, such as fibroblasts, myoblasts 
and neuroblasts (Hirata et al., 2002; Kageyama et al., 2007; Yoshiura et al., 2007). This
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expression is cell autonomous and requires transient negative autoregulation in which 
Hesl binds to its own promoter to repress transcription (Hirata et al., 2002). Real-time 
imaging analysis has shown that Hesl expression is often oscillatory within single cells 
but this expression is asynchronous between cells (Masamizu et al., 2006). However, 
the biological significance of this observation in relation to Hesl function in 
development is still unclear.
5.3.1.3 Hey genes and cardiovascular development
To date, a role for Hes genes in cardiovascular development has not been identified. In 
contrast. Hey genes have been shown to play diverse roles in formation of the heart and 
vasculature. In vascular development, Heyl and Hey2 are required to regulate arterial- 
venous differentiation (Fischer et al., 2004b; Kokubo et al., 2005) while Hey2 also plays 
a role in vascular maturation (Sakata et al., 2006).
Hey2'^' mutants exhibit a range of cardiac malformations including cardiomyopathy, 
VSDs, atrioventricular valve defects and tetralogy of Fallot (Donovan et al., 2002; 
Gessler et al., 2002; Kokubo et al., 2004; Sakata et al., 2002). Heyl'^';HeyL'^' mutants 
bave similar VSD and atrioventricular valve anomalies (Fischer et al., 2007). Heyl, 
Hey2 and HeyL have all been shown to play a critical role in regulating epithelial to 
mesenchymal transition (EMT) which is required for correct formation of the 
atrioventricular valves and the interventricular septum (Fischer et al., 2007; Kokubo et 
al., 2005). In addition. Hey2' '^ mice have been shown to exhibit thin ventricular walls 
and defects in trabeculation suggesting a role for Hey2 in cardiomyocyte maturation 
(Kokubo et al., 2005; Kokubo et al., 2004; Sakata et al., 2006). Indeed, recent studies 
have shown that Hey2 acts to repress atrial gene expression within ventricles and 
promote myocardial proliferation (Koibuchi and Chin, 2007; Xin et al., 2007). 
Furthermore, Heyl and Hey2 have also been demonstrated to regulate atrioventricular 
boundary formation during development (Kokubo et al., 2007; Rutenberg et al., 2006).
5.3.1.4 Summary
In conclusion, Hes and Hey genes play diverse roles in development and act as the 
primary effectors of Notch signalling. In particular, Hesl functions in development of 
many organs including the brain, sensory organs, endocrine glands and the gut while the 
Hey transcription factors are mainly involved in aspects of cardiovascular development.
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5.3.2 Hesl Functions in pharyngeal and cardiovascular development
Hesl was identified as a gene downregulated in Thxl-rmW cells within the pharyngeal 
apparatus of Tbxl'^' mouse mutants. Analysis of Hesl'^' mutants revealed that a 
proportion of embryos exhibit DGS-like craniofacial, thymic and cardiovascular defects 
including great vessel and OFT anomalies reminiscent of the Tbxl mutant phenotype. 
These results suggest that Hesl may lie downstream of Tbxl in pharyngeal and heart 
development and may act as a modifier gene in DOS patients.
5.3.2.1 Hesl and vascular development
In the original paper describing the HesT^' mouse mutant, a proportion of HesT^' 
embryos were embryonic lethal from E l2.5 (Ishibashi et al., 1995). HesT^' mutants 
were found to exhibit a variable phenotype ranging from severe neural tube and brain 
defects to a grossly normal appearance. However, these mice still died perinatally 
(Ishibashi et al., 1995). Reports have since described additional defects in the Hesl 
knockout mouse such as lung and pancreatic abnormalities which could contribute to 
neonatal lethality (Ito et al., 2000; Jensen et al., 2000). However, the HesT^' 
malformations described to date still cannot account for embryonic lethality at E l2.5.
In the course of this study on the functional role of Hesl in pharyngeal and heart 
development, a proportion of HesT^' mutants at El 1.5 were found to exhibit body 
haemorrhage, indicative of a possible vascular defect that could account for 
midgestation lethality.
Interestingly, the stage of embryonic lethality and haemorrhaging observed in HesT^' 
mice is reminiscent of the DllT^' mutant phenotype (Hrabe de Angelis et al., 1997).
Hesl has been shown to be preferentially induced by the Notch ligand Dill in cell 
culture (Jarriault et al., 1998; Kuroda et al., 1999) and together, these results suggest 
that Hesl may regulate vascular development downstream of D//7-induced Notch 
signalling. However, it still remains to be determined whether Hesl plays a similar role 
to other Notch signalling components in arterial-venous specification (Domenga et al., 
2004; Duarte et al., 2004; Fischer et al., 2004b; Gale et al., 2004; Kokubo et al., 2005; 
Krebs et al., 2004).
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5.3.2.2 Hesl and Tbxl in pharyngeal arch artery development
HesT^' mice exhibit great vessel anomalies similar to those observed in Tbxl^^' mice 
including right-sided and interrupted aortic arch, aberrant right-subclavian artery and 
right-sided ductus arteriosus, which occur due to defective fourth and sixth arch artery 
development. The most consistent pharyngeal arch artery defect found in Hesl mutants 
at El 0.5 was fourth arch artery hypo/aplasia, although defects in development of the 
other arch arteries were also detected.
Hesl is downregulated within Tbxl'^' mutants in the pharyngeal endoderm, a tissue in 
which Tbxl may be required for normal growth and remodelling of the fourth arch 
artery (Zhang et al., 2005). Considering that both Hesl^^' and Tbxl^^' mutants exhibit 
fourth arch artery defects, it was hypothesized that the reduced dosage of Hesl may 
play a role downstream of Tbxl in causing arch artery defects. Investigation of double 
heterozygous mice from E l0.5 to E l2.5 did not reveal any differences in either the 
severity or penetrance of the arch artery phenotype compared to single heterozygotes 
alone, thus demonstrating that Hesl and Tbxl do not appear to genetically interact in 
pharyngeal arch artery development in the mouse. However, there are several factors 
that may have affected the analyses including the effect of genetic modifiers, functional 
redundancy among related Hes/Hey proteins and phenotypic variability.
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5.3.2.2.1 The influence o f  genetic background on phenotype
In the analysis of HesT^' mutants on two different strains, a pure MFl background and a 
mixed MFl;C57Bl/6 background, it became obvious that the genetic background was 
altering the phenotype. In the MFl strain, HesT^' mutants were embryonic lethal from 
E l2.5 apparently from vascular defects, and they also presented with severe neural tube 
defects. On a mixed background, HesT^' mutants did not exhibit any neural tube defects 
and were present in normal mendelian ratios at E l5.5. These observations indicate that 
modifiers within the C57B1/6 background may rescue the severe vascular and 
neurulation defects in HesT^' mutants.
The effect of genetic background on the severity of brain defects in HesT^' mutants has 
been noted previously (Nakamura et al., 2000; Ohtsuka et al., 2001). The phenotypes of 
mouse mutants for other members of the Notch signalling pathway have also been 
shown to be affected by genetic background. Hey2, a 7/e5-related family member is 
heavily influenced by genetic modifiers (Fischer et al., 2004a; Sakata et al., 2006). The 
cardiovascular phenotype observed in Hey2'^' mutants independently generated on 
different strains ranges from fatal cardiomyopathy (Gessler et al., 2002) and 
cardiomyopathy with a ventricular septal defect (Sakata et al., 2002), to tetralogy of 
Fallot-like defects (Donovan et al., 2002) and atrioventricular valve anomalies (Kokubo 
et al., 2004).
ThxÜ^' mouse mutants also exhibit a variable phenotype depending on the genetic 
background which influences the penetrance of arch artery, thymic and parathyroid 
defects (Taddei et al., 2001). In this study only 14% of Tbxl^^' mutants on the mixed 
MFl;C57Bl/6 background exhibited fourth arch artery defects at E l2.5 compared to 
50% of Tbxl^^' mice on a C57B1/6 background (Taddei et al., 2001) indicating that the 
MFl strain causes increased recovery from pharyngeal arch artery defects.
The effect of the MFl background on the Tbxl^^' pharyngeal arch artery phenotype, 
together with the recovery of HesT^' vascular defects on the C57B1/6 background may 
have prevented the identification of an epistatic interaction between Tbxl and Hesl. In 
addition, relatively small numbers of embryos were examined and the HesT^' phenotype 
is not fully penetrant which also may have affected the results.
166
The analysis of Hesl^^'Tbxl^^' double heterozygotes did not include investigation of the 
palate, thymic or outflow tract, structures which are similarly defective in Hesl'^' and 
Tbxl'^' mutants. Hesl was found to be downregulated in Tbxl'^' mice within the 
pharyngeal endoderm and second heart field, Tbxl domains required for development of 
these structures (Arnold et al., 2006b; Xu et al., 2004; Zhang et al., 2006) suggesting 
that an interaction between Tbxl and Hesl during mouse development may yet exist.
5.3.2.2.2 The ejfect o f  functional redundancy on phenotype
Hesl is a member of the hairy/enhancer of split (Hes) family which in mouse includes 
Hes2, -3, -5, -6 and -7 and the functionally related, /Yej-related with YRPW {Hey) 
genes, Heyl, -2 and -L  which are also effectors of Notch signalling (Iso et al., 2003). 
Hesl, -3, and -5 have been shown to compensate for one another during neural 
development. Hes3'^' mutants are phenotypically normal (Hirata et al., 2001) and Hes5' 
mice exhibit mild defects in central nervous system (CNS) and sensory organ 
development (Cau et al., 2000; Hojo et al., 2000; Ohtsuka et al., 1999; Zine et al.,
2001). When these mice are crossed with Hesl mutants, double and triple knockout 
embryos have much more severe CNS defects than any single gene mutant (Cau et al., 
2000; Hatakeyama et al., 2004; Hatakeyama et al., 2006; Ohtsuka et al., 1999; Ohtsuka 
et al., 2001).
Similarly, the Hey genes also act redundantly during cardiovascular development.
HeyT^' and HeyL'^' mice are viable and fertile (Fischer et al., 2004b; Fischer et al., 2007; 
Kokubo et al., 2005), however, a combined loss of Heyl and HeyL results in similar 
VSD and atrioventricular valve anomalies to Hey2' '^ mutants (Fischer et al., 2007).
Hey T '^ ; Hey 2' '^ mice also exhibit severe vascular defects in arterial-venous 
differentiation and vascular maturation not observed in either HeyT^' or Hey2' '^ mutants 
alone (Fischer et al., 2004b; Kokubo et al., 2005). This phenotype more closely reflects 
the zebrafish gridlock {hey2) mutant (Zhong et al., 2001; Zhong et al., 2000). hey2 is 
the only hey gene family member expressed within blood vessels in the zebrafish 
(Winkler et al., 2003) whereas Heyl, Hey2 and HeyL are coexpressed in mouse 
vasculature (Fischer and Gessler, 2003; Iso et al., 2003).
These experiments clearly show that functional redundancy among Hes and Hey genes 
plays an important role during development however, the question still remains as to 
whether Hey genes can compensate for loss of Hes genes and vice versa. In the
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pharyngeal region, Hesl expression overlaps with members of the Hey gene family 
within the pharyngeal mesenchyme {Heyl, Hey2 and HeyL) and pharyngeal endoderm 
{Heyl and HeyL) (Irinna Papangeli, pers. comm., (High et al., 2007)).
Evidence for functional redundancy among Notch effectors in pharyngeal development 
is provided by the analysis of DNMAML mouse mutants in which Notch
signalling was specifically ablated in NC tissues using a dominant negative form of 
MAML (High et al., 2007). DNMAML mice exhibited OFT and arch artery
defects highly reminiscent of the heart defects in HesP^' mutants (High et al., 2007). 
Heyl, Hey2 and HeyL were shown to be downregulated in NC-derived cells but the 
cardiovascular and pharyngeal arch artery defects represented a novel phenotype which 
had never been detected in any type of Hey knockout mice (Donovan et al., 2002; 
Fischer et al., 2004b; Fischer et al., 2007; Gessler et al., 2002; Kokubo et al., 2005; 
Kokubo et al., 2004; Sakata et al., 2002). Functional redundancy among the Hey genes 
was suggested as a possible reason why great vessel defects were unique to this mouse 
mutant. However, Hesl expression was not analysed in DNMAML embryos and 
considering the phenotype, it seems likely that downregulation of Hesl may play the 
dominant role in pathogenesis of OFT and pharyngeal arch artery defects in these mice.
These results, in combination v^th the overlapping expression of Hes and Hey genes 
within Tbxl domains, indicate that functional redundancy between Hesl and Hey genes 
could have affected the penetrance of pharyngeal arch defects not only in HesT^' 
mutants but also in Tbxl^^';Hesl^^' transheterozygotes. This represents another factor 
which may have prevented the identification of a genetic interaction between Tbxl and 
Hesl in mice.
The effects of genetic background, functional redundancy and the variability of the 
phenotype may have masked an epistatic interaction between Tbxl and Hesl in 
pharyngeal arch artery development. Alternatively, Tbxl and Hesl may not interact in 
this process and the similar defects observed in Hesl and Tbxl mutants could have been 
caused by disruptions to distinct developmental pathways. However, epistatic 
interaction studies conducted in zebrafish indicate that tbxl and herb (the zebrafish 
homologue of Hesl) interact in formation of the pharyngeal arch arteries (see Section 
5.3.2.2.7).
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5.3.2.2.3 Analysis o f  epistasis between tbxl and herb in zebrafish pharyngeal 
development
As mentioned above, a number of issues may have affected the identification of an 
epistatic interaction between Tbxl and Hesl in mouse development. In order to 
circumvent some of these issues to determine whether Tbxl and Hesl genetically 
interact in pharyngeal development, studies were carried out in the zebrafish. All 
zebrafish experiments were carried out by Catherine Roberts in our lab but the results 
have been included in this discussion to highlight the advantages of using the zebrafish 
model system to investigate epistatic interactions with tbxl.
Zebrafish represent an excellent model system to study developmental processes 
because of their small size, optical transparency, the large numbers of embryos which 
can be obtained from a single mating and their relatively rapid development in which 
most organs are formed within the first five days (Beis and Stainier, 2006). In addition, 
the biological function of one or multiple genes can be easily and simultaneously 
analysed by using a specific antisense morpholino oligonucleotide to downregulate 
expression of a particular gene (Heasman, 2002).
Tbxl appears to play a similar role in pharyngeal development of the mouse and 
zebrafish. van gogh (vgo) zebrafish mutants exhibit pharyngeal, otic vesicle and thymic 
defects reminiscent of the TbxT^' mouse phenotype (Piotrowski et al., 2003; Piotrowski 
and Nusslein-Volhard, 2000). In vgo mutants, the posterior pharyngeal arches fail to 
segment because the endodermal pouches do not develop, aortic arches are reduced or 
absent, the otic vesicle is hypoplastic and embryos also exhibit thymic hypo/aplasia 
(Piotrowski et al., 2003; Piotrowski and Nusslein-Volhard, 2000). The gene mutated in 
vgo fish has been cloned and verified as the zebrafish homologue of Tbxl (Kochilas et 
al., 2003; Piotrowski et al., 2003). The similar malformations in mouse and zebrafish 
suggest that they may share genetic pathways downstream of Tbxl important for 
development of the pharyngeal apparatus. Therefore, the role of herb (the zebrafish 
homologue of Hesl) in pharyngeal development and its potential interaction with tbxl 
was investigated.
Herb is important in zebrafish somite formation (Pasini et al., 2004) but there has been 
no previously reported role for herb in pharyngeal or heart development. Studies in our
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lab have shown that her6 is downregulated or absent from the pharyngeal apparatus in 
vgo/vgo mutants compared to vgo/+ or wild type embryos, similar to Hesl 
downregulation in Tbxl'^' mice. Injection of high concentrations of herd antisense 
morpholino oligonucleotides recapitulates the vgo/vgo pharyngeal phenotype, herd and 
tbxl appear to genetically interact in zebrafish since injection of double morpholinos 
results in a statistically significant increase in the severity and penetrance of pharyngeal 
defects compared to either morpholino alone. Furthermore, preliminary experiments 
have shown that injecting tbxl morpholino plus full length herd mRNA into zebrafish 
embryos appears to decrease the penetrance of pharyngeal arch artery defects compared 
to embryos injected with tbxl morpholinos alone. Therefore, herd must play a critical 
role downstream of tbxl in zebrafish pharyngeal development.
Together, these experiments clearly support a genetic interaction between tbxl and herd 
in zebrafish pharyngeal development. The difference in epistasis results between mouse 
and zebrafish may reflect the fact that all experiments can be carried out within the 
same genetic background. Since herd morpholinos give a more highly penetrant 
pharyngeal arch artery phenotype than Hesl'^' mouse mutants (-60% vs, -20%), 
morpholino knockdown may reduce herd to below 50% of wild type levels. There may 
also be less functional redundancy amongst the her and hey genes in zebrafish than in 
mouse.
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5.3.3 The molecular role of Hesl downstream of Tbxl in pharyngeal development
One of the underlying cellular defects in Tbxl'^' mutants is decreased proliferation of the 
pharyngeal endoderm, mesoderm and otic epithelium, a process considered to play a 
major role in the aetiology of Tbxl'^' malformations (Vitelli et al., 2003; Xu et al., 2005; 
Xu et al., 2007a; Xu et al., 2004; Xu et al., 2007b; Zhang et al., 2006). Tbxl has been 
proposed to play a role in maintenance of progenitor cell populations within the SHF for 
contribution to the OFT (Xu et al., 2004; Zhang et al., 2005) and within the endoderm 
for proper expansion of cells for pharyngeal segmentation (Xu et al., 2005). In the ear, 
Tbxl is required in the otic epithelium to regulate the size of the otocyst and in the 
periotic mesenchyme for formation of the pericochlear capsule and part of the cochlea 
(Xu et al., 2007a; Xu et al., 2007b). However, the underlying mechanisms through 
which Tbxl may act to regulate proliferation are unknown.
Hesl is also required to maintain or regulate progenitor cell populations within the 
thymus (Tomita et al., 1999), eye (Tomita et al., 1996), pituitary gland (Kita et al.,
2007; Raetzman et al., 2007), brain (Hatakeyama et al., 2004; Ishibashi et al., 1995) and 
pancreas (Jensen et al., 2000). This function of Hesl may occur partly through direct 
downregulation of the cyclin-dependent kinase inhibitor,/?27(X/p7^ which was found to 
be upregulated in the hypoplastic thymus and brains of HesT^' mice (Murata et al.,
2005). Tbxl may exert some of its effects on cell proliferation through Hesl.
Tissue-specific deletion experiments have demonstrated that Tbxl is required in both 
the endoderm and mesoderm for correct alignment and septation of the OFT (Arnold et 
al., 2006b; Zhang et al., 2006). So far, only outflow tract alignment defects have been 
detected in HesT^' mutants but Hesl could act downstream of Tbxl in either or both 
tissues in this aspect of development. In TbxT^' mice, insufficient addition of SHF 
precursors to the developing heart is considered to be the underlying defect resulting in 
a shortened OFT and subsequent alignment and septation defects (Xu et al., 2004). It is 
possible that in addition to decreased proliferation, the differentiation of SHF precursors 
could also be defective in TbxT^' mutants. Hesl may be required to maintain 
proliferation of SHF precursor cells and/or to prevent premature differentiation of 
mesodermal cells into outflow tract cardiomyocytes or endothelial cells.
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In pharyngeal arch artery development. Notch signalling has been shown to regulate the 
differentiation of NC cells into VSM cells (High et al., 2007). Similarly, mice 
heterozygous for Tbxl also exhibit a lack of NC-derived VSM lining the fourth 
pharyngeal arch arteries (Kochilas et al., 2002; Lindsay and Baldini, 2001). These 
results suggest that Tbxl could regulate VSM cell differentiation through the 
Notch/Hesl signalling pathway. Tbxl is not expressed in NC tissues but is required in 
the pharyngeal epithelia for correct pharyngeal arch artery formation and remodelling 
(Zhang et al., 2005). Tbxl could induce NC differentiation by activating a Notch ligand 
such as Jagl within the pharyngeal epithelia to signal to adjacent NC cells expressing 
Notch receptors and downstream effectors. Alternatively, direct regulation of Hesl by 
Tbxl within the pharyngeal epithelia could also affect Notch signalling within adjacent 
NC cells depending on the distribution of Notch ligands and receptors.
The role of Tbxl in palate development has not been well characterised. It is known 
that Tbxl is required in the pharyngeal epithelia for normal palate development and is 
only necessary after El 1.5 for secondary palatogenesis (Arnold et al., 2006b; Xu et al., 
2005; Zhang et al., 2006; Zoupa et al., 2006). Normal secondary palate development 
requires growth of the bilateral palatal shelves down from the maxillary processes, 
rotation and elevation of these shelves above the tongue and fusion of the shelves at the 
midline (Gritli-Linde, 2007). Tbxl is expressed in the palatal shelf epithelia and medial 
epithelial seam (Zoupa et al., 2006) and may be required to maintain proliferation of 
palatal epithelial cells or function in the epithelial to mesenchymal tranformation of 
medial epithelial seam cells for correct fusion (Gritli-Linde, 2007). HesT^' mutants 
exhibit a similar cleft palate phenotype and it is possible that Hesl could act in one of 
these processes downstream of Tbxl to control palate formation.
In thymic development, Tbxl has been demonstrated to play two distinct roles, one in 
thymic induction between E8.5 and E9.5 which occurs secondary to defective pouch 
formation and another in thymic morphogenesis between E10.5 and El 1.5 (Xu et al.,
2005). Development of the thymus requires Tbxl in both the pharyngeal epithelia and 
mesoderm (Arnold et al., 2006b; Zhang et al., 2006). HesT^' mutants exhibit a similar 
thymic hypo/aplasia phenotype which is at least partly due to the cell-autonomous role 
of Hesl in expansion of thymocytes (Tomita et al., 1999). Hesl may also play another 
role in thymic organogenesis downstream of Tbxl in which it could act in regulating
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proliferation of endodermal cells, differentiation of NC cells or in the specification of 
thymic epithelial cells.
5.3.4 Analysis of biological pathways downstream of H esl in pharyngeal 
development
5.3.4,1 Analysis ofpharyngeal patterning in Hesl'^' mutants
To determine which developmental pathways and mechanisms were affected within the 
pharyngeal region of Hesl'^' mutants, and how closely the Hesl'^' defects resembled the 
Tbxl mutant phenotype, patterning of the pharyngeal apparatus was examined in 
addition to expression of other genes known to be regulated by Tbxl.
Paxl, a marker of pharyngeal pouch endoderm and a gene required for normal thymus 
and parathyroid development (Su et al., 2001; Wallin et al., 1996), was found to be 
aberrantly expressed within the pharyngeal endoderm between pouches two and three in 
a HesT^' embryo, demonstrating a lack of pharyngeal pouch identity. This patterning 
defect most closely resembles Paxl expression in RA-treated mouse embryos which fail 
to properly form arches caudal to pharyngeal arch two and exhibit thymic and 
parathyroid defects (Mulder et al., 1998). In contrast, Paxl expression is 
downregulated in the fourth pharyngeal pouch of Tbxl^^' heterozygotes (Guris et al.,
2006) and is completely absent in the unsegmented caudal pharyngeal endoderm of 
TbxT^' mutants (Guris et al., 2006; Jerome and Papaioannou, 2001).
Altered Paxl expression in HesT^' mutants is indicative of a defect in pharyngeal 
patterning which could affect endocrine gland and/or pharyngeal arch artery 
development. Even though aberrant Paxl expression was only seen in one out of six 
HesT^' embryos, this incidence of altered marker expression corresponds with the low 
percentage of HesT^' embryos with pharyngeal arch artery defects at this stage. In 
addition, this altered expression pattern was not seen in any wild type or Hesl^^' 
embryos (n=5) used for controls or in any wild type embryos used in previous Paxl in 
situ experiments (Ivins et al., 2005). Therefore, even though parathyroid abnormalities 
were not identified through analysis of Gcm2 expression in HesT^' mutants, defects in 
this structure may still occur due to aberrant patterning in HesT^' mice since there is a 
close association between thymus and parathyroid development. This should be 
investigated with markers such as HoxaS, which is important for endocrine gland
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development (Manley and Capecchi, 1995; Su et al., 2001) and further analysis of 
parathyroid morphology.
To better characterise potential patterning abnormalities in Hesl'^' embryos, the 
expression of additional Hox genes could also be examined in the future. Hox genes 
confer anterior-posterior positional identity within the pharyngeal apparatus and each 
Hox gene paralog group (of which there are four) is segmentally expressed within the 
pharyngeal arches (Schilling, 1997). Although Hox gene expression within Tbxl^^' 
heterozygotes appears to be normal, Hoxbl, Hoxb4 and Hoxd4 have been found to be 
ectopically expressed in more anterior pharyngeal regions of Tbxl'^' embryos compared 
to wild type mice (Guris et al., 2006).
The similar malformations seen in Hesl and Tbxl mouse mutants and herb morpholino 
and vgo/tbxl zebrafish mutants suggests that similar mechanisms may underlie the 
defects in pharyngeal development. However, the low penetrance of cardiovascular 
defects in HesT^' mutants made it particularly difficult to determine which biological 
pathways or processes were affected and how closely they related to TbxT^' mutants. 
Given that the penetrance of pharyngeal defects in herb morpholino-inj ected zebrafish 
is much higher and a greater number of embryos can be examined simultaneously, it 
may be easier to dissect out the mechanisms responsible in zebrafish rather than mice.
5.3.4.2 Analysis o f Tbxl targets in HesT^' mutants
5.3.4.2.1 Hesl and Gbx2 in pharyngeal and heart development
Analysis of the transcriptional profile of TbxT^' embryos (Ivins et al., 2005) and cells, 
identified dysregulated genes such as the transcription factor Gbx2 and the Cyp2b RA 
metabolizing genes which have been shown to function in pharyngeal and heart 
development (Byrd and Meyers, 2005; Roberts et al., 2006). Mutations of these genes 
results in DGS-like malformations, similar to those seen in TbxT^' embryos. However, 
it remains uncertain how the activity of these genes is integrated in pharyngeal and heart 
development. To investigate whether similar genetic pathways are disrupted in Hesl 
and Tbxl mutants, the expression of Gbx2 and members of the RA signalling pathway 
were analysed in HesT^' embryos.
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Gbx2'^' mutants exhibit craniofacial and cardiovascular defects including cleft palate, 
otic vesicle hypoplasia, great vessel and OFT alignment defects reminiscent of Tbxl and 
Hesl mouse mutants (Byrd and Meyers, 2005; Wassarman et al., 1997). Gbx2 was 
found to be downregulated within the caudal pharyngeal ectoderm at E9.5 and the 
pharyngeal endoderm at E l0.5 in mutants similar to Tbxl'^' embryos ((Ivins et
al., 2005), A. Calmont, pers. comm.). However, expression of Gbx2 within the 
pharyngeal endoderm was diminished in Tbxl'^' mutants prior to that seen in Hesl'^' 
mice and the increased levels of Gbx2 in the second pharyngeal arch ectoderm of HesV^' 
mutants at E l0.5 has not been observed in Tbxl'^' mutants (Ivins et al., 2005).
These results suggest that Tbxl and Hesl may interact in regulating the expression of 
Gbx2 in the pharyngeal arches. However, considering the timing of Gbx2 
downregulation and the fact that the only overlapping expression domain for all three 
genes is the pharyngeal endoderm, it appears likely that both Tbxl and Hesl also 
regulate Gbx2 through independent pathways.
Recently our lab has demonstrated an epistatic interaction between Tbxl and Gbx2 in 
fourth pharyngeal arch artery development (A. Calmont and S. Ivins, pers. comm). 
However, the tissue(s) in which this interaction occurs has not been defined and it still 
remains to be determined whether these genes interact in the development of other 
pharyngeal-derived structures.
These studies have demonstrated that Tbxl interacts with numerous genes to regulate 
pharyngeal arch artery development. The challenge now is to dissect out the links 
between downstream effectors and determine how different pathways integrate in 
regulating development of pharyngeal-derived structures. Gbx2 may represent one node 
of convergence between Tbxl and Hesl although it is clear from expression and 
functional analyses that these genes also act through independent signalling pathways in 
pharyngeal and heart development. Reciprocal expression analyses of Gbx2, Hesl and 
other Tbxl target genes such as Fgf8 within their respective loss of function mouse 
mutants will help to identify common links between pathways. In addition, conditional 
deletion of multiple Tbxl targets simultaneously within specific pharyngeal tissues at 
various timepoints should also help to characterise the genetic pathways acting 
downstream of, and in parallel to, Tbxl.
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5.3.4.2.2 Hesl and retinoic acid signalling in pharyngeal development
Maintenance of the correct RA levels is extremely important for normal pharyngeal 
development. Many studies have demonstrated that disrupting RA homeostasis during 
development (by either upregulating or downregulating RA levels) leads to a DGS-like 
phenotype (Mulder et al., 1998; Niederreither et al., 2003; Niederreither et al., 2001; 
Vermot et al., 2003; Wendling et al., 2000). .
In Tbxl'^' mutants, regulation of RA levels is severely perturbed in the pharyngeal 
region due to downregulation of the RA-metabolizing enzymes, Cyp26al, Cyp26bl and 
Cyp26cl and upregulation of Raldh2, the enzyme required for generating the majority 
of embryonic RA (Guris et al., 2006; Ivins et al., 2005; Roberts et al., 2006). The 
altered expression of these genes results in an overall increase in RA within the 
pharyngeal apparatus and head mesenchyme of Tbxl'^' mutants. This has been 
demonstrated by expression of the RARE reporter transgene which consists of a hsp68 
promoter and lacZ gene under control of a canonical RA response element (Guris et al.,
2006). Ablating the function of all the Cyp26 enzymes in chick phenocopies DGS and 
results in caudal pharyngeal arch and arch artery defects, a hypoplastic otic vesicle and 
OFT defects similar to Tbxl'^' mice. These defects are considered to occur as a result of 
the subsequent increase in RA levels within these embryos (Roberts et al., 2006).
As a preliminary analysis of whether RA levels are affected in Hesl'^' mutants, the 
expression of Raldh2 and Cyp26cl was investigated. Raldh2 expression was not altered 
in Hesl'^' embryos at E9.5 but Cyp26cl expression was expanded into the second 
pharyngeal arch and ectopically expressed in the caudal pharyngeal ectoderm. In 
contrast, Cyp26cl expression in Tbxl'^' mice was generally downregulated within the 
pharyngeal region except for expanded expression within the first arch mesenchyme 
(Roberts et al., 2006). Despite the different expression patterns, these results imply that 
RA levels may be altered in Hesl'^' mutants and suggest that further experiments should 
be carried out to investigate whether expression of other genes important for regulation 
of RA such as Cyp26al and Cyp26bl are also dysregulated in Hesl'^' mutants. In 
addition, crossing Hesl mutants to RARE-lacZ transgenic mice should confirm whether 
the expression of RA is aberrant within the pharyngeal region.
RA has also been shown to induce or repress proliferation and differentiation by altering 
Hesl levels in different carcinoma cell lines ((Hartman et al., 2004; Muller et al., 2002;
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Murata et al., 2005; Wakabayashi et al., 2000). Hesl is also upregulated in vitamin A- 
treated limb buds (Ali-Khan and Hales, 2006). There have been no reports so far 
demonstrating regulation of RA by Hesl, although in zebrafish, morpholino knockdown 
of the Notch signalling transcription factor Su(H), the fish homologue of Rbp-J, causes 
downregulation of cyp26al within the tailbud, leading to altered RA levels and defects 
in somitogenesis. These findings demonstrate a close link between Notch signalling 
and the control of RA metabolism (Echeverri and Oates, 2007).
Together, these reports and preliminary expression analysis of RA-regulating genes 
provide intriguing evidence that both Tbxl and Hesl regulate RA levels. Disruption of 
RA homeostasis could be a common mechanism through which pharyngeal and heart 
defects occur in TbxT^' and HesT^' mouse mutants.
5.3.5 A stochastic model for H esl haploinsufficiency
The presence of the same range of pharyngeal arch artery defects in both Hesl 
heterozygotes and homozygotes at El 0.5 implies that haploinsufficiency of Hesl is 
sufficient to cause pharyngeal defects and that this phenotype represents an autosomal 
dominant defect with incomplete penetrance. However, later in development only 
HesT^' mice exhibit pharyngeal arch artery malformations, suggesting that Hesl^^' 
mutants recover from the earlier defects. The effect of genetic modifiers and functional 
redundancy among related Hes/Hey proteins may go some way to explaining the 
penetrance and recovery from these defects during development. However, if the 
phenotype is truly dominant, these factors cannot fully account for why Hesl^^' mice are 
able to recover during development while HesT^' mutants cannot.
Haploinsufficiency is often defined as a reduction in gene dosage to approximately 50% 
of normal levels which is insufficient for normal function. Another mechanism by 
which haploinsufficiency could lead to an abnormal phenotype is through disruption to 
stochastic gene expression. In this model, a gene can exist in an active or inactive state 
due to cellular noise which affects the initiation of transcription (Kaem et al., 2005). 
This stochastic nature of gene expression means that gene products fluctuate around a 
mean level and copy number influences the probability of gene expression (Figure 5.11) 
(Cook et al., 1998). If one copy of a gene is mutated, the mean level of product 
decreases by 50% but also fluctuates below this level, meaning that it could transiently
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act like a null allele (Cook et al., 1998). If a threshold level of transcription factor was 
required for activation of downstream targets and an “all or nothing” phenotype, 
haploinsufficiency could be explained in this model by the transient fluctuations of 
transcription factor below this threshold point leading to failure to regulate downstream 
targets and a subsequent phenotype (Figure 5.11) (Cook et al., 1998; Karmakar and 
Bose, 2006). This model may explain the presence of pharyngeal arch artery defects in 
mice at E l0.5. However, throughout development in HesT^' heterozygotes, the 
stochastic expression of the remaining Hesl allele may lead to sufficient activation of 
downstream pathways which could overcome the arch artery defect. In Hesl'^' mutants, 
this “rescue” could not occur although genetic modifiers and functionally redundant 
proteins could influence the phenotype. The finding that Hesl expression exhibits 
oscillatory behaviour in multiple cell types (Hirata et al., 2002; Kageyama et al., 2007; 
Yoshiura et al., 2007) lends strong support to a stochastic model of Hesl expression in 
which downregulation of Hesl decreases the probability of gene expression.
Hesl 
expression level
Threshold for regulation 
o f downstream targets
W T
Figure 5.11 A stochastic model for Hesl expression in pharyngeal arch artery 
development
In wild type (WT) mice containing two copies of Hesl, the levels of Hesl fluctuate due 
to stochastic gene expression but are always sufficient to maintain regulation of 
downstream targets. In Hesl^^' mutants, the mean levels of Hesl decrease and 
sometimes fall below the threshold required to regulate downstream genes, resulting in 
pharyngeal arch artery defects.
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5.3.6 Hesl and human disorders
5.3.6.1 H esl and DiGeorge Syndrome
Analysis of Hesl'^' mice has highlighted the importance of this gene in many aspects of 
development including brain, sensory organ, gut, cardiovascular and craniofacial 
development. Hesl is downregulated in Tbxl'^' embryos and HesV^' mutant mice 
exhibit all of the major features of DGS, including cleft palate, thymic hypo/aplasia and 
cardiovascular malformations involving the great vessels and outflow tract. An 
epistatic interaction between Thxl and Hesl has yet to be described in development of 
these structures. However, the range of DGS-like defects in the Hesl'^' mouse, in 
addition to the haploinsufficient pharyngeal arch artery phenotype and the role for Hesl 
in development of many other organs, suggests that HESl represents a candidate 
modifying locus for DGS, not only in the expressivity of pharyngeal-derived defects, 
but also in the penetrance of less frequent DGS defects in organs such as the brain, eye 
and kidney.
5.3.6.2 H esl and chromosome 3q syndrome
In addition to its potential role as a modifier in DGS, HESl may also be involved in 
other human chromosomal disorders. Human HESl is located on chromosome 3q29 
and chromosomal disruption of this segment in humans has been described in which the 
terminal region of 3q has been duplicated, triplicated or deleted.
Only five cases with terminal deletion of the long arm of chromosome 3q have been 
identified. However, some of the clinical features presented resemble those seen in 
Hesl'^' mutant mice (Alvarez Arratia et al., 1984; Brueton et al., 1989; Chitayat et al., 
1996; Jokiaho et al., 1989; Sargent et al., 1985). Cardiovascular defects, micro or 
anopthalmia (small or absent eyes), microcephaly and small kidneys, similar to the 
malformations present in Hesl'^' mutants have been described for these patients 
suggesting that haploinsufficiency of HESl could be an underlying cause of these 
symptoms.
Duplication of chromosome 3q syndrome (Dup(3q)) is associated mainly with 
craniofacial defects, microcephaly, ear malformations, hand and feet anomalies, 
genitourinary defects, growth retardation and cardiovascular abnormalities (Aqua et al.,
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1995; Faas et al., 2002; Rizzu et al., 1997; Steinbach et al., 1981). Patients with trisomy 
of chromosome 3q also exhibit similar clinical features (Ounap et al., 2005).
Considering that precise levels of Hesl may be required to control such processes as 
proliferation, differentiation and determination of cell fate, disruption of HESl levels 
either through up or downregulation, could hypothetically lead to developmental defects 
in humans. An increase in HESl levels may be responsible for, or contribute to, some 
of the clinical features seen in patients with duplication and triplication of chromsome 
3q such as the brain, heart and genitourinary defects which derive from structures in 
which Hesl is expressed and has been shown to play a role during development (Chen 
and Al-Awqati, 2005; Ishibashi et al., 1995; Iso et al., 2003; Piscione et al., 2004). It is 
possible that increased copies of HESl could affect development through aberrant 
increases in overall levels, or possibly by acting in a dominant negative fashion 
whereby increased amounts of HES1 could titrate other interacting partners.
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5.4 FUTURE DIRECTIONS
5.4.1 Is H esl a direct or indirect target of Tbxll
Downregulation of Hesl within Tbxl expression domains in the pharyngeal apparatus 
and the similar range of DGS-like defects exhibited by HesT^' mutants suggests that 
Hesl represents an excellent potential target of Tbxl. However, the molecular basis of 
Hesl regulation by Tbxl remains to be elucidated. In order to determine if Hesl is a 
primary Tbxl target, similar experiments could be carried out to those suggested for 
other potential Tbxl targets (see chapter 7). These include bioinformatic analyses to 
identify potential Tbxl binding sites within regulatory regions of Hesl with subsequent 
testing by transient transfection experiments to determine if Tbxl can bind to these sites 
and induce expression. Gel shift assays could also be undertaken to analyse binding of 
Tbxl, in vitro or in vivo. Finally, ChIP experiments using a Tbxl antibody could be 
analysed to find out if any DNA sequences isolated represent potential Tbxl binding 
sites contained within the regulatory regions of the Hesl gene.
Hesl has been primarily described as an effector of Notch signalling, but there is 
evidence to suggest that Hesl may also act independently of the Notch pathway; its 
expression can still be detected in Rbp-J null mice and in cultured cells without addition 
of Rbp-J (de la Pompa et al., 1997; Iso et al., 2003). Recent studies have demonstrated 
that Shh, V egf, Jnk and Ras signalling can directly regulate Hesl to control cell 
proliferation, providing strong support for a non-canonical role for Hesl in development 
(Curry et al., 2006; de la Pompa et al., 1997; Hashimoto et al., 2006; Ingram et al.,
2007; Stockhausen et al., 2005). Furthermore, Tbx transcription factors have been 
shown to regulate members of the //e^-related family. Tbx5 regulates expression of 
Hey2 in the heart (Mori et al., 2006; Plageman and Yutzey, 2006) and Tbx2 represses 
Heyl and Hey2 expression independent of Notch signalling, in patterning of the 
atrioventricular canal (Rutenberg et al., 2006). These results suggest that a conserved 
regulatory pathway may exist between T-box transcription factors and members of the 
Hes family.
It is also possible that instead of, or in addition to, direct regulation of Hesl by Tbxl, 
Hesl expression could be controlled indirectly through the Notch signalling pathway. 
This mechanism of regulation is supported by the identification of Notch3 as a potential 
Tbxl target in the microarray comparing Tbxl null cells to Tbxl heterozygous cells.
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NotchS is expressed in areas overlapping with Hesl during development such as the 
pharyngeal endoderm, thymus, central nervous system, kidney and lung (Chen and Al- 
Awqati, 2005; Felli et al., 1999; Lardelli et al., 1994; Sasai et al., 1992; Tomita et al., 
1999). In vitro experiments have indicated that Hesl is most sensitive to NotchS 
activation (Shimizu et al., 2002). However, NotchS'^' mice do not exhibit any gross 
abnormalities during development (Krebs et al., 2003) and adult mice present with 
small thymic lobes and defects in vascular smooth muscle cell maturation (Domenga et 
al., 2004; Kitamoto et al., 2005). Transgenic mice expressing a mutant form of NotchS 
exhibit vascular dysfunction and develop vascular lesions characteristic of CADASIL 
(cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy), a type of adult-onset vascular dementia (Dubroca et al., 2005; 
Ruchoux et al., 2003).
Notch 1, -2 and -4 are co-expressed with NotchS in many domains and may function 
redundantly. This could explain the lack of defects in NotchS'^' mice (Kitamoto et al., 
2005). Proper characterisation of the role of NotchS in development will require 
NotchS'^' mice to be crossed with conditional knockouts of Notchl,- 2 and -4.
5.4.2 What are the tissue and time-specific requirements for H esl in pharyngeal 
development?
Hesl is expressed in multiple overlapping domains with Tbxl within the pharyngeal 
endoderm and splanchnic mesoderm, but it is also expressed within the pharyngeal 
mesenchyme in areas which appear to be neural crest-derived. In TbxT^' embryos, 
expression of Hesl within all of these domains was found to be downregulated and 
analysis of the Hesl knockout mouse has demonstrated the importance of this gene in 
development of pharyngeal-derived structures similar to Tbxl. It remains unclear what 
role Hesl plays within each tissue in pharyngeal and heart development. Conditional 
deletion experiments should clarify whether downregulation of Hesl in Tbxl- 
expressing tissues is sufficient to cause the pharyngeal defects observed in HesT^' mice 
or whether loss of Hesl function in NC cells is the primary cause of HesT^' 
malformations. It is possible that ablation of Hesl in different tissues may lead to the 
same range of defects as seen for Tbxl (Arnold et al., 2006b; Zhang et al., 2006). If this 
is the case then restoration of Hesl function in specific tissues on a HesT^' or TbxT^' 
background should clarify the cell-autonomous functions of Hesl in development.
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In addition, generating compound Hesl and Hey gene mouse mutants should address 
the issue of functional redundancy. To better define the role of Notch signalling in 
cardiovascular and pharyngeal development downstream of Tbxl, tissue and time- 
specific ablation experiments should be carried out to knockdown Notch signalling 
within all Tbxl domains and specific pharyngeal tissues such as the endoderm and SHF. 
This could be achieved by crossing tissue-specific and tamoxifen-inducible Cre lines 
with DNMAML/+ mice to downregulate Notch signalling. Combined with results 
obtained from conditional knockouts of Hesl, these experiments should lead to a clearer 
understanding of how Tbxl and Notch/Hesl signalling may interact in pharyngeal and 
heart development.
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CHAPTER 6. ANALYSIS OF DGS PATIENTS WITH ATYPICAL 
CHROMOSOME REARRANGEMENTS
6.1 INTRODUCTION
DGS is a clinically heterogeneous syndrome associated with over 180 symptoms 
however the characteristic features involve craniofacial, cardiovascular, thyroid and 
thymic anomalies, defects in structures which derive from the pharyngeal apparatus 
(Robin and Shprintzen, 2005). Most DGS patients have the same 3 Mb heterozygous 
deletion of chromosome 22ql 1 or a smaller, nested 1.5Mb deletion, both of which 
include TBXL Mouse models and mutation searches have since identified 
haploinsufficiency of TBXl to be one major determinant of the clinical phenotype 
(Jerome and Papaioannou, 2001; Lindsay et al., 2001; Merscher et al., 2001; Yagi et al., 
2003). However, there are several DGS patients with atypical deletions or 
translocations within and outside of the common 3Mb region that do not disrupt TBXl 
(Amati et al., 1999; Rauch et al., 1999; Rauch et al., 2005; Saitta et al., 1999; Weksberg 
et al., 2006; Wieser et al., 2005). Studies have shown that the severity and penetrance 
of the symptoms in DGS varies greatly among patients and does not correlate with the 
size or position of the deletion (Sullivan, 2004) suggesting that multiple genes within 
chromosome 22ql 1 may contribute to similar phenotypes. Mouse mutants of other 
genes within the commonly deleted 3Mb region such as Crkl, (Guris et al., 2006; Guris 
et al., 2001 ; Moon et al., 2006) and on other chromosomes such as Fgf8 and Vegf (Abu- 
Issa et al., 2002; Frank et al., 2002; Stalmans et al., 2003; Vitelli et al., 2002b) have 
been shown to exhibit DGS-like defects in pharyngeal and heart development. In order 
to identify additional genes which may contribute to the DGS phenotype, DGS patients 
with atypical chromosome rearrangements were analysed.
FYl 198 was one such DGS patient who was negative for the common deletion but 
exhibited features reminiscent of the disorder. FYl 198 presented with pulmonary 
stenosis and an atrial septal defect and also exhibited other developmental abnormalities 
including primary hypothyroidism, cleft palate, small stature, delayed menarche, 
bilateral fifth finger clinodactyly, toe webbing, neck webbing, beaked nose, low 
columella, bilateral ptosis and learning difficulties. It was discovered that this patient 
had an apparently balanced t(l 1 ;22)(q23.3;ql 1.2) translocation. The parents and sister 
of FYl 198 also carried the translocation but did not exhibit any obvious phenotype.
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Subsequent investigation of the Mendelian Cytogenetics Network Database (MCDB) 
(http://www.mcndb.org/) identified another patient with a t(l 1 ;22) translocation, FN 
who exhibited a partial atrioventricular canal defect,
. The mother of FN also carried the translocation and had the same heart
malformation.
The t(l 1;22) translocation is the most common non-Robertsonian translocation to occur 
in humans. Carriers of this balanced translocation are phenotypically normal.
However, their offspring are at risk of having der(22) syndrome due to 3:1 meiotic non­
disjunction events (Fraccaro et al., 1980; Zackai and Emanuel, 1980). The breakpoints 
on chromosome 11 and 22 in t(l 1 ;22) translocation carriers have been well 
characterised and occur within a low copy repeat, LCR-B on chromosome 22 and 
within markers, D11S1340 and APOC3 on chromosome 11 (Edelmann et al., 2001a; 
Edelmann et al., 1999c; Funke et al., 1999).
The aim of this study was to determine where the t(l 1;22) breakpoints occurred in 
patients FN and FYl 198, whether the breakpoints were the same between the two 
patients, and whether the breakpoint locations were identical to the common t(l 1 ;22) 
translocation. If the translocation breakpoints in FYl 198 and FN were different to the 
recurrent t(l 1;22) translocation, this would strongly suggest that the new breakpoint 
disrupts a gene important in heart development. Therefore, FISH analysis was 
undertaken to map the translocation breakpoints and determine which gene(s) may be 
disrupted and cause the developmental defects.
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6.2 RESULTS
6.2.1 Mapping the chromosome 22 translocation breakpoint
YPELl is a gene which localises to human chromosome 22ql 1 and was identified as 
part of a screen for genes involved in craniofacial development (Farlie et al., 2001) 
Mouse Ypell is expressed in the branchial arches and heart (Farlie et al., 2001) and was 
therefore considered to be a potential candidate gene for the defects seen in these 
patients. BACs were obtained surrounding this 22ql 1 region, fluorescently labelled and 
hybridised to metaphase spreads of the patients’ and control cell lines. BACs 
containing the YPELl gene, RPl 1- 47L18 and RPl 1-794K20 did not appear to 
hybridise over the breakpoint and the probe signal was located only on chromosome 22 
and the derivative chromosome 11. Subsequently, BAG probes were chosen which 
localised to more centromeric regions. BACs, CTD-2295P14 and CTD-2589K18 
hybridised over the breakpoint in both the FYl 198 and FN cell line (Figure 6.1C, D). 
CTD2589K18 appeared to hybridise more strongly on the derivative chromosome 22 
whereas the CTD2295P14 signal was stronger on the derivative chromosome 11 
suggesting that the breakpoint on chromosome 22 occurred closer to the LOC440804 
gene as mapped by Ensembl (Figure 6.2).
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Figure 6.1 FISH mapping studies of the chromosome 22 breakpoint
(A,B) In control patients’ ceil lines, BACs CTD2295P14 and CTD2589K18 hybridised 
only to chromosome 22 along with the chromosome 22 control probes, bamccos and 
e289. (C, D) In both FYl 198 and FN patients’ cell line, these BACs hybridised over the 
breakpoint on chromosome 22 giving a signal on chromosome 22, 22-derivative and 11- 
derivative. (E) BAC, RPl 1-89208 also hybridised over the chromosome 22 breakpoint. 
(F) RPl 1-991H7 was centromeric to the breakpoint giving a signal only on 
chromosome 22 and 22-derivative. (E, F) Control probe RPl 1-8706 hybridised over 
the chromosome 11 breakpoint giving a signal on chromosome 11,11-derivative and 
22-derivative.
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Figure 6.2 Mapping the chromosome 22 breakpoint in FYl 198 and FN
BACs CTD-2295P14, CTD-2589K18 and RPl 1-89208 hybridised over the breakpoint 
on chromosome 22ql 1.21 indicating that the breakpoint (red asterisk) occurs just 
upstream of LOC440804 and HIC2. This region also lies within the distal LCR-D 
which mediates the common 3Mb 22ql 1 deletion. Blue lines represent genes and black 
lines represent BAC clones.
Further BACs were chosen to investigate more centromeric regions and confirm that the 
breakpoint did indeed disrupt the region located within BACs CTD-2295P14 and CTD- 
2589K18. RPl 1-89208 which overlapped with CTD-2589K18 and the 5’ end of CTD- 
2295P14 hybridised over the breakpoint in both patients but only gave a very faint 
signal on derivative chromosome 11 indicating that the breakpoint may be located at the 
more 3'end of the BAC (Figure 6. IE). RPl 1-991H7 which overlapped with the 5’ end 
of RP 11 -89208 did not appear to hybridise over the breakpoint in either patient, only 
giving a signal on chromosome 22 and derivative chromosome 22 (Figure 6.IF). 
However, both of these BACs, RPl 1-89208 and RPl 1-991H7 also often seemed to 
bind non-specifically to the metaphase spreads. LCRs are regions of high sequence 
homology which are present in multiple sites on chromosome 22 and which mediate 
aberrant recombination events (Edelmann et al., 1999a; Edelmann et al., 1999b). The 
breakpoint in these patients appears to occur within LCR-D which mediates the typical 
3Mb deletion which may explain the non-specific binding. The chromosome 22 control 
probe, bamccos also hybridises to these repeat elements which is why it sometimes 
appeared to bind to the derivative chromosome 11 (containing part of chromosome 22). 
The location of the breakpoint as characterised by the above FISH experiments revealed
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that it occurs approximately 60Kb upstream from a gene of unknown function, 
LOC440804 and 80Kb upstream from the HICl homologue, Hypermethylated in cancer 
2 (H1C2) (Figure 6.2). Due to the repeat modules and non-specific binding on 
chromosome 22, it was difficult to precisely define the breakpoint location. The 
breakpoint may actually be located closer to these two genes than can be determined by 
FISH analysis using these BAC clones and disruption of these genes or their regulatory 
regions may have led to the DiGeorge-like symptoms displayed by the patients.
6.2.2 Mapping the chromosome 11 translocation breakpoint
The breakpoint on chromosome 11 in FN and FYl 198 was also mapped to determine if 
it occurred within the same region as the recurrent t(l 1 ;22) translocation breakpoint.. 
The BAC probe, RPl 1-8706 which contains the recurrent, chromosome 11 
translocation breakpoint region, also hybridised over the breakpoint in the patients’ cell 
lines (Figure 6.3A). BAC RPl 1-4N9 was telomeric to the breakpoint (Figure 6.3B) 
demonstrating that the translocation breakpoint in patients FN and F Y 1198 was 
identical or at least very similar to the constitutional t(l 1 ;22) translocation breakpoint.
It is therefore unlikely that genes contained within this region are responsible for the 
patients’ phenotype since carriers of this translocation are phenotypically normal. 
However, the genes which could have been directly disrupted include NP_116114.1, 
ZNF259, APOA4 ondAPOAS. Alternatively, the regulatory regions of genes APOC3, 
APOAl and NP 079440.2 may have been affected (Figure 6.4).
Therefore, in comparison to the common t(l 1 ;22) translocation, the chromosome 11 
breakpoint in patients FN and FYl 198 was similar however, the chromosome 22 
breakpoint occurred in a different region.
189
R P11-8706
bamccos
FY1198 RP11-4N9 
bamccos
FY1198
Figure 6.3 FISH mapping studies of the chromosome II breakpoint
(A)The chromosome 11 BAC, RPl 1-8706 (red) localises over the breakpoint, 
hybridising on chromosome 11,11 -derivative and 22-derivative whereas the 
chromosome 22 control probe, bamccos (green) hybridises to chromosome 22, 22- 
derivative and also to chromosome 11-derivative. (B) RPl 1-4N9 (red) is telomeric to 
the breakpoint hybridising to chromosome 11 and chromosome 22-derivative and the 
chromosome 22 control probe, bamccos (green) hybridises to chromosome 22 and 22- 
derivative.
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Figure 6.4 Mapping the chromosome 11 breakpoint in FYl 198 and FN
BAC RPl 1-8706 hybridises over the breakpoint on chromosome 1 lq23 whereas RPl 1- 
4N9 is telomeric to the breakpoint. This breakpoint region (red asterisk) corresponds to 
the location of the constitutional t( 11 ;22) non-Robertsonian translocation breakpoint 
which occurs between markers D11S1340 and APOCS. The genes which map around 
this breakpoint are shown in blue.
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6.2.3 Analysis of Gm603 and Hic2 expression patterns
The genes potentially disrupted on chromosome 22 were investigated further because 
this region is associated with DGS patients who have atypical 22ql 1 deletions (Amati et 
al., 1999; Rauch et al., 1999; Rauch et al., 2005; Saitta et al., 1999; Weksberg et al., 
2006; Wieser et al., 2005). The human genes, LOC440804 and HIC2 occurred closest 
to the breakpoint and expression of their mouse homologues, Gm603 and Hic2, 
respectively were analysed during development to determine whether either gene may 
be a candidate for the heart defects occurring in the translocation patients.
Gm603, the mouse homologue of LOC440804 is contained within the syntenic region of 
mouse chromosome 16 and Ensembl revealed that Gm603 was also the homologue of 
LOCI50221 which appears to be a copy o f LOC440804. LOCI50221 occurs 160Kb 
telomeric to LOC440804 (Figure 6.2) and these genes share 99% amino acid identity. 
They are contained within LCR-D on chromosome 22 and represent replicated genes or 
pseudogenes which occur in many regions of chromosome 22ql 1 (Collins et al., 1997; 
Edelmann et al., 1999a; Edelmann et al., 1999b; Edelmann et al., 2001b; Heisterkamp 
and Groffen, 1988; Shaikh et al., 2000). Gm603 expression was analysed at E9.5 and 
was detected strongly in the pharyngeal arches and limbs but also appeared ubiquitously 
throughout the embryo at lower levels (Figure 6.5A). However, this expression may not 
be specific because a similar pattern was observed using the sense probe (Figure 6.5B).
Hic2 is also contained within the syntenic mouse chromosome 16 region and expression 
was assessed at E l0.5, appearing strongly within the pharyngeal arches and limbs 
(Figure 6.5C, D). Hic2 was also detected at this stage in the forebrain, eyes, neural tube 
and heart (Figure 6.5C, D). The corresponding sense probe was clean (Figure 6.5E) 
confirming that the antisense probe was specific for Hic2.
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Figure 6.5 Whole mount in situ hybridisation of Gm603 and Hic2
Gm603 expression at E9.5 (A) and the negative control sense probe (B). Hic2 
expression at E l0.5 (C, D) and the negative control sense probe (E). Abbreviations: e, 
eye; f, forebrain; h, heart; 1, limb; pa, pharyngeal arches; nt, neural tube; ot, outflow 
tract.
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6.2.4 Expression analysis of the Hic2 genetrap mouse
The expression pattern of Hic2 in the pharyngeal arches and heart suggested that it was 
the best candidate gene for the heart defects exhibited by the translocation patients. To 
further investigate a potential role for Hic2 in development, Hic2 gene trap mice were 
obtained from Bay Genomics, derived from the RRN127 embryonic stem cell line in 
which the pGTOLxf vector had integrated within intron 2 of Hic2 (re-verified by Bay 
Genomics) (Figure 6.6). The first experiments were aimed at characterising the 
expression of the trapped vector and confirming that the expression pattern of the 
galactosidase reporter matched that of Hic2 mRNA visualised by whole mount in situ 
hybridisation. The gene trap vector incorporates a p-galactosidase reporter within an 
intron and under the control of the gene of interest and therefore X-gal staining should 
recapitulate the expression pattern of the gene.
Figure 6.6 The Hic2 gene trap allele
The pGTOlxf gene trap vector integrated within intron 2 of Hic2. The unfilled boxes 
represent the 5’ and 3’ untranslated regions and the filled boxes represent the coding 
exons of Hic2. The blue arrow represents a loxP site, the green arrow, Lox71 and the 
red arrow, a FRT site. Abbreviations: En2 intrl, mouse En2 intron 1; SA, splice 
acceptor of mouse En2 exon 2; p-geo, fusion of P-galactosidase and neomycin 
transferase; pA, SV40 polyadenylation signal. Modified from 
http://www.sanger.ac.uk/PostGenomics/genetrap/vectors/pGT01xf-500.png.
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X-gal staining of heterozygous embryos (hereafter referred to as Hic2^^^^)
collected at multiple stages throughout development demonstrated that at the earliest 
stages examined, the Hic2 genetrap allele was primarily expressed in extra-embryonic 
tissues. At E7.0, Hic2 was expressed within the posterior amniotic fold and 
extraembryonic ectoderm. Hic2 was also detected in the extraembryonic mesoderm and 
visceral endoderm and contiguous portions of the embryonic mesoderm and endoderm 
(Figure 6.7A, I). At E7.5, staining was observed in the chorionic ectoderm, yolk sac 
mesoderm, amnion, visceral endoderm and allantois, all extraembryonic tissues (Figure 
6.7B, J). Hic2 was not detected at this stage within the cardiac crescent but slightly 
later at E7.75 just prior to formation of the linear heart tube. Hie2 began to be expressed 
in the more anterior regions of the cardiac crescent and was also expressed in the 
adjoining mesoderm just medial to the cardiac crescent which comprises part of the 
second heart field (Figure 6.7C, K). In addition. Hie2 was detected in the developing 
neural tube. At E8.0, Hie2 was expressed in the myocardium of the linear heart tube 
and also in the second heart field mesoderm just dorsal to the heart. Hie2 was also 
detected in the pericardial mésothélium at this stage and also in the head folds (Figure 
6.7E, L). At E8.5, the looping stage of heart development, Hie2 was expressed 
throughout the myocardium in the proximal outflow tract and developing ventricles and 
atria and continued to be expressed in the neural tube and forebrain (Figure 6.7F, M). 
Later, at El 0.5, Hie2 was observed in the myocardium of both ventricles and atria, 
including the ventricular trabeculae and was still present in the proximal outflow tract 
(Figure 6.7G, N). Hie2 continued to be expressed in the heart until E l2.5, the last stage 
examined (Figure 6.7H).
At E l0.5, Hie2 was also present in other embryonic tissues throughout the body. 
Expression was observed in the pharyngeal arches, limb buds, forebrain, eyes and 
neural tube (Figure 6.7G, O, R). In addition, Hie2 was expressed in the midgut, foregut 
and developing lungs (Figure 6.7P, Q). The expression pattern of the gene trap allele at 
this stage of development matched the expression pattern of Hie2 mRNA confirming 
that the gene trap recapitulated endogenous Hie2 expression. The only differences 
apparent between the gene trap allele and Hie2 mRNA concerned the levels of 
expression in certain tissues, namely the heart, pharyngeal arches and limbs. The Hie2 
P-geo reporter appeared to be expressed at a higher level in the heart than Hie2 mRNA 
whereas Hie2 mRNA was stronger in the pharyngeal arches and limbs than the Hie2 
gene trap allele.
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Figure 6.7 Expression of the Hic2 gene trap by X-gal staining at a range of 
gestational ages
(A H) Whole embryos. (I-R) Transverse sections. Abbreviations: 2hf, second heart 
field; a, amnion; al, allantois; at; atria; c, chorion; cc, cardiac crescent; e, eye; en, 
endoderm; f, forebrain; fg, foregut; h, heart; 1, limb; lb, lung buds; Iv, left ventricle; m, 
mesoderm; md, mandible; mg, midgut; nt, neural tube; ot, outflow tract; pa, pharyngeal 
arches; rv, right ventricle; ys, yolk sac.
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6.2.5 Analysis of the phenotype of Hic2 genetrap mice
Hic2 gene trap mice were investigated to determine whether they exhibited a heart 
phenotype reminiscent of that seen in FN and FYl 198. Genotyping of the offspring 
from wild type X matings at PIO revealed that only 19% (13/70) instead of the
expected 50% were heterozygotes, suggesting that a percentage of
mice die during embryogenesis or shortly after birth (Table 6.1). To determine the 
stage of lethality, embryos were collected and genotyped at El 0.5 and El 5.5. 
mice were present at the expected mendelian ratios until and including E l5.5, the latest 
stage examined (Table 6.1). Closer examination of newborn litters revealed that several 
Hic2^^^^micQ died within 24 hours of birth. Therefore, it appears that a proportion of 
mice may die perinatally.
Table 6.1 Genotype of progeny from wild type x matings
Stage
Genotype
wild type (%) (%) Total
E10.5 6 (43%) 8 (57%) 14
E15.5 23 (47%) 26 (53%) 49
PIO* 57(81%) 13 (19%) 70
* Significantly different from normal Mendelian ratios (P<0.001, 
statistics based on Chi-squared test)
In order to determine the cause of the heterozygous lethality, E14.5 to E15.5 litters were 
collected from matings between wildtype and mice for MRJ and histological
analysis. Analysis of the embryos by MRI revealed that approximately 24%
had a ventricular septal defect (n = 8/34) (Figure 6.8D) and transverse histological 
sections through the hearts of these embryos confirmed the MRI results (Figure 6.8H). 
Two of these Hic2'^^^^ embryos also appeared to have an overriding aorta 
accompanying the VSD (Figure 6.8C, G). No DGS-like arch artery abnormalities were 
identified in heterozygotes nor were any defects in palate formation or thymic
development, structures which are affected in DGS and derive from the pharyngeal 
apparatus. All other organs appeared to be normal. However, there may be subtle 
morphological or physiological changes which were not detected in this study.
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Figure 6.8 Cardiovascular defects in E15.5 mutant embryos
Transverse, MRI scans (A-D) and H and E-stained heart sections (E-H) from E l5.5 
embryos. (A, B, E, F) A wild type heart showing the aorta arising from the left 
ventricle and the interventricular septum separating the left and right ventricles. (C, D, 
G, H) A, mutant heart with an overriding aorta and a ventricular septal defect.
Abbreviations: ao, aorta; ivs, interventricular septum; Iv, left ventricle; rv right 
ventricle; vsd, ventricular septal defect; wt; wild type.
///c2^^^^heterozygous mating pairs were also set up to determine if homozygous mutant 
mice would be bom in mendelian ratios. Out of 3 pairs of ///c2^^^^heterozygous 
intercrosses set up over 2 -3 months only one litter of two pups were born and survived 
until weaning. There was evidence that small litters were born (3-4 pups compared to 
6-8 pups from wild type C57B1/6 matings) but it appeared that several pups died within 
the first 24 hours and the rest of the litter was cannibalized. To determine whether the 
Hic2 mutation was embryonically lethal, embryos were collected at midgestation from 
intercrosses. Due to difficulty in determining the exact position of the genetrap 
vector within the intron, it was not possible to distinguish homozygotes from 
heterozygotes. However, from preliminary analysis of embryos collected at El 0.5, 
some resorptions were noticed. One possible embryo was identified by
stronger lacZ staining, delayed growth compared to wild type embryos, and an enlarged 
heart that had not turned properly (Figure 6.9B, D). These results suggest that 
//ic2^^^^homozygotes may die during embryogenesis prior to E l0.5. Examination of 
litters collected from intercrosses after this stage revealed multiple resorptions,
presumably representing homozygotes, and providing further evidence
suggesting that disruption of Hic2 is embryonically lethal.
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Figure 6.9 A potential embryo
(A) An E l0.5 wild type embryo in comparison to (B) a growth-delved, potential
embryo. Ventral views of (C) a wild type and (D) a Hic2 heart which 
does not appear to have undergone correct looping (compare dashed lines in (C) to (D).
In conclusion, the analysis of DGS patients with atypical t(l 1;22) translocations has led 
to the identification of HIC2, a gene potentially disrupted by the breakpoint on 
chromosome 22. Expression analysis and functional characterisation of Hic2 gene trap 
mice has demonstrated a role for Hic2 in heart development suggesting that mutations 
in this gene may contribute to the phenotype of DGS patients.
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6.3 DISCUSSION
6.3.1 Mapping the t(ll;22) translocation breakpoint in DGS patients
DiGeorge syndrome (DGS) is primarily caused by deletion of a 3Mb region of 
chromosome 22ql 1. This region is flanked by low copy repeats (LCRs), highly 
homologous sequences which are common within chromosome 22 and mediate 
rearrangements and deletions including the 3Mb and 1.5Mb DGS deletion and are also 
sites of breakpoints in translocations involving chromosome 22 (Carlson et al., 1997; 
Edelmann et al., 1999a; Edelmann et al., 1999b). The most common 3Mb and 1.5Mb 
deletions contain TBXl^ the main candidate gene for DGS however there have been 
multiple reports of DGS patients who have atypical deletions of chromosome 22 which 
do not include TBXl suggesting that additional genes on chromosome 22ql 1 may be 
involved in the aetiology of the disease. Crkl, a cell adaptor protein located within the 
3Mb, 22ql 1 deletion has since been shown to also contribute to the pathophysiology of 
DGS (Guris et al., 2006; Guris et al., 2001 ; Moon et al., 2006). Crkt^' mouse mutants 
have DGS-like craniofacial, heart and glandular defects and Tbxl^^';Crkt^' compound 
heterozygotes exhibit aortic arch, thymic and parathyroid defects with significantly 
increased penetrance and expressivity compared to either heterozygote alone 
demonstrating that Thxl and Crkl interact within the same genetic pathway in 
pharyngeal development (Guris et al., 2006). Haploinsufficiency of CRKL may 
contribute to the development of malformations in some of the DGS patients with 
atypical deletions but it is not deleted in all atypical deletions of chromosome 22 
suggesting that additional 22ql 1 genes may be involved in heart and/or pharyngeal 
development.
In order to identify genes on chromosome 22ql 1 which could play a role in pharyngeal 
or heart development, DGS patients who exhibited atypical rearrangements of 
chromosome 22 were investigated. Two such patients presented with an apparently 
balanced t(l l;22)(q23.3;ql 1.2) translocation and exhibited some features reminiscent of 
DGS. In particular, both patients had cardiovascular anomalies.
The chromosome 11 breakpoint in these patients occurred in the same location as the 
breakpoint in phenotypically normal carriers of the constitutional t(l 1;22) translocation. 
It is therefore it is unlikely that disruption of any of the genes within or surrounding this 
region contributed to the heart phenotype observed. In addition, investigation of the
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potential function of these genes does not support any role in pharyngeal or heart 
development. ZNF259 interacts with the SMN protein which when mutated leads to 
spinal muscular atrophy (Gangwani et al., 2001) and Z«/25P’^ 'mice exhibit axonal 
defects (Gangwani et al., 2005). APOAl, AP0A5 and AP0C3 are involved in 
lipoprotein metabolism (Lai et al., 2005) and the function of NP_116114.1 and 
NP 079440.2 is yet to be characterised.
The chromosome 22 breakpoint in FN and FYl 198 occurs within LCR-D and 
distinguishes these patients from carriers of the common t(l 1 ;22) translocation. 
Therefore, the potentially disrupted chromosome 22 genes were characterised in more 
detail. Disruption of the genes, LOC440804 and Hypermethylated in cancer 2 (HIC2) 
or their regulatory regions may be the cause of the heart defects presented by these 
patients. The gene closest to the breakpoint on chromosome 22 was LOC440804 or 
KIAAJ666 which is predicted to contain several protein-protein interaction domains 
including SH3 and fibronectin type III domains. Chromosome 22ql 1 contains several 
low copy repeat regions comprised of replicated genes such as DGCR6, BCR AND 
GOT (Collins et al., 1997; Edelmann et al., 1999a; Edelmann et al., 1999b; Edelmann et 
al., 2001b; Heisterkamp and Groffen, 1988; Shaikh et al., 2000). LOC440804 also 
appears to be a duplicated gene or pseudogene and another copy, named LOCI50221 
can be found on chromosome 22. These genes are contained within LCR-D and it is 
possible that they may participate in mediating aberrant recombination events. There is 
little information on the expression or function of LOC440804. However, RT-PCR 
analysis has revealed that this gene is detected in fetal tissue and in many adult, human 
tissues including the heart, brain, lung and testis
(http://www.kazusa.or.jp/huge/gfpage/KIAA1666/). Whole mount in situ hybridisation 
of the mouse homologue, Gm603, did not reveal a specific expression pattern for this 
gene. Further analysis using probes against different regions of Gm603 may yield more 
information regarding its potential role in development.
HIC2 is located approximately 80Kb telomeric to the chromosome 22 breakpoint and its 
expression may have been affected by the translocation. To date, there has been little 
information concerning the expression or function of HIC2. RT-PCR analysis has 
shown that HIC2 (annotated as KIAA1020) is expressed in fetal tissue and a variety of 
adult, human tissues including the brain, ovary, testis, liver, lung and heart 
(http://www.kazusa.or.jp/huge/gfpage/KIAAlG2G/). The zebrafish orthologue, hrg22 is
2GG
expressed in brain, retina, somite borders, spinal cord, pectoral fin buds and branchial 
arches during development (Bertrand et al., 2004). The expression of mouse Hic2 has 
been characterised through whole mount in situ hybridisation and X-gal staining of a 
Hic2 gene trap allele. These methods demonstrate an overlapping expression pattern in 
mouse which is highly reminiscent of the zebrafish hrg22 expression pattern (Bertrand 
et al., 2004). While the similar localisation of the Hic2 B-geo reporter and Hic2 mRNA 
in embryos confirms that the gene trap recapitulates the endogenous Hic2 expression 
pattern, levels of expression of Hic2 were slightly different between the two methods, 
particularly in the heart, pharyngeal arches and limb buds. Other groups have also 
reported differences in expression between gene trap alleles and endogenous mRNA 
(Koshiba-Takeuchi et al., 2006; Pennisi et al., 2007). This may occur due to differences 
in detection sensitivity between X-gal staining and in situ hybridisation, differences in 
protein and RNA stability or alternatively, the gene trap insert may have disrupted an 
intronic regulatory element. Nevertheless, the expression patterns exhibited by the Hic2 
gene trap and Hic2 mRNA were very similar and together give a clear profile of the 
expression pattern of Hic2 throughout development.
The presence of Hic2 in both the first and second heart fields just prior to heart tube 
formation and subsequently, the persistent expression in the myocardium of the 
ventricles, atria and proximal OFT strongly suggests that Hic2 may play an important 
role in heart development.
6.3.2 Hic2 mutants exhibit heart defects
Analysis of Hic2^^^^ heterozygotes revealed that a proportion were perinatal lethal 
indicating that they exhibit a haploinsufficient phenotype. MRI and histology revealed 
that embryos have VSDs which could contribute to their mortality and a
smaller proportion of embryos had an overriding aorta accompanying the VSD. These 
heart defects exhibited by Hic2^^^^ heterozygotes phenocopy those seen in DGS 
patients where OFT abnormalities are the most prevalent heart defects and VSDs also 
account for a significant proportion (13-18%) (Momma, 2007).
The ventricular septum closes through fusion of the interventricular septum with the 
atrioventricular cushions and outflow tract (Gruber and Epstein, 2004). Defects in the 
development of any of these structures can lead to VSDs which are the most common
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congenital heart malformation in humans occurring at a frequency of 1 in 300 births 
(Hoffman and Kaplan, 2002). Mutations in many genes have been associated with 
VSDs in mouse development including transcription factors such as Tbxl^ Nhc2.5 and 
Hey2, signalling factors and receptors such as Fg/8, Fgfr2 and Bmprla and cell 
adhesion molecules such as Vcaml (Abu-Issa et al., 2002; Gaussin et al., 2002; Jerome 
and Papaioannou, 2001; Kwee et al., 1995; Lindsay et al., 2001; Marguerie et al., 2006; 
Merscher et al., 2001; Prall et al., 2007; Sakata et al., 2002). The VSD exhibited by 
mutants may occur as a result of malalignment of the OFT in a proportion of 
embryos with the defect. However, VSDs also appear to occur in isolation in 
mice suggesting that Flic2 may also function in other aspects of septum formation.
The mice examined did not exhibit any other DGS-like heart defects such as
great vessel anomalies nor were any defects in atrial septation or valve morphogenesis 
detected despite both translocation patients exhibiting atrioventricular canal defects. 
However, subtle abnormalities in atrioventricular development are difficult to identify at 
El 5.5, the stage examined. In addition, the type of heart defects exhibited by Hie 2 
mutants may depend on the mouse strain. Nevertheless, these studies have 
demonstrated that Hic2 is dose-sensitive in heart development which strongly suggests 
that disruption of HIC2 in humans may predispose individuals to heart defects, the type 
and penetrance of which may depend on genetic background.
6.3.3 The function of Hic2 in development
Little is known about the functional role of HIC2 in development or the molecular 
pathways in which HIC2 interacts. However, clues as to its function, interacting 
partners and target genes can be obtained from analysis of its better characterised 
homologue, HICl.
HICl and HIC2 are both members of the BTB/POZ (Broad complex, Tramtrack, Brick 
à brae (BTB) or poxvirus and zinc finger (POZ)) family of transcription factors which 
all contain the conserved BTB/POZ, N-terminal protein interaction domain (Kelly and 
Daniel, 2006). In addition to the BTB/POZ domain, HICl and HIC2 also share two 
other highly conserved domains, a C-terminal DNA-binding domain consisting of five, 
Kriippel-like C2H2 zinc fingers and another internal protein interaction domain, the 
evolutionarily conserved GLDLSKK/R motif (Deltour et al., 1999; Deltour et al., 2002).
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The original BTB/POZ transcription factors were discovered in Drosophila and all play 
important roles in development. BR-C is required for central nervous system 
development in Drosophila (Karim et al., 1993; Restifo and White, 1991). TtK plays a 
role in compound eye development (Xiong and Montell, 1993) and Bab is important for 
ovary and limb development (Sahut-Bamola et al., 1995). The vertebrate members of 
the POZ domain family are also required for correct development including P lzf which 
is important for limb and skeletal formation (Bama et al., 2000) and M izl and Kaiso 
which are both required for gastrulation (Adhikary et al., 2003; Park et al., 2005).
Similarly, HICl has been proposed to play a major role in the developmental disorder, 
Miller-Dieker syndrome (MDS) (Carter et al., 2000). HICl is located within the 350Kb 
critical region on chromosome 17pl3.3 which is deleted in most patients with Miller- 
Dieker syndrome, characterised by lissencephaly, craniofacial and limb defects and 
omphalocele (Hirotsune et al., 1997; Wales et al., 1995). Haploinsufficiency of LISl is 
considered to be the main cause of the lissencephaly and mental retardation phenotype 
(Chong et al., 1996; Hirotsune et al., 1998; Paylor et al., 1999; Pilz et al., 1999). 
However, the cause of other developmental anomalies which are part of the aetiology of 
Miller-Dieker syndrome could be attributed to loss of HICl function since Hicl'^' null 
mice have defects highly reminiscent of the disease, exhibiting craniofacial, limb and 
ventral body wall defects (Carter et al., 2000).
HICl, like the majority of other BTB/POZ transcription factors, acts as a transcriptional 
repressor (Deltour et al., 1999) and mediates this activity through two, distinct domains. 
The BTB/POZ domain acts to repress trancription in a Hi stone Deacetylase (HDAC)- 
independent manner (Deltour et al., 1999) whereas the GLDLSKK/R motif interacts 
with the co-repressor, CtBP and recruits HDACs to repress downstream targets (Deltour 
et al., 1999; Deltour et al., 2002). These two domains are highly conserved between 
HICl and HIC2, showing greater than 80% homology between the BTB/POZ domains 
and 100% homology in the GLDLSKK/R motif (Deltour et al., 2001) suggesting that 
HIC2 may also act as a transcriptional repressor and could interact with and regulate the 
expression of similar proteins.
HICl and HIC2 both localise to nuclear bodies within the cell (Deltour et al., 2001) and 
HICl has been shown to recruit mCtBPl to these nuclear dots through binding to its 
GLDLSKK/R motif (Deltour et al., 2002), a mechanism by which HICl acts to repress
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the activity of proteins such as TCF-4 and B-catenin, effectors of Wnt signalling 
(Valenta et al., 2006). HICl also represses transcription by binding to the sequence 
specific site, 5’-C/GNGC/GGGGCAC/ACC-3’and requires multiple sites for optimal 
binding (Pinte et al., 2004). HIC2 shares over 80% homology with the HICl zinc 
fingers indicating that it may bind to similar sequences. Therefore, the identification of 
genes containing putative HICl binding sites may actually/also represent HIC2 targets.
The signalling pathways that may interact with H id  are also starting to be 
characterised. In addition to repression of the Wnt signalling mediators, Tcf-4 and B- 
catenin. H id  has also been proposed to regulate Fgfbpl in response to TgfB signalling, 
a process important in angiogenesis (Briones et al., 2006). In addition, the H id  ;CtBP 
repressor complex acts to downregulate Sirt-J expression (Chen et al., 2005; Zhang et 
al., 2007) particularly in response to redox changes in the environment (Zhang et al., 
2007). Most of these potential H id  target genes have been identified through in vitro 
experiments however the actual role that H id  may play in vivo in regulating these 
genes is unknown. Furthermore, mCtBPl, mCtBP2 and Sirt~l knockout mice exhibit 
heart and/or vascular defects (Cheng et al., 2003; Hildebrand and Soriano, 2002) and in 
particular, SirtP^' mice have VSDs and ASDs reminiscent of the phenotype exhibited by 
Hic2^^^^ m\Q,Q (Cheng et al., 2003). The close similarity in structure between HICl and 
HIC2 and the results from this study revealing a role for Hic2 in heart development 
strongly suggest that Hic2 may interact with at least some of these potential H id  target 
genes.
6.3.4 Hic2 and its role in DGS
FISH mapping studies determined that the breakpoint in patients, FN and FYl 198 
occurs within the LCR-D region on chromosome 22 in approximately the same location 
as the distal breakpoint of the common 3Mb deletion. LCR-D is approximately 250Kb 
in length and is defined by the markers D22S936 and D22S801 (Figure 6.10) (Shaikh et 
al., 2000). HIC2 is located within LCR-D surrounded by repeated modules that mediate 
aberrant recombination events. Most studies have used FISH mapping to define the 
endpoint of the deletions in DGS patients however recently, studies using high density 
tiling oligonucleotide arrays and quantitative real time PCR have been able to more 
clearly define the breakpoints at the nucleotide level revealing that there are some 
variations of the deletion endpoints among patients with the common 3Mb deletion
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(Jalali et al., 2007; Urban et al., 2006; Weksberg et al., 2006). Weksberg and 
colleagues (2006) showed that in a cohort of 44 patients with 22ql IDS, most patients 
had the approximate 3Mb deletion (41/44, 93%) and of these, most deletions occurred 
within and including the markers PRODH dmà. D22S936, in which the distal endpoint 
occurred just proximal to HIC2. However, 7 of these 3Mb deletion patients had 
variable proximal and distal deletion endpoints including 2 patients whose deletion 
included HIC2 (2/41, 5%) (Weksberg et al., 2006) (Figure 6.10). This suggests that a 
proportion of patients with the 3Mb deletion may be haploinsufficient for HIC2.
Indeed, this proportion could be even higher if transcription of HIC2 is found to be 
controlled by a long-range cis regulatory element. In addition, there are numerous 
reports of DGS patients with atypical deletions of 22ql 1 which do not include TBXl but 
which include HIC2 (Figure 6.10) (Amati et al., 1999; Jalali et al., 2007; Rauch et al., 
1999; Rauch et al., 2005; Saitta et al., 1999; Weksberg et al., 2006; Wieser et al., 2005). 
Therefore, hemizygous expression of HIC2 may contribute to the heart phenotype not 
only in DGS patients Avith atypical rearrangements of chromosome 22ql 1 but also in a 
proportion of patients with the common 3Mb deletion. This is supported by evidence in 
this study demonstrating that Hic2 is dosage sensitive and is the only gene on 
chromosome 22ql 1 apart from TBXl which results in a heterozygous heart phenotype 
in mice.
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Figure 6.10 DGS patients with aty pical deletions
Most patients with DGS have the typical 3Mb or 1.5Mb deletion of chromosome 22ql 1. 
A proportion of patients with the 3Mb deletion have atypical distal deletion endpoints 
which include HIC2 (red asterisk on 3Mb atypical). Some DGS patients have atypical 
22ql 1 deletions which also include HIC2 (red asterisk on blue lines). Modified from 
(Shaikh et al., 2007).
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6.4 FUTURE DIRECTIONS
6.4.1 Hic2 and long range transcriptional regulation
The expression of Hic2 in the heart and the phenotype of ///c2^^^^mice provides strong 
support for disruption of HIC2 as the underlying mechanism causing the heart defects in 
DGS patients with atypical 22ql 1 deletions and in t(l 1 ;22) patients FN and FYl 198. 
However, FISH experiments map the breakpoint on chromosome 22 to an intergenic 
region approximately 80Kb upstream of HIC2 suggesting that long-range cis regulatory 
elements may be disrupted by the translocation.
Further experiments need to be carried out to determine whether the breakpoint disrupts 
HIC2 expression. A number of experiments could be conducted to assess HIC2 
expression in the patients’ cell lines. These include real-time quantitative PCR or an 
allele-specific PCR to more precisely determine if HIC2 expression from the disrupted 
chromosome 22 is altered. However, in vitro experiments on transformed cell lines may 
not accurately represent the in vivo expression of HIC2. In addition, disruption to 
regulatory elements may not affect gene expression in the same way as coding sequence 
mutations (see below).
Position effects caused by chromosomal rearrangements often occur as the result of 
disruption to long-range cis regulatory elements and become apparent when the 
phenotype caused by disruption of the regulatory element is the same or similar to the 
phenotype caused by intragenic mutations. Many of the genes which are regulated in 
this manner are important in developmental control and include TWIST, POU3F4, 
PITX2, S0X9, SHH  and MAF which are regulated by enhancers located up to 1Mb 
away (Cai et al., 2003b; de Kok et al., 1996; Jamieson et al., 2002; Lettice et al., 2002; 
Pfeifer et al., 1999; Trembath et al., 2004).
These genes are expressed in a complex spatiotemporal pattern during development 
requiring a complex mode of regulation which long-range cis regulatory elements may 
provide. Hic2 is expressed in multiple tissues during embryogenesis and disruption of 
Hic2 leads to a heterozygous heart phenotype in mice and more severe developmental 
defects in homozygous nulls indicating that Hic2 is an important developmental gene.
It is therefore a good candidate for control by long-range regulation.
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Long-range cis elements are often contained within evolutionarily conserved sequences 
in non-coding regions of the genome (Kleinjan and van Heyningen, 2005) and future 
experiments should aim to determine if any such conserved sequences are contained 
within the breakpoint region upstream of HIC2. Transgenic mouse studies could then 
be carried out to characterise any putative c/5-regulatory elements and determine if 
disruption leads to a similar heart phenotype as that seen in Hic2 genetrap mutants. 
However, it is important to note that defects caused by disruption to regulatory regions 
may be different to those caused by mutation within a gene’s coding region. Mutations 
within regulatory elements may disrupt only certain tissues and/or lead to aberrant up or 
down-regulation of genes. Disruption to a cis regulatory element contained more than 
1Mb upstream from Shh leads to misregulation of Shh only in the limbs and causes 
preaxial polydactyly but doesn’t affect Shh expression in any other tissues (Lettice et 
al., 2003; Lettice et al., 2002). It would be interesting to determine how a c/j-acting 
regulator contained within the translocation breakpoint region may affect expression of 
Hic2 in the heart.
6.4.2 Further characterisation of the role for Hic2 in development
These studies have shown that Hic2^^^^ micQ exhibit heart defects reminiscent of DGS. 
Hic2^^^^^ mutants may exhibit more severe developmental abnormalities, which may be 
due to defects in the embryo itself or to defects in extraembryonic development since 
the yolk sac also expresses Hic2. In order to better characterise the spatial and temporal 
role of Hic2 in development, conditional knockouts need to be generated.
Hic2 gene trap mice could also be used to investigate the tissue-specific role for Hic2 in 
development. The Hic2 genetrap allele was constructed to contain loxP sites flanking 
the splice-acceptor-B-galactosidase insert. Theoretically, Cre-mediated excision of the 
vector should be possible, which would restore normal splicing and function of the 
trapped gene. It would be useful to restore function of Hic2 in all extra-embryonic 
tissues using an extra-embryonic, tissue specific Cre line in order to define the role of 
Hic2 in the embryo proper while circumventing any extra-embryonic defects. The 
Cypl9-CxQ line is restricted to the extra-embryonic ectoderm and ectoplacental cone and 
all derivatives of the trophoblast stem cells (Wenzel and Leone, 2007). However, it is 
not expressed within the extraembryonic mesoderm which gives rise to the amnion or 
the primitive endoderm which contributes to cells of the yolk sac, both tissues which
208
express Hic2. Alternatively, the Mox2-Cre (MORE) line is restricted to epiblast 
derivatives including the embryo proper and extraembryonic mesoderm (Tallquist and 
Soriano, 2000) therefore restoring function of Hic2 to these tissues should reveal 
whether the early embryonic lethality of / / / homozygotes is due to an 
extraembryonic requirement for Hic2.
Chimeric embryo studies could also be undertaken to distinguish between the extra­
embryonic and embryonic requirement for Hic2 in development by introducing mutant 
ES cells into wild type embryos or vice-versa. In the resulting chimeric embryo, the 
epiblast will be a mixture of wild type and mutant cells however, ES cells only give rise 
to epiblast derivatives which include the embryo proper and the extra-embryonic 
mesoderm but do not contribute to extraembryonic cells of the primitive endoderm or 
trophectoderm which will only be derived from the diploid embryo (Tam and Rossant, 
2003). Therefore, mutant ES cell;diploid wild type embryo chimeras could be used to 
determine the effect of knocking out Hic2 only in embryonic tissues. The reciprocal 
experiment, making wild type ES-cell;diploid mutant embryo chimeras would reveal the 
role of Hic2 in extra-embryonic tissues.
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CHAPTER 7. GENERAL DISCUSSION AND FUTURE 
DIRECTIONS
7.1 OVERVIEW
My thesis work involved using multiple tools to investigate pharyngeal and heart 
development, the major processes affected in DiGeorge syndrome. Haploinsufficiency 
of TBXl, which encodes a T-box transcription factor is considered to be the major 
underlying cause of this syndrome. I optimised a novel method to isolate embryonic 
-expressing cells from transgenic mice, by using a fluorogenic lacZ substrate to 
label and flow-sort Tbxl-lacZ cells, thereby enabling cell-autonomous effects of Tbxl to 
be analysed by microarray. This work has led to the identification of a number of novel 
target genes that are dependent on Tbxl activity. In addition, I have conducted BAG 
recombineering experiments to generate a transgenic mouse line carrying a GFP- 
labelled, mutant Tbxl allele. This transgenic mouse will enable further direct 
downstream targets of Tbxl to be identified in future experiments, providing a valuable 
resource to study the role of Tbxl in development.
The microarray experiment identified Hesl as a potential Tbxl target. Analysis of the 
Hesl mouse mutant demonstrated an important, novel role for this gene in craniofacial, 
PAA and OFT development. These results suggest that Hesl may act downstream of 
Tbxl in development and potentially may act as a genetic modifier of DGS, (in the 
context of TBXl haploinsufficiency).
In addition to focusing on the developmental pathways downstream of Tbxl, this work 
also identified other pathways important in heart development. The analysis of DGS 
patients with atypical chromosome rearrangements has led to the identification of H1C2, 
a novel candidate gene on chromosome 22 involved in cardiovascular development and 
human disease. Examination of Hic2 gene trap mice has revealed a dose-sensitive role 
for Hic2 in heart development, strongly suggesting that H1C2 may act as a modifier of 
the DGS phenotype.
Overall, these experiments have led to the elucidation of novel genes and genetic 
pathways which may cause or modify the DGS phenotype and function in pharyngeal 
apparatus and heart development. These studies will provide the basis for future
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investigations into the molecular and developmental mechanisms which regulate these 
processes.
7.2 IDENTIFICATION OF DIRECT TBXl TARGETS
The microarray analysis of -expressing cells identified a number of potential 
downstream targets, including Hesl, but it is unclear whether these genes represent 
direct or indirect targets of Tbxl. This is important in order to define the transcriptional 
networks governing pharyngeal and heart development. The TgTbxlfloxGFP mice 
generated in this project should help to enrich for direct targets in future microarray 
experiments. Full length Tbxl expression is inducible in cells carrying this mutant 
allele, allowing control of the precise timepoint at which Tbxl is activated. Thus, 
FACS-sorted cells can be induced in culture and RNA isolated shortly after Tbxl is 
translated.
In order to distinguish direct from indirect targets identified in microarray analyses, a 
number of approaches are possible. Bioinformatic analyses could be used to identify 
putative T-half sites in the genomic sequence surrounding potential Tbxl target genes. 
Tools such as rVISTA (http://rvista.dcode.org/) and Mulan (http://mulan.dcode.org/) 
use multiple sequence alignment to identify DNA binding elements within 
evolutionarily conserved regions of the genome (Loots and Ovcharenko, 2004; 
Ovcharenko et al., 2005). These conserved regions have been shown to correlate with 
functionally important DNA sequences such as exons and regulatory elements. Thus, 
such regions are more likely to contain biologically relevant T-box binding sites 
(Elnitski et al., 2001; Gilligan et al., 2002; Loots et al., 2000; Pennacchio and Rubin, 
2001). Considering that T-box proteins interact with other transcription factors such as 
Nkx2.5 and Gata4, to synergistically regulate target genes (Naiche et al., 2005; 
Nowotschin et al., 2006; Stennard et al., 2003), the identification of T-half sites in close 
proximity to Nkx2.5 or Gata binding elements may indicate that these regions are good 
candidate binding sequences for Tbxl.
To subsequently test whether putative binding sites are functionally relevant, in vitro 
experiments such as luciferase reporter and electrophoretic mobility shift assays 
(EMSAs) could be carried out. A putative DNA regulatory element (from a potential 
Tbxl target) could be cloned upstream of a bioluminescent expression reporter, such as
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luciferase, to examine whether Tbxl binds to the site and activates transcription.
EMSAs could also be used to test whether Tbxl protein directly binds to a specific, 
putative binding sequence (Gamer and Revzin, 1981). However, these in vitro 
experiments may not accurately reflect the in vivo situation and interactions between 
Tbxl and a target gene are likely to depend on factors such as the tissue analysed and 
the presence of coactivators.
Chromatin immunoprécipitation (ChIP) experiments could be used to analyse the in 
vivo interactions between Tbxl and genomic DNA. ChIP involves using formaldehyde 
to crosslink proteins to their genomic DNA binding sites in vivo, followed by shearing 
of the chromatin into DNA fragments. Crosslinked Tbxl protein-DNA fragment 
complexes could then be immunoprecipitated using an antibody to Tbxl. The bound 
DNA fragments can be analysed in multiple ways. PCR can be used to amplify specific 
sequences (representing putative binding sites for potential target genes) to determine if 
these DNA fragments were isolated by ChIP. This relies on knowing, or predicting the 
binding site sequence in the first place. Alternatively, a more high-throughput method 
of analysing the isolated DNA fragments (which does not require prior knowledge of 
binding sites), would be to combine ChIP with a microarray, a method termed ChlP- 
chip. Following ChIP, the DNA is labelled and hybridised to a microarray containing 
genomic DNA sequences. Results from ChlP-chip could be compared to the gene 
expression microarray to determine if any identified genomic DNA binding sites for 
Tbxl occur within the vicinity of dysregulated genes. These ChIP experiments would 
be extremely helpful for identifying multiple, direct Tbxl targets. Moreover, these 
studies should help to determine whether Hesl is directly regulated by Tbxl or whether 
it functions downstream of Notch signalling.
The usefulness of ChlP-chip is limited by the genomic regions included on the 
microarray. Even whole genome oligonucleotide tiling arrays do not cover repetitive 
sequences (Kim et al., 2005; Lee et al., 2006). Therefore, recent studies have used ChIP 
followed by high-throughput sequencing in an effort to circumvent the limitations of 
microarray platforms (Bhinge et al., 2007; Johnson et al., 2007; Robertson et al., 2007; 
Wei et al., 2006). Further experiments, such as in vitro expression assays and the 
analysis of regulatory elements in transgenic animal models, will determine the 
functional effect of binding and confirm which gene the binding site regulates. 
Combining gene expression data with ChIP analysis should enable the prioritisation of
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genes, which likely act as direct downstream Tbxl targets for further functional 
analysis.
7.3 IN VIVO FUNCTIONAL ANALYSIS OF GENES
To investigate the in vivo function of Tbxl targets and their role in pharyngeal and/or 
heart development, phenotypic analysis of animal mutants is required. This could be 
rapidly achieved by using antisense morpholino oligonucleotides in zebrafish to 
knockdown gene expression. Tbxl plays a similar role in both mouse and zebrafish 
pharyngeal development, suggesting that downstream effectors important in this process 
are conserved between species. Her6 morpholino injections have already been carried 
out and demonstrate that herb, the zebrafish homologue of Hesl also functions in 
pharyngeal development. The developmental role of other Tbxl targets such as Gbx2 
and the Cyp26 genes are currently being investigated in zebrafish. Knockout mouse 
mutants should also be generated, or gene trap mouse models obtained, to investigate 
the biological function of Tbxl target genes in an organism which more closely 
resembles the human condition.
For genes proposed to act downstream of Tbxl in development, genetic interactions 
with Tbxl should also be investigated in animal models. The analysis of epistatic 
interactions with Tbxl is important not only for defining downstream genetic pathways 
but also for determining whether genes may act as genetic modifiers of DGS. Double 
morpholino injections in zebrafish have been used to investigate such epistasis in our 
lab and have already shown that tbxl and herb interact genetically in development of 
the pharyngeal arches. In mice, conventional knockouts for Tbxl and potential target 
genes could be intercrossed to examine whether they act in the same pathway during 
development. However, heterozygous and homozygous mouse phenotypes may not 
accurately reflect the human situation, being too mild or too severe, respectively. This is 
the case for Tbxl^^' and TbxT^' mouse mutants, which may make it difficult to establish 
precise epistatic interactions. The recent characterisation of a series of hypomorphic 
Tbxl alleles has demonstrated the acute dosage sensitivity of structures such as the 
PAAs to altered Tbxl levels (Zhang and Baldini, 2007). These studies have also 
demonstrated that the Tbxl^^°^^^^° hypomorphic mouse more closely resembles the 
variable OFT phenotype exhibited by human DGS patients. Therefore, hypomorphic 
Tbxl mouse mutants may be better suited for epistasis experiments, for example, to
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study the effect of Hesl mutations on the OFT phenotype. Another way to investigate 
epistasis with Tbxl involves crossing mice with conditional, floxed mouse
mutants for potential downstream genes. In this way, the complete loss of target gene 
expression from Tbxl expression domains can be analysed in the presence of 
hemizygous Tbxl expression. Conducting the above epistasis experiments with Hesl 
may reveal an interaction with Tbxl in mouse development.
During the course of this project, the chromosome 22ql 1 gene, HIC2 was identified as a 
potential modifier of the heart phenotype in DGS patients as evidenced by the presence 
of OFT alignment and ventricular septal defects in Hic2^^‘ mouse mutants. Hic2 and 
Tbxl are both expressed in the SHF at the cardiac crescent stage of mouse development 
and mouse mutants for these genes exhibit similar heart defects. Thus, it is possible that 
they may interact in heart development.
7.4 CONDITIONAL GENE INACTIVATION
The investigate the spatial and temporal role of novel pharyngeal and heart development 
genes identified during this project, conditional mouse mutants will need to be 
generated so that gene function can be knocked out or reactivated in specific tissues, at 
precise timepoints. This could be achieved by crossing conditional mouse mutants 
(expressing floxed genes) to mouse lines expressing tissue-specific and/or tamoxifen 
inducible Cre-drivers. For potential Tbxl targets, suitable Cre-lines which could be 
used include Tbxl-Cre (Huynh et al., 2007) and the tamoxifen-inducible Cre, Tbxl-mcm 
(Xu et al., 2004) as well as drivers for specific tissues where Tbxl is known to be 
functionally active, such as the pharyngeal endoderm (Foxa2-mcm) (A. Moon, pers. 
comm.), mesoderm {Mespl-Cre) (Saga et al., 1999), ectoderm (Ap2a-Cre) (Macatee et 
al 03) and the secondary heart field (Isll-Cre) (Yang et al., 2006) and {Mef2c-Cre) 
(Verzi et al., 2005). Furthermore, to investigate the role of Hic2 in the heart, 
myocardial Cre-drivers such as aMHC-Cre (Agah et al., 1997) and Nkx2.5-Cre (Moses 
et al., 2001) could be used.
These studies will help to characterise the specific roles of genes acting downstream of 
Tbxl in development and will be especially informative in the context of what is already 
known concerning the time, tissue and dose-requirements for Tbxl and the cellular 
processes which Tbxl regulates.
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7.5 MICRO ARRAY EXPERIMENTS
Further insight into the role of downstream Tbxl targets in development will require 
gene expression microarrays to be carried out for the most relevant genes, such as Hesl. 
The TgTbxlfloxGFP mice can be used to label -expressing cells in target gene 
mouse mutants so that their role, specifically in T6%7-expressing cells, can be examined. 
Hic2, a transcriptional repressor, represents a potential modifier of DGS and a novel 
gene involved in cardiovascular development. However, there is very little known 
about the transcriptional network acting downstream of Hic2. A  microarray will 
therefore, be particularly useful for characterising the role of Hic2 in heart development.
In conclusion, the genomic and transcriptomic approaches I have taken during my thesis 
work, have led to the identification of a number of novel Tbxl targets and genetic 
modifiers of DGS. The future work outlined above would allow these genes to be 
investigated to further increase our understanding of the genetic cascade regulated by 
Tbxl and to elucidate the gene network governing the DGS phenotype and pharyngeal 
and heart development.
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APPENDIX A: DYSREGULATED GENES
CD attached on the back cover includes the full list of 1553 downregulated genes 
identified in the microarray which werer downregulated to 0.83 in 5 out of 6 
Dfl/Tbxl^°^^ arrays compared to arrays. A list of the 171 upregulated genes
which were upregulated to 1.17 in 5 out of 6 Dfl/Tbxl^^^^ chips compared to Tbxl^^^^^^ 
chips, are also included.
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